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ABSTRACT 
          The ovary is the ovum-producing female reproductive organ composed of follicles at 
different stages of development. Chemicals which selectively damage large growing or antral 
follicles only temporarily interrupt reproductive function because these follicles can be 
replaced by recruitment from the greater pool of primordial follicles. However, chemicals 
that destroy oocytes contained in primordial follicles can cause permanent infertility and 
premature ovarian failure (early menopause in women), since once a primordial follicle is 
destroyed, it cannot be replaced. We hypothesized that ovotoxic chemicals can bind to DNA 
to induce DNA damage and that the ovarian cells activate DNA repair, cell cycle arrest and 
apoptosis to cause chemical-induced toxicity. Additionally, we investigated cell to cell 
communication as targets of ovotoxicants. Gap junction proteins are involved in 
folliculogenesis and we questioned whether an external factor such as ovotoxicant exposure 
and obesity alters gap junction proteins to cause follicle loss. To test this hypothesis, ovarian 
mRNA and protein expression profiles involved in DNA repair, cell cycle arrest, apoptosis 
and gap junction formation were quantified using qRT-PCR, western blotting or 
immunohistochemistry techniques after exposure to two different chemicals: Phosphoramide 
mustard (PM) and 7,12-dimethylbenz[a]anthracene (DMBA). In addition, we investigated 
the impact of PM and/or DMBA in three physiological paradigms: 1) spontaneously 
immortalized rat granulosa cells (SIGC); 2) In vitro neonatal ovarian culture system; 3) In 
vivo obese mouse model. Overall, our data demonstrates that the ovarian DNA damage 
responses are activated and up-regulated in both a dose- and time-dependent manner. Also, 
chemical exposure alters the gap junction protein expression in ovaries, interfering with 
inter-cellular communication, leading to follicular demise. Taken together, our discoveries 
xii 
  
 
detailed herein shed new mechanistic light on the events that precipitate ovarian follicle 
depletion leading to female infertility, and potential targets for prevention of chemical-
induced infertility are described. 
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ORGANIZATION OF THE DISSERTATION 
          This dissertation is organized into 9 chapters and an appendix. Chapter 1 is the general 
introduction to the research. In Chapter 2, we hypothesized that DMBA induces DNA double 
strand breaks and that the ovary activates repair mechanisms to protect the gamete against 
DMBA-induced DNA damage, leading to follicle loss. Our results demonstrated that DMBA 
induces ovarian DNA damage and those DNA repair mechanisms are induced as a potential 
mechanism to prevent follicle depletion, thus confirming our hypothesis. Chapter 3 focuses 
on the impact of obesity on the ovarian response to DMBA exposure in mice. Since obesity 
is associated with increased incidence of offspring birth defects, we hypothesized that a 
DMBA-induced DNA damage repair response might be compromised in ovarian tissue from 
obese females. This study showed that DMBA exposure induced DNA damage as well as the 
ovarian DNA repair response, further supporting that DMBA causes ovarian DNA damage as 
an ovotoxic insult in an in vivo model. Additionally, the ovarian DNA repair response was 
partially attenuated in obese females raising concern that obesity may be an additive factor 
during chemical-induced ovotoxicity. Chapter 4 describes the impact of chemical exposure 
on the gap junction (GJ) connexin (CX) protein in neonatal cultured rat ovaries. We 
hypothesized that GJ protein level might be altered by DMBA exposure during follicle loss, 
contributing to loss of follicular viability. We found that DMBA exposure impacts ovarian 
CX protein prior to and at the time of follicle loss. It is possible that such interference in 
follicular cell communication is detrimental to follicle viability, and may play a role in 
DMBA-induced follicular atresia. Chapter 5 details the impact of obesity on ovarian CX GJ 
proteins during DMBA exposure in a murine in vivo model. Since DMBA and obesity altered 
GJ protein expression in extra ovarian tissues, this study investigated both the impact of 
xiv 
  
 
obesity and DMBA exposure on ovarian CX protein levels using the lethal yellow mouse 
model of progressive obesity. This study showed that that obesity temporally alters GJ 
protein abundance and that DMBA-induced ovotoxicity may involve reduced GJ protein 
function. Chapter 6 describes our work to identify PM-induced DNA adduct formation and 
activation of the DNA damage repair response in rat ovarian granulosa cells. PM was found 
to form DNA adduct in ovarian granulosa cells to induce DNA damage and elicit the ovarian 
DNA repair response. Chapter 7 investigated on signaling mechanisms of PM-induced 
ovarian follicle loss, and demonstrated that PM-induced follicle loss may occur through an 
E2F1-P73 dependent mitochondrial apoptotic pathway. Additionally results from protein 
kinase C (PKCδ) deficient mice indicated that PKCδ is essential for survival of ovarian 
follicles, but that no additional impact of PM was found in these mice. ATM can act as a pro-
apoptotic factor at the time of PM-induced follicle loss and ATM inhibition improve the 
survival of ovarian follicles. In Chapter 8, we hypothesized that obesity might alter PM-
induced DNA repair mechanism in ovaries. Our data indicate that PM induces ovarian DNA 
damage in in vivo model as a mode of ovotoxicity and that the ovary is responsive to such an 
insult and activates the DNA repair response. Additionally, and of concern, obesity altered 
the ovarian response to an ovotoxic exposure. Chapter 9 presents the general conclusion for 
all these studies. In the appendix, some results which were not included in the manuscripts 
prepared for publication to date are summarized. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
The Ovary 
          The female reproductive system is comprised of ovaries, fallopian tubes, uterus, 
vagina, vulva, mammary glands and breasts. These organs are essential for the production 
and transportation of gametes and the production of sex hormones. Also, the female 
reproductive system facilitates the fertilization of ova by sperm and supports the 
development of offspring during pregnancy.   
          The ovaries are a pair of small glands located on the left and right sides of the pelvic 
body cavity lateral to the superior portion of the uterus. The ovary produces female sex 
hormones such as estrogen and progesterone as well as ova (commonly called "eggs"), the 
female gamete. The ovary contains two important endocrine glands: the follicle and the 
corpus luteum. The dominant follicle(s) is essential for the production of estrogens which 
controls the development of the mammary glands and uterus during puberty and stimulates 
the development of the uterine lining during the menstrual cycle. The corpus luteum is 
derived from follicular tissue following ovulation and required for progesterone production 
which acts on the uterus during pregnancy to allow the embryo to implant and develop in the 
womb.  
 
Follicular Development 
          Folliculogenesis describes the progression of primordial follicles into large pre-
ovulatory follicles, in which the oocyte is maintained in meiosis I of oogenesis. The follicles 
containing germ cells, or oocytes, develop from primordial germ cell (PGC) populations 
which are established during the embryonic period and are motile and invasive (Witschi, 
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1948). The somatic components of the follicles (granulosa, theca, endothelial cells and 
connective tissue) are derived from the embryonic indifferent gonad (Yoshinaga et al., 1988; 
Hirshfield, 1991). After germ cells invade the indifferent gonad, both cell types undergo 
extensive hyperplasia. The germ cells lose their motile characteristics and proliferate rapidly 
for 15-16 h in mouse to form 85,000 germ cells (Tam and Snow, 1981; Wylie et al., 1986). 
There are approximately 75,000 germ cells in rat ovary (Beaumont and Mandl, 1963). While 
the germ cells are undergoing mitosis, the somatic cells of the gonad proliferate rapidly also 
(Hirshfield, 1991).  
          The somatic cells continue to proliferate throughout the embryonic period, gradually 
enveloping individual oocytes and forming primordial follicles. Each primordial follicle 
consists of a single oocyte surrounded by a few flattened somatic cells, referred to as “pre-
granulosa cells” (Gondos, 1970). The time of appearance of the first primordial follicles in 
rats are the first day postpartum and in mice the second day postpartum (Ueno et al., 1989).  
After formation of primordial follicles, pre-granulosa cells cease to divide and enter a period 
of quiescence and the oocytes remain arrested in the first meiotic prophase. In rats, the 
primordial follicle contains approximately 4 granulosa cells in its gross section (Hirshfield 
and Schmidt, 1987). The first sign of growth is the resumption of cell proliferation by 
squamous granulosa cells and later stages of growth can be recognized by an increase in the 
size of the oocyte and a change in shape and number of the granulosa cells (Lintern-Moore 
and Moore, 1979). Primordial follicles provide the pool for recruitment of developing 
follicles; therefore, they are a fundamental reproductive unit within the ovary. Some 
primordial follicles leave the quiescent state relatively quickly after they are formed, and 
some are dormant for months or years. The process by which primordial follicle activation 
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occurs is called “initial recruitment” which is mediated by the counterbalance of various 
stimulatory and inhibitory hormones and locally produced growth factors (Fortune et al., 
2000). 
          The first sign of oocyte growth in primordial follicles is alteration of the surrounding 
squamous (flattened) granulosa cells into cuboidal-shaped cells which are around 8 granulosa 
cells in its gross section in the primary follicular stage (Hirshfield, 1991). The oocyte genome 
is activated and genes become transcribed. Rudimentary paracrine signaling pathways that 
are vital for communication between the granulosa cell and oocyte are formed (Gilchrist et 
al., 2008). Both the oocyte and the follicle grow dramatically, increasing to almost 100 µm in 
diameter. Once the follicle makes this transition from primordial to primary, other structural 
changes occur such as development of the zona pellucida and acquisition of the theca layer 
(Hirshfield, 1991). The zona pellucida is a glycoprotein polymer capsule which forms around 
the oocyte, separating it from the surrounding granulosa cells to provide protection for the 
oocyte as well as to provide attachments for the specialized inner layer of granulosa cells, 
known as “cumulus cells” (Richards, 1980; Hirshfield, 1991). At this stage, another layer of 
specialized somatic cells begin to proliferate and form a shell outside the basement 
membrane enclosing the oocyte and granulosa cell layer. These cells appear in concentric 
rings surrounding the follicle and are designated theca interna cells (Peters, 1969). Theca 
cells provide two important functions: (1) attachment of arterioles for the development of an 
independent blood supply and (2) secretion of progestins and androgens to regulate follicle 
development (Hirshfield, 1991). The zona pellucida, which remains with the oocyte after 
ovulation, contains enzymes that catalyze with sperm to allow penetration. Primary follicles 
are remaining gonadotropin-independent until the antral stage. 
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          The oocyte contained in a secondary follicle has a large, spherical nucleus (germinal 
vesicle) that grows in proportion to the growth of the oocyte and the follicular cells continue 
to proliferate and form a second layer around the oocyte. The layers of granulosa cells 
surrounding the oocyte increase rapidly to reach follicular diameters of up to 250 μM. Gap 
junctions (GJ) are formed between individual cells in the granulosa cell layer to facilitate 
intercellular transport of nutrients and metabolites to the oocyte (Goodenough et al., 1996).  
A rise in pituitary FSH caused by the disintegration of the corpus luteum from the previous 
follicular cycle, precipitates the selection of follicles. The selected follicles, called antral 
follicles, compete for growth-inducing FSH. At that point an antrum begins to form within 
the granulosa cell layer and this fluid-filled cavity enlarges as the final stages of follicular 
development are reached (Shalgi et al., 1973). The number of follicles that reach the antral 
stage is quite small. In response to the rise of circulating FSH, the antral follicles begin to 
secrete estrogen and inhibin, which have a negative feedback effect on FSH (De Ziegler et 
al., 2007). Follicles that have fewer FSH-receptors will not be able to develop further; they 
will show retardation of their growth rate and become atretic. Collectively, primordial, 
primary and secondary follicles are less than 250 μm in diameter and are referred to as pre-
antral follicles. Eventually, only one follicle will be viable and this remaining follicle, called 
the dominant follicle (mono bearing species), will grow quickly and dramatically up to 20 
mm in diameter to become the pre-ovulatory follicle. In the pre-ovulatory follicle, the basic 
structure of the mature follicle remains unchanged and no novel cells are detectable. 
Granulosa and theca cells continue to undergo mitosis concomitant with an increase in 
antrum volume. Pre-ovulatory follicles can attain a tremendous size that is hampered only by 
the availability of FSH, thus, it is now dependent on gonadotrophins (Farmer et al., 2005).  
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Under action of an oocyte-secreted morphogenic gradient, the granulosa cells of the tertiary 
follicle undergo differentiation into four distinct subtypes: corona radiata, surrounding the 
zona pellucida; membrana, interior to the basal lamina; peri-antral, adjacent to the antrum 
and cumulus oophorous, which connects the membrana and corona radiata granulosa cells 
together. Theca cells express receptors for luteinizing hormone (LH) which induces the 
production of androgens by the theca cells, most notably androstenedione, which are 
aromatized within granulosa cells to produce estrogens, primarily estradiol (Richards et al., 
1976; Richards, 1980). In humans, 1-2 pre-ovulatory follicles develop approximately every 
28 days, whereas, in rats, 6-12 follicles develop every 4-5 days (Richards, 1980). By the end 
of antral stage, however 99.9% of antral follicles will have undergone atresia (Barnett et al., 
2006) (Figure 1). 
          By the end of the follicular, or proliferative, phase of the menstrual cycle, the cumulus 
oophorus layer of the pre-ovulatory follicle will develop an opening, or stigma, and expulse 
the oocyte with a complement of cumulus cells in a process called ovulation (Niswender et 
al., 1972). The oocyte is now called the ovum and is competent to undergo fertilization. The 
ovum will now travel down one of the fallopian tubes to eventually be discharged through 
menstruation, if not fertilized by a sperm cell, or implanted in the uterus, if fertilized. The 
fully developed oocyte (gamete) is now at the behest of the menstrual cycle. The corpus 
luteum develops from an ovarian follicle during the luteal phase of the menstrual cycle or 
estrous cycle, following the release of a secondary oocyte from the follicle during ovulation 
(Mackenzie, 1922; Parkes, 1928). While the oocyte (later the zygote if fertilization occurs) 
traverses the fallopian tube into the uterus, the corpus luteum remains in the ovary. The 
corpus luteum is typically very large relative to the size of the ovary; in humans, the size of 
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the structure ranges from under 2 cm to 5 cm in diameter. The development of the corpus 
luteum is accompanied by an increase in the level of the steroidogenic enzyme cytochrome 
P450scc that converts cholesterol to pregnenolone in the mitochondria (Rapoport et al., 
1998). Pregnenolone is then converted to progesterone that is secreted out of the cell and into 
the blood stream and it is essential for maintenance of pregnancy. 
           Throughout the reproductive life span of a female, the total number of primordial 
follicles selected to develop for ovulation is small compared to the total population. Instead, 
the vast majority are lost to attrition in various stages of development by a process called 
atresia. This process of follicle death is characterized by radical apoptosis of all constituent 
cells and the oocyte. Although it is not known what causes atresia, the presence of high 
concentrations of FSH has been shown to prevent it (Peluso and Steger, 1978). The ovarian 
content of oocytes is dynamic and fluctuates with age and it reaches peaks during embryonic 
development. In humans, the peak number of oocytes ever present, about seven million, 
occurs at five months gestation, at birth the number has dropped to two million, 250,000-
400,000 at puberty, and no functional oocytes remain at menopause (Hirshfield, 1991).  
During the lifetime of a woman, ovulation only accounts for 400–600 oocytes. Therefore, of 
the primordial follicles a female is born with, greater than 99 % will be lost by atresia at 
various stages of development.     
       
Gap Junction Proteins 
           A gap junction (GJ) or nexus is a specialized membrane domains (White and Paul, 
1999), composed of collections of channels that directly connect the cytoplasm of two cells 
and allows various molecules, amino acids, nucleotides, and second messengers and ions to 
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pass freely between cells (Pitts and Simms, 1977; Lampe and Lau, 2000; Lampe and Lau, 
2004).   
GJ channels are oligomeric structures made up of connexin (CX) subunits (Beyer and 
Berthoud, 2009).  CX’s are four-pass transmembrane proteins with both C and N cytoplasmic 
termini, a cytoplasmic loop (CL) and two extra-cellular loops, (EL-1) and (EL-2) (Tripathi 
and Tripathi, 2010) (Figure 2).  CX’s are assembled in groups of six to form hemichannels, 
or connexons, and two hemichannels then combine to form a GJ (Beyer et al., 2013) (Figure 
3). The Cx gene family is diverse, with twenty-one identified members in the sequenced 
human genome, and twenty in the mouse (nineteen of which are orthologous pairs). They 
usually weigh between 26 and 60 kDa, and have an average length of 380 amino acids. The 
various CXs have been observed to combine into both homomeric and heteromeric GJ, each 
of which may exhibit different functional properties including pore conductance, size 
selectivity, charge selectivity, voltage gating, and chemical gating (Saez, 2003; Harris, 2007).  
Several GJ channels (hundreds) assemble within a macromolecular complex called a GJ 
plaque (Spray and Scemes, 2013). GJs are involved in the regulation of cellular growth, 
metabolism, differentiation (Sohl and Willecke, 2003; Wei et al., 2004) and ovarian 
folliculogenesis (Simon et al., 1997). Granulosa:granulosa and granulosa:oocyte cell to cell 
communication are necessary for maintenance of follicular viability. Oocyte growth and 
development depends on upon the supply of nutrients transmitted from follicle cells via GJ’s. 
Interconnection by GJ’s was observed between the innermost layer of cumulus and the 
oocyte, between the adjacent cumulus cells, between the granulosa cells and also between 
cumulus and granulosa cells (Dekel, 1987). In the mouse genome, nearly 20 Cx genes have 
been identified and at least five members of the CX family are localized to the rodent ovarian 
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follicle: CX26, CX32, CX37, CX43, and CX45 (Kidder and Mhawi, 2002). The most 
abundant gap junction proteins expressed in the mice ovaries are CX37, CX43 and CX45 
(Simon et al., 1997; Ackert et al., 2001; Wright et al., 2001). 
          The most abundant GJ protein in granulosa cells is CX43 and its expression is elevated 
as follicle size increases in response to FSH (Beyer et al., 1989; Valdimarsson et al., 1993; 
Okuma et al., 1996). In addition to granulosa cells, CX43 has been noted in rat oocytes 
(Granot et al., 2002).  C57BL/6 mice lacking CX43 exhibit follicular developmental arrest at 
the primary follicle stage, indicating a failure of granulosa cells to proliferate (Ackert et al., 
2001). WNT4 signaling is necessary during maturation of the ovarian follicles and Wnt4 
knockout mice had found reduced (30%) expression of CX43 compared to that of controls 
(Prunskaite-Hyyryläinen et al., 2014). The WNT2/CTNNB1 pathway regulates CX43 
expression and GJ intracellular communication in granulosa cells by modulating CTNNB1 
stability and localization in adherens junctions. Furthermore, Ctnnb1 knockdown interfered 
with the ability of FSH to promote mobilization of CX43 into GJ’s (Wang et al., 2013). FSH 
induces the development of the clock system by increasing the abundance of CX43 in rat 
granulosa cells (Chen et al., 2013). High levels of androgen reduce CX43 abundance and 
impair GJ intercellular communication between human granulosa cells through androgen 
receptors (Wu et al., 2010a). Cx43 and Cx45 transcripts were judged too static to be a 
regulator of GJC, while CX43 protein expression was highly responsive to gonadotropins, 
suggesting that it might be the principal regulator of GJ communication (GJC) (Santiquet et 
al., 2013). CX43 was decreased in association with atresia supporting the concept that loss of 
GJC plays a coordinating role in the process of atresia (Feranil et al., 2005). CX43 levels are 
increased in granulosa cells following activation of follicular growth and maturation (Melton 
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et al., 2001), while reduced granulosa cell expression of CX43 is linked to elevated apoptosis 
in porcine, bovine (Johnson et al., 1999; Cheng et al., 2005) and avian (Krysko et al., 2004) 
species. CX45 has also been identified as a component of GJs between granulosa cells, where 
it co-localizes with CX43 in some plaques (Okuma et al., 1996; Kidder and Mhawi, 2002).  
           Heterocellular GJs between oocytes and granulosa cells contain CX37, and there is 
evidence that CX37 is expressed both by the oocyte and by the adjacent granulosa cells 
(Simon et al., 1997).  CX37 is thought to be involved in follicular development and ovulation 
as well as luteal tissue growth, differentiation, and regression (Borowczyk et al., 2006).  
Ablation of Cx37 in mice results in the loss of oocyte-granulosa cell dye-transfer and the 
failure of follicle to progress to the antral stage. In addition, oocytes in the follicles of these 
mice are small and fail to reach meiotic competence, and follicles as a whole undergo 
premature luteinization (Simon et al., 1997; Carabatsos et al., 2000). Both follicle 
development and oocyte maturation were impaired in ovaries containing either wild-type 
oocytes and Cx43-deficient granulosa cells or Cx37-deficient oocytes and wild-type 
granulosa cells (Gittens and Kidder, 2005). After cryopreservation and subcutaneous 
transplantation of ovarian tissue, proteins forming GJ between oocytes and granulosa cells 
are under-expressed compared with normal controls (Lee et al., 2008). Also, continuous 
activation of FOXO3a in oocytes caused a dramatic reduction in the expression of bone 
morphogenic protein 15 (BMP15), CX37 and CX43, all of which contribute to the 
establishment of paracrine and GJC in follicles (Liu et al., 2007). These studies indicate that 
at least three CXs: CX43, CX45 and CX37, are necessary for normal folliculogenesis. 
          CXs are also targets for a number of chemicals including retinoids, carotinoids 
chemotherapy (King and Bertram, 2005), cigarette smoke components (McKarns et al., 
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2000) and poly aromatic hydrocarbons (PAH) like benzo/a/pyrene (BaP), benzo/e/pyrene 
(BeP), benz/a/anthracene (BA), dibenz/ah/anthracene (DBahA), 3-methylcholanthrene (3-
MC), phenanthrene (PA) (Sharovskaya et al., 2006). In utero flutamide exposure reduces 
Cx43 mRNA and protein expression during the rat embryonic period (Cai et al., 2014). 
Oocyte-directed depletion of Cx43 using the Cre-LoxP system leads to subfertility in female 
mice (Gershon et al., 2008). Lindane suppresses FSH and transforming growth factor beta-
induced CX43 GJ formation and steroidogenesis in rat granulosa cells (Ke et al., 2005). CXs 
are also altered in mesenteric arteries of insulin resistant obese rat (Young et al., 2008). A 
high fat diet reduces the CX expression in the heart tissue of female rats which increase the 
risk of ventricular arrhythmia (Aubin et al., 2010). These studies indicate that GJ proteins are 
not only altered by chemicals but also potentially by obesity.  
 
Obesity 
          Obesity is a health issue of epidemic proportions worldwide and in the Unites States. 
In 2008, it was estimated that up to 10% of all medical spending in the United States was 
attributed to the medical burden of obesity (Finkelstein et al., 2009). Obesity is a particularly 
important concern in the health of women because 64.1% of women in the United States 
(Flegal Km et al., 2010) and 30% of reproductive age women are obese or overweight 
(Boney et al., 2005). Obesity is associated with menstrual cycle disturbances, ovulatory 
dysfunction, infertility, decreased conception, early pregnancy loss and congenital 
abnormalities (Cardozo et al., 2012; Sauber-Schatz et al., 2012). These reproductive sequelae 
result from the effects of obesity on a number of different steps in the reproductive process, 
including ovarian follicular recruitment, oocyte development and quality, oocyte fertilization, 
11 
  
 
and embryo development and implantation (Jungheim et al., 2013). Epidemiologic 
investigation of obesity and time to pregnancy demonstrated that the time to spontaneous 
pregnancy was increased among obese women including those experiencing regular 
ovulation (Gesink Law et al., 2007). Obese women (OW) undergoing treatment with assisted 
reproductive technology (ART) require significantly higher doses of gonadotropin than 
normal-weight women (NWW) to produce a similar number of ovarian follicles during 
controlled ovarian hyperstimulation (Jungheim and Moley, 2010).  
          Mature oocytes from OW are less likely to be fertilized than oocytes from NWW, 
suggesting that oocytes from OW are of poorer quality (Shah et al., 2011). Compared with 
NWW, OW are less likely to achieve a clinical pregnancy after in vitro fertilization (IVF) 
(Jungheim et al., 2009), are at higher risk of miscarriage after an ART conception 
(Rittenberg et al., 2011a; Rittenberg et al., 2011b) and are less likely to achieve a live birth 
after IVF (Luke et al., 2011). These findings may be attributable to poor embryo quality 
among OW (Metwally et al., 2007). Lipotoxicity is a mechanism by which obesity may 
impact oocyte quality (Wu et al., 2011) and induces DNA damage in obese men (Dupont et 
al., 2013b) further contributing to infertility. Women with normal weight and body mass 
index, but high fat mass (> 30%) designated as normal-weight obese syndrome (NWO) (Di 
Renzo et al., 2006), in which the concentration of plasma pro-inflammatory cytokines and 
oxidative stress markers are higher than in non-obese women (Di Renzo et al., 2010). Alkali 
labile sites were higher in obese women compared to NWO and 8-oxo-dG level was also 
slightly higher in NWO (Tomasello et al., 2011). Maternal obesity also has adverse effects as 
early as the oocyte and pre-implantation embryo stage which may contribute to lasting 
morbidity in their offspring (Jungheim et al., 2010). Understanding obesity and its impacts 
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on female reproductive function is important because future generations, namely, the 
children of obese women, ultimately will be affected.  
           High body mass index has also been associated with increased risk for various cancers 
induced by 7,12-dimethylbenz[a]anthracene (DMBA) exposure, including breast cancer in 
female zucker rats (Hakkak et al., 2005). Brca1 and Brca2, down-regulated in human breast 
cancer cells by DNA damaging agent (Andres et al., 1998), are crucial members of the ATM-
mediated DSB repair family of genes and mutation in these genes are associated with 
increased risk of ovarian, breast and other cancers (Robson et al., 1998; Kauff et al., 2002).  
Women who carry germ line mutations in the Brca1 gene, show low response to ovarian 
stimulation while undergoing fertility preservation by oocyte or embryo cryopreservation 
(Oktay et al., 2010). Recent research also suggests that women with Brca1 mutations may 
experience earlier menopause (Rzepka-Górska et al., 2006). Impairment of DNA DSB repair 
was associated with accelerated loss of ovarian follicular reserve and accumulation of DSB 
in human oocytes which also implicate DNA DSB repair efficiency as an important 
determinant of oocyte aging in women (Titus et al., 2013).  
 
Ovarian Toxicity 
Published in the book Ovarian Toxicology as a subsection of 
Chapter 2: Ovarian Metabolism of Xenobiotics, 2013, p15-38 
(p12-20 in the introduction) 
(S. Ganesan, J.A. Madden and Aileen F. Keating) 
 
          The stage of development at which the follicle is targeted by an ovotoxicant 
determines the impact of chemical exposure on reproduction (Hoyer and Sipes, 1996).  
Damage to large growing or antral follicles can cause a disruption of cyclicity by impacting 
ovarian steroid production and ovulation. Chemicals which selectively damage large growing 
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or antral follicles may only temporarily interrupt reproductive function because these 
follicles can be replaced by recruitment from the greater pool of primordial follicles. If an 
ovotoxic chemical destroys oocytes of primordial follicles, which can cause permanent 
infertility and premature ovarian failure will ensure, since once a primordial follicle is 
destroyed, it cannot be replaced. Destruction of oocytes contained in primordial follicles may 
have a delayed effect on reproduction until such a time that recruitment for the number of 
growing and antral follicles can no longer be supported (Generoso et al., 1971; Hooser, 
1994). Ultimately, if the ovary is depleted of primordial follicles, ovarian failure occurs, 
defines as cessation of ovarian cyclicity. The average age of menopause in the United States 
is 51, and is a direct consequence of depletion of the follicular reserve. Menopause has been 
associated with a variety of health problems in women. These include increased incidences of 
osteoporosis, cardiovascular disease, depression and Alzheimer’s disease (Avioli, 1981; 
Paganini-Hill and Henderson, 1994; Sowers and La Pietra, 1995). Additionally, in laboratory 
animals, premature ovarian failure is associated with an increased incidence of ovarian 
neoplasms (Hoyer and Sipes, 1996) (Figure 4). A variety of environmental factors have been 
highly correlated with early menopause in women (Everson et al., 1986; Cooper et al., 1995).  
Therefore, as a woman ages, her overall health is affected by the onset of menopause, and 
this can be further impacted by environmental factors to which she has been exposed (Hoyer 
and Sipes, 1996). A number of chemical classes can deplete ovarian follicles and altered 
steroidogenesis, leading to impaired ovarian funtion and infertility, including but not limited 
to environmental, industrial, chemotherapeutic and xenoestrogenic chemicals (Hoyer and 
Sipes, 1996). 
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          Chemotherapy for cancer treatment uses chemical substances in single or combined 
form to cure the cancer, prolong the life or to reduce the symptoms. For many childhood 
cancers, the 5-year survival rate is now 70% with survival rates in adult cancers also 
increasing (Thomson et al., 2002). The most common malignancy in adult women is breast 
cancer, affecting one in nine women, with an estimated 25% of these women bring pre-
menopausal at diagnosis (Stearns et al., 2006). Given this success, clinical concern in good-
prognosis malignancies can now also focus on the long-term adverse effects of 
chemotherapy. The main reproductive side effects associated with chemotherapy in female 
survivors include early menopause and an increased infertility rate in women who maintain 
ovarian activity after chemotherapy (Letourneau et al., 2012). The offspring of treated 
individuals can potentially also be affected by early embryonic mortality through oocyte 
chromosomal aberration (Gonfloni et al., 2009). Studies have shown that exposure to 
chemotherapy drugs such as alkylating or DNA damaging agents cause rapid amenorrhea, 
likely from antral follicle destruction or premature ovarian failure, from primordial follicle 
depletion (Brunner et al., 2006; Chemaitilly et al., 2006; Manger et al., 2006). Female 
infertility by chemotherapy appears to be secondary to premature ovarian failure by loss of 
primordial follicles but this is not necessarily a direct effect of the chemotherapeutic agents. 
Instead, the disappearance of primordial follicles could be due to increased rate of growth 
initiation to replace damaged developing follicles (Keating et al., 2009; Morgan et al., 2012).  
Likewise, the loss of oocytes need not necessarily be a direct result of damage: evidence 
suggests that chemotherapy drugs can also induce oocyte death indirectly via damage to 
somatic cells (Morgan et al., 2012) (Figure 5).  
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          Cyclophosphamide (CPA) is chemotherapeutic drug used to treat cancer and 
autoimmune diseases in human. In cancer patients, CPA can induce rapid amenorrhea, likely 
from antral follicle destruction or premature ovarian failure, from primordial follicle 
depletion (Brunner et al., 2006; Chemaitilly et al., 2006; Manger et al., 2006; Hudson, 2010). 
CPA significantly reduced the number of primordial and antral follicles in C57BL/6N and 
DBA/2N mice and in Sprague-Dawley (SD) rats (Shiromizu et al., 1984; Plowchalk and 
Mattison, 1991). Mice treated with CPA in low doses for 1 year found reduced numbers of 
oocytes (especially primordial) and corpora lutea with no effect on other tissues such as the 
kidney, spleen, thymus or lymph nodes (Miller and Cole, 1970). Estrous cyclicity was 
destroyed and cysts/tumors were observed in the ovarian germinal epithelium. CPA 
destroyed primordial follicles but left larger follicles intact in Balb/c mice (Meirow et al., 
1999). Also time- and dose-dependent relationship between CPA and ovarian toxicity was 
observed by looking at changes in ovarian structure and function (Plowchalk and Mattison, 
1992). In C57BL/6N mice given a single i.p. injection of CPA (75, 200, or 500 mg/kg), 
primordial follicle numbers were significantly reduced to 73, 42 and 38 percent of controls, 
respectively. The loss of primordial follicles was essentially complete in three days, and the 
estimated ED50 (concentration that produced 50 percent follicle loss) was 122 mg/kg body 
weight (Plowchalk and Mattison, 1992).  From these results it appears that premature ovarian 
failure in women treated with CPA is likely to be via destruction of primordial follicles. 
Interestingly, in a rat study, it was shown that a single injection of CPA caused damage to 
growing and antral follicles, but spared an effect on primordial follicles, because cyclicity 
was disrupted within a week, but had been restored 2 weeks post-exposure (Jarrell et al., 
1991). Therefore, the impact of CPA on ovarian follicles may be species dependent. 
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          The integrity of the genome in gametes is critical for the health of offspring. If 
alterations in DNA of primordial follicles linger in surviving follicles, these changes may be 
able to remain for decades. Such changes in gamete health could be a mechanism by which 
exposures lead to detrimental changes in offspring. Evidence for this was observed as an 
increase in malformations in mice exposed once to CPA (Meirow and Nugent, 2001), 
although existing clinical and epidemiological studies do not show a higher incidence of birth 
defects in children of women given chemotherapy and/or radiation (Meirow and Nugent, 
2001; Sklar et al., 2006; Hudson, 2010). This remains, however, is a major concern for 
women wishing to have children subsequent to cancer treatments (Signorello et al., 2006). 
          CPA is a precursor for the active form of the drug and must be bioactivated to exert its 
functional activity (Brock, 1976). The active metabolites include 4-hydroxy-CPA, 
aldophosphamide and phosphoramide mustard (PM), which is thought to be the active 
anticancer agent (Boddy and Ratain, 1997; Boddy and Yule, 2000). Although the 
mechanisms underlying the cytotoxic and teratogenic properties of CPA are not completely 
understood, it is generally believed that CPA-induced toxicity is related to the induction of 
DNA-DNA interstrand cross-links by PM (Brookes and Lawley, 1961).  The initial reaction 
leading to the formation of DNA-DNA cross-links is alkylation at the N-7 position of 
guanine. This initial PM-DNA adduct is relatively unstable and converted to the 
corresponding nor-nitrogen mustard adducts, one of which is the N, N-bis [2-(N7-guaninyl) 
ethyl] amine (G-NOR-G) cross links (Hemminki, 1985). Tentative evidence, based upon 
alkaline elution studies, suggests that DNA cross-links are responsible for the embryo toxic 
effects of CPA (Little and Mirkes, 1987). The study reported that not only the G-NOR-G 
adduct but also the mono adducts NOR-G and N-[2-(N7-guaninyl) ethyl]-N-[2-
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hydroxyethyl]-amine (NOR-G-OH) were formed in calf thymus DNA alkylated in vitro with 
PM using tandem mass spectrometric parent ion scanning (Cushnir et al., 1990).  
          Previous studies reported that ∼90% of CPA-induced DNA lesions were guanine 
mono adducts (Hemminki, 1985; Souliotis et al., 2003) and that the emergence of such 
adducts correlated with the onset of cytotoxicity (Benson et al., 1988). However, 1,3-
interstrand G-NOR-G lesions are also thought to play a central role in the cytotoxic response 
because they prevent DNA strand separation which is required for DNA replication and 
transcription (Rajski and Williams, 2000; Souliotis et al., 2003). Therefore, G-NOR-G 
lesions are considered the primary cytotoxic adducts responsible for the antineoplastic 
activity of CPA in vivo (Hemminki, 1985; Benson et al., 1988). PM destroys rapidly dividing 
cells including cancer cells by covalently binding to DNA, inducing DNA-DNA, DNA-
protein cross links and DNA double strand breaks (DSB) (Helleday et al., 2008; Johnson et 
al., 2011) (Figure 6). 
          PM is also thought to be responsible for the ovarian follicle destruction caused by CPA 
(Plowchalk and Mattison, 1991; Anderson et al., 1995; Desmeules and Devine, 2006; Petrillo 
et al., 2011). The ovary does not appear to bioactivate CPA, rather CPA bioactivation is 
thought to occur in the liver by cytochrome P450 enzymes with uptake of the reactive 
metabolites from the blood (Anderson et al., 1995; Colvin, 1999). PM is the ultimate 
ovotoxicant of CPA (Plowchalk and Mattison, 1991) in that it can, with only a brief 
exposure, induce rapid loss of dormant and small preantral follicles at concentrations relevant 
to those found in the blood of human patients (Struck et al., 1987). The cellular target of PM 
appears to depend on the follicle type, with oocytes being affected in smaller follicles and 
granulosa cells being predominantly affected in larger growing follicles (Desmeules and 
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Devine, 2006). PM causes dose- and time-dependent primordial and primary ovarian follicle 
loss in mice and rat oocytes (Petrillo et al., 2011). Also, an in vitro study demonstrating that 
a volatile compound can induce primordial follicle loss suggests this breakdown product may 
be also toxic to the ovary (Madden et al., 2014). Flowers et al. (2000) provided strong 
evidence that this chemical is chloroethylaziridine (CEZ) presented in cultured human breast 
tumor cell lines MCF-7wt (wild type) and MCF-7hc (4-HC resistant subline). Such effects 
suggest that CEZ could contribute significantly to CPA-induced ovarian toxicity in vivo, 
since concentrations in those wells in vitro are likely much less than that of PM in wells (i.e., 
<10 µM). CEZ is volatile as well as cytotoxic and is liberated through alkylation reactions 
with nucleophiles and P-N bond hydrolysis from PM (Shulman-Roskes et al., 1998). The 
generated CEZ was very stable in the culture medium with a degradation half-life of 265 h. 
The distribution of products from PM as well as the lifetime of CEZ itself is very dependent 
upon the nature and concentration of nucleophiles in solution (Shulman-Roskes et al., 1998).  
Nevertheless, CEZ must be considered an alternative (or additional) source of ovarian 
toxicity (Flowers et al., 2000; Madden et al., 2014).  
          Polycyclic aromatic hydrocarbons (PAHs) are atmospheric pollutants that consist of 
fused aromatic rings, and human exposure arises from byproducts of organic matter burning.  
PAH’s have carcinogenic, mutagenic and teratogenic effects (Shimada, 2006). DMBA is a 
PAH liberated from burning of organic matter, cigarette smoke and car exhaust fumes. 
Cigarette smoking accelerates entry of females into the post-menopausal physiological state 
(Jick and Porter, 1977) and contains high level of the PAH’s DMBA, BaP and 3-MC 
(Mattison et al., 1983). In vivo exposure of mice and rats has demonstrated that DMBA 
depletes primordial follicles (Mattison and Schulman, 1980; Borman et al., 2000) and 
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induces ovarian tumor formation (Krarup, 1967; Krarup, 1969). Mice treated with DMBA 
(80 mg/kg) also showed signs of necrosis in primordial follicles (Mattison and Nightingale, 
1980). DMBA destroys all ovarian follicle types in mice and rats in a dose-dependent manner 
(Matikainen et al., 2001; Rajapaksa et al., 2007; Igawa et al., 2009), and follicle destruction 
is initiated by oocyte loss followed by somatic cell apoptosis (Morita and Tilly, 1999). Due 
to the loss of all follicle types, a reduction in ovarian volume typically occurs (Mattison and 
Schulman, 1980; Weitzman et al., 1992). DMBA causes apoptosis in granulosa and theca 
cells of pre-ovulatory follicles through increased expression of pro-apoptotic BAX and 
activation of the executioner protein caspase 3 (CASP3) (Tsai-Turton et al., 2007). PAH’s 
require metabolism to produce reactive ovotoxic metabolites (Mattison et al., 1983) that bind 
to cellular macromolecules including DNA, RNA and protein (Sims and Grover, 1974). In 
hepatic tissue, DMBA undergoes extensive metabolism to form bioactive metabolites 
(Bengtsson et al., 1983).  The metabolism pathway begins with DMBA oxidation to DMBA-
3,4-diol by CYP 1B1 and hydrolysis by microsomal epoxide hydrolase (mEH). The 3,4-diol 
metabolite undergoes further epoxidation by CYP1A1 and CYP1B1 to form the ultimate 
ovotoxicant and  carcinogen, DMBA-3,4-diol-1,2 epoxide (Miyata et al., 1999; Kleiner et al., 
2004; Shimada and Fujii-Kuriyama, 2004) (Figure 7). Utilizing a whole ovary culture model 
to study metabolism of DMBA has further supported the capacity of the ovary for 
bioactivation of DMBA (Igawa et al., 2009). Cultured rat ovaries were exposed to DMBA or 
DMBA-3,4-diol at concentrations ranging from 12.5 to 1000 nM for 15 days. Primordial 
follicle loss occurred at a concentration of 75 nM DMBA and 12.5 nM DMBA-3,4-diol. 
Small primary follicle loss followed a similar pattern, with follicle destruction occurring at 
375 nM DMBA and 75 nM DMBA 3,4-diol (Igawa et al., 2009). Therefore, the lower 
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concentrations required to cause follicle loss indicate that the 3,4-diol metabolite is more 
ovotoxic than the DMBA parent compound. These metabolites are capable of covalent 
binding to macromolecules such as DNA, RNA and protein to form adducts. DMBA-3,4-
diol-1,2-epoxide binds to DNA to form DNA adduct in female rat mammary tissue which 
ultimately leads to DNA damage (Singletary et al., 1996).  DMBA can cause dose-dependent 
DNA damage in extra-ovarian tissues (peripheral lymphocytes, liver and skin cells) when 
exposed along with physical stress in rats (Muqbil et al., 2006).  
 
DNA Damage Responses 
          The maintenance of genome integrity and fidelity is essential for the proper function 
and survival of all organisms. This task is particularly daunting due to constant assault on the 
DNA by genotoxic agents (both endogenous and exogenous) (Lindahl, 1993). DNA damage 
is an alteration in the chemical structure of DNA, such as a break in a strand of DNA, a base 
missing from the backbone of DNA, or a chemically changed base such as 8-OHdG. Failure 
to repair DNA lesions may result in blockages of transcription and replication, mutagenesis, 
and/or cellular cytotoxicity. In humans, DNA damage has been shown to be involved in a 
variety of genetically inherited disorders, in aging (Finkel and Holbrook, 2000) and in 
carcinogenesis (Hoeijmakers, 2001). All eukaryotic cells have evolved a multifaceted 
response to counteract the potentially deleterious effects of DNA damage. Upon sensing 
DNA damage or stalls in replication, cell cycle checkpoints are activated to arrest cell cycle 
progression to allow time for repair before the damage is passed on to daughter cells. In 
addition to checkpoint activation, the DNA damage response leads to induction of 
transcriptional programs, enhancement of DNA repair pathways, and when the level of 
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damage is severe, to initiation of apoptosis (Zhou and Elledge, 2000; Friedberg, 2003) 
(Figure 8). All of these processes are carefully coordinated so that the genetic material is 
faithfully maintained, duplicated, and segregated within the cell. Cell cycle checkpoints are 
regulatory pathways that govern the order and timing of cell cycle transitions to ensure 
completion of one cellular event prior to commencement of another. 
 
Cell Cycle Arrest 
          The key regulators of the checkpoint pathways in the mammalian DNA damage 
response are the ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) 
protein kinases. ATM is the primary mediator of the response to DNA double strand breaks 
(DSBs) that can arise by exposure to ionizing radiation (IR), chemotherapeutic drug and 
other environmental exposures. Central to this checkpoint is the accumulation and activation 
of the P53 protein; two properties carefully controlled by the ATM and ATR kinases. 
Following IR damage, ATM activates downstream kinase check point kinase 2 (CHK2) (by 
phosphorylation at position T68) (Matsuoka et al., 2000) which in turn phosphorylates a 
residue of P53. The phosphorylation of P53 blocks P53/MDM2 interaction, resulting in P53 
accumulation. The residue of P53 can be phosphorylated directly by ATM or ATR in 
response to IR (ATM and ATR), UV irradiation (ATR) and stalls of DNA replication forks 
(ATR). Activated P53 then up-regulates a number of target genes, several of which are also 
involved in the DNA damage response (MDM2, GADD45a, and P21). The accumulation of 
P21 (cyclin-dependent kinase inhibitor) suppresses CCNE1/CDK2 kinase activity thereby 
resulting in G1 arrest (Bartek and Lukas, 2001) (Figure 9). Upon IR damage, ATM 
phosphorylates a number of downstream substrates including Nijmegen breakage syndrome 
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(NBS1), the product of the breast cancer susceptibility gene 1 (BRCA1), and structural 
maintenance of chromosome protein 1 (SMC1). Loss of any of these proteins or mutation of 
the indicated phosphorylation sites results in attenuated S-phase checkpoint activation (Kim 
et al., 2002).  Upon DNA damage, the downstream kinases CHK1 and CHK2 phosphorylate 
CDC25C on position S216.
 
Phosphorylation of this residue creates a binding site for the 14-
3-3 proteins. The 14-3-3/CDC25C protein complexes are sequestered in the cytoplasm, 
thereby preventing CDC25C from activating CDC2 through removal of the T14 and Y15 
inhibitory phosphorylation. This results in the maintenance of the CDC2/CCNB1 complex in 
its inactive state and blockage of entry into mitosis (Peng et al., 1997). 
 
DNA Repair Pathways 
          The simplest of the human DNA repair pathways involves the direct reversal of the 
highly mutagenic alkylation lesion O6-methylguanine (O6-mG) by the product of the O6-
methylguanine DNA methyltransferase (Mgmt) gene (Margison and Santibáñez-Koref, 
2002). Base excision repair (BER) is a multi-step process that corrects non-bulky damage to 
bases resulting from oxidation, methylation, deamination, or spontaneous loss of the DNA 
base itself. These alterations, although simple in nature, are highly mutagenic and therefore 
represent a significant threat to genome fidelity and stability. Nucleotide excision repair 
(NER) is perhaps the most flexible of the DNA repair pathways considering the diversity of 
DNA lesions it acts upon. The most significant of these lesions are pyrimidine dimers 
(cyclobutane pyrimidine dimers and 6-4 photoproducts) caused by the UV component of 
sunlight. Other NER substrates include bulky chemical adducts, DNA intra-strand crosslinks, 
and some forms of oxidative damage. The common features of lesions recognized by the 
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NER pathway are that they cause both a helical distortion of the DNA duplex and a 
modification of the DNA chemistry (Buschta-Hedayat et al., 1999). Heterotrimeric 
replication protein A (RPA) binds at the site of injury to aid in damage recognition. The 
DNA mismatch repair (MMR) pathway plays an essential role in the correction of replication 
errors such as base-base mismatches and insertion/deletion loops (IDLs) that result from 
DNA polymerase misincorporation of nucleotides and template slippage, respectively. 
           DNA DSBs are perhaps the most serious form of DNA damage because they pose 
problems for transcription, replication, and chromosome segregation. Damage of this type is 
caused by a variety of sources including exogenous agents such as IR and certain genotoxic 
chemicals, endogenously generated reactive oxygen species, replication of single-stranded 
DNA breaks, and mechanical stress on the chromosomes. DSBs differ from most other types 
of DNA lesions in that they affect both strands of the DNA duplex and therefore prevent use 
of the complementary strand as a template for repair. Failure to repair these defects can result 
in chromosomal instabilities leading to dysregulated gene expression and carcinogenesis 
(Hoeijmakers, 2001). DSBs and stalled replication forks cause the phosphorylation of 
neighboring histone 2AX at Ser139 (γH2AX) via ATM and ATR respectively. For DSBs, the 
distribution of γH2AX within the nucleus is localized around the DSB and these γH2AX foci 
appear approximately 10 min after DSB induction (Rogakou et al., 1998). Over time the 
amount and intensity of these γH2AX foci reaches a maximum (at about 1 h) and later on 
decreases due to the activity of the phosphatase PP4 showing that DSB repair has occurred 
(Nakada et al., 2008). As stated above, stalled replication forks activate ATR which 
phosphorylates H2AX. The functional significance of γH2AX is assumed to be a signal that 
facilitates the repair of free DSBs or DSBs that are formed at stalled replication forks, 
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presumably by causing the chromatin to be more accessible for DNA repair. To counteract 
the detrimental effects of these potent lesions, cells have evolved two distinct pathways of 
DSB repair, homologous recombination (HR) and non-homologous end joining (NHEJ) 
(Jackson, 2002) (Figure 10). The cellular decision, to which pathway to utilize for DSB 
repair is unclear, however, it appears to be largely influenced by stage within the cell cycle at 
the time of damage acquisition (Takata et al., 1998). 
          HR-directed repair corrects DSB defects in an error-free manner using a mechanism 
that retrieves genetic information from a homologous, undamaged DNA molecule. The 
majority of HR-based repair takes place in late S- and G2-phases of the cell cycle when an 
undamaged sister chromatid is available for use as repair template. The RAD52 epistasis 
group of proteins, including RAD50, RAD51, RAD52, RAD54, and MRE11 mediate this 
process (Sonoda et al., 2001).  The RAD52 protein itself is thought to be the initial sensor of 
the broken DNA ends. Processing of the damaged ends ensues resulting in the production of 
3' single-stranded DNA (ssDNA) overhangs. The newly generated ssDNA ends are bound by 
RAD51 to form a nucleoprotein filament. Other proteins including RPA, RAD52, RAD54, 
BRCA1, BRCA2, and several additional RAD51-related proteins serve as accessory factors 
in filament assembly and subsequent RAD51 activities (Jackson, 2002). The RAD51 
nucleoprotein filament then searches the undamaged DNA on the sister chromatid for a 
homologous repair template. Once the homologous DNA has been identified, the damaged 
DNA strand invades the undamaged DNA duplex in a process referred to as DNA strand 
exchange. A DNA polymerase then extends the 3' end of the invading strand and subsequent 
ligation by DNA Ligase I yields a heteroduplexed DNA structure. This recombination 
intermediate is resolved and the precise, error-free correction of the DSB is complete. In 
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contrast to HR, NHEJ does not require a homologous template for DSB repair and usually 
results in the correction of the break in an error-prone manner. Essential to the NHEJ 
pathway is the activity of the KU70/KU80 heterodimeric protein (Featherstone and Jackson, 
1999).
  
The KU heterodimer initiates NHEJ by binding to the free DNA ends and recruiting 
other NHEJ factors such as DNA-dependent protein kinase (DNA-PK), XRCC4, and DNA 
Ligase IV to the site of injury (Jackson, 2002). DNA-PK becomes activated upon DNA 
binding, and phosphorylates a number of substrates including P53, KU, and the DNA Ligase 
IV cofactor XRCC4. Phosphorylation of these factors is believed to further facilitate the 
repair process. Because the ends of most DSBs generated by genotoxic agents are damaged 
and unable to be directly ligated, they often have to undergo limited processing by nucleases 
and/or polymerases before NHEJ can proceed. The nuclease(s) responsible for this activity, 
include MRE11/Rad50/NBS1 complex, FEN-1(Haber, 1998; Wu et al., 1999; Petrini, 2000), 
and the Artemis protein (Moshous et al., 2001). The final step in NHEJ repair involves 
ligation of the DNA ends by Ligase IV in a complex that also includes XRCC4 and KU. If 
DNA repair fails, cells undergo death by activating an apoptotic pathway. 
 
Apoptosis 
          The integrity of genomic DNA is constantly under threat, even in perfectly healthy 
cells. DNA damage can result from the action of endogenous reactive oxygen species or from 
stochastic errors in replication or recombination, as well as from environmental and 
therapeutic genotoxins. The current paradigm states that if DNA repair fails, cells undergo 
death by activating one of the programmed death pathways, i.e. apoptosis. This implies that 
cells containing sufficient DNA damage to overwhelm its capability of repairing its DNA 
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will be eliminated from the population in a given tissue. Induction of apoptosis has been 
recognized as a possible outcome of DNA damage for more than 20 years (Wyllie et al., 
1980). There are various experimental systems, which show that defects in the execution of 
apoptosis increase cancer incidence (Wirtz et al., 2010). Thus apoptosis following DNA 
damage is a protective mechanism that prevents carcinogenesis.           
          Apoptosis is a process of programmed cell death that occurs during DNA damage in 
some cells. The mechanisms of apoptosis are highly complex and sophisticated, involving an 
energy-dependent cascade of molecular events. There are two main apoptotic pathways: the 
extrinsic or death receptor pathway and the intrinsic or mitochondrial pathway (Elmore, 
2007) (Figure 11).  However, there is now evidence that the two pathways are linked and 
that molecules in one pathway can influence the other (Igney and Krammer, 2002). There is 
an additional pathway that involves T-cell mediated cytotoxicity and perforin-granzyme-
dependent killing of the cell. The perforin/granzyme pathway can induce apoptosis via either 
granzyme B or granzyme A. The extrinsic, intrinsic, and granzyme B pathways converge on 
the same terminal, or execution pathway. This pathway is initiated by the cleavage of CASP3 
and results in DNA fragmentation, degradation of cytoskeletal and nuclear proteins, cross-
linking of proteins, formation of apoptotic bodies, expression of ligands for phagocytic cell 
receptors and finally uptake by phagocytic cells. The granzyme A pathway activates a 
parallel, caspase-independent cell death pathway resultant from single stranded DNA damage 
(Martinvalet et al., 2005). 
          Tumor cells and virus-infected cells are killed by perforin/granzyme pathways where 
secretion of the transmembrane pore-forming molecule perforin and exophytic release of 
cytoplasmic granules into the target cells occur (Trapani and Smyth, 2002). The serine 
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proteases granzyme A and granzyme B are the most important component within the 
granules (Pardo et al., 2004). Granzyme B uses both the mitochondrial pathway and direct 
activation of CASP3 to kill cells (Goping et al., 2003). Granzyme A is also important in 
cytotoxic T cell induced apoptosis and activates caspase independent pathways. Inactivation 
of this complex (SET, Ape1, pp32, and HMG2) by granzyme A most likely contributes to 
apoptosis by blocking the maintenance of DNA and chromatin structure integrity (Lieberman 
and Fan, 2003). 
          The extrinsic signaling pathways that initiate apoptosis involve transmembrane 
receptor-mediated interactions. These involve death receptors that are members of the tumor 
necrosis factor (TNF) receptor gene superfamily (Locksley et al., 2001). The binding of Fas 
ligand to Fas receptor results in the binding of the adapter protein, Fas-associated protein 
with death domain (FADD) and the binding of TNF ligand to TNF receptor results in the 
binding of the adapter protein, Tumor necrosis factor receptor type 1-associated death 
domain (TRADD) with recruitment of FADD and RIP (Hsu et al., 1995; Wajant, 2002).  
FADD then associates with pro-CASP8 via dimerization of the death effector domain. At this 
point, a death-inducing signaling complex (DISC) is formed, resulting in the auto-catalytic 
activation of pro-CASP8 (Kischkel et al., 1995). Once CASP8 is activated, the execution 
phase of apoptosis is triggered. 
          The intrinsic signaling pathways that initiate apoptosis involve a diverse array of non-
receptor-mediated stimuli that produce intracellular signals that act directly on targets within 
the cell and are mitochondrial-initiated events. The stimuli that initiate the intrinsic pathway 
include but are not limited to, radiation, toxins, hypoxia, hyperthermia, viral infections, and 
free radicals. All of these stimuli cause changes in the inner mitochondrial membrane that 
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results in an opening of the mitochondrial permeability transition (MPT) pore, loss of the 
mitochondrial transmembrane potential and release of cytochrome c (CYCS) from the 
intermembrane space into the cytosol (Saelens et al., 2004). CYCS binds and activates Apaf-
1 as well as pro-CASP9, forming an apoptosome (Chinnaiyan, 1999; Hill et al., 2004). The 
clustering of pro-CASP9 in this manner leads to CASP9 activation. The control and 
regulation of these apoptotic mitochondrial events occurs through members of the BCL-2 
family of proteins (Cory and Adams, 2002), regulate mitochondrial membrane permeability 
and can be either pro-apoptotic or anti-apoptotic. To date, a total of 25 genes have been 
identified in the Bcl-2 family. Some of the anti-apoptotic proteins include BCL-2, BCL-X, 
BCL-XL, BCL-XS, BCL-W, BAG, and some of the pro-apoptotic proteins include BCL-10, 
BAX, BAK, BID, BAD, BIM, BIK, and BLK. The BCL-2 and BCL-XL inhibit apoptotic 
death primarily by controlling the activation of caspase proteases (Newmeyer et al., 2000).  
P53 up regulated modulator of apoptosis (PUMA) and Phorbol-12-myristate-13-acetate-
induced protein 1 (PMAIP1) are two members of the BCL2 family that are also involved in 
pro-apoptosis. PUMA plays an important role in P53-mediated apoptosis. It was shown that, 
in vitro, overexpression of PUMA is accompanied by increased BCL2-associated X protein 
(BAX) expression, BAX conformational change, translocation to the mitochondria, CYCS 
release and reduction in the mitochondrial membrane potential (Liu et al., 2003).  PMAIP1 is 
also a candidate mediator of P53-induced apoptosis. Studies show that this protein can 
localize to the mitochondria and interact with anti-apoptotic BCL-2 family members, 
resulting in the activation of CASP9 (Oda et al., 2000). Since both PUMA and PMAIP1 are 
induced by P53, they might mediate the apoptosis that is elicited by genotoxic damage or 
oncogene activation.  
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          The extrinsic and intrinsic pathways both end at the point of the execution phase, 
considered the final pathway of apoptosis. It is the activation of the execution CASP that 
begins this phase of apoptosis. Execution CASP activates cytoplasmic endonuclease, which 
degrades nuclear material, and proteases that degrade the nuclear and cytoskeletal proteins. 
CASP3, CASP6, and CASP7 function as effector or executioner CASP, cleaving various 
substrates including cytokeratins, PARP, the plasma membrane cytoskeletal protein alpha 
fodrin, the nuclear protein NUMA and others, that ultimately cause the morphological and 
biochemical changes seen in apoptotic cells (Slee et al., 2001). CASP3 is considered to be 
the most important of the executioner CASP and is activated by any of the initiator CASP. In 
apoptotic cells, activated CASP3 cleaves inhibitor of CASP -activated DNase (ICAD) to 
release CASP-activated DNase (CAD) (Sakahira et al., 1998). CAD then degrades 
chromosomal DNA within the nuclei and causes chromatin condensation. CASP3 also 
induces cytoskeletal reorganization and disintegration of the cell into apoptotic bodies. 
 
P53-Independent Apoptotic Pathway 
          As mentioned above, DSBs activate ATM resulting in phosphorylation of P53. Upon 
phosphorylation, P53 blocks proliferation by upregulation of P21, which triggers G1-S arrest 
at low level of DSBs (Roos and Kaina, 2006). With higher level of DSBs, P53 accumulates 
and activate pro-apoptotic genes such as BAX and PUMA (Lane, 1992). Atm mutated cells 
showed low level of apoptosis than normal cells following irradiation exposure (Sengupta et 
al., 2013), indicating that ATM-P53 pathway is crucial for DNA damage-induced apoptosis. 
Fibroblasts that express ATM are less sensitive to apoptosis induced by alkylating agents 
than Atm knockout fibroblast in a P53-mutated background (Debiak et al., 2004). This 
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suggests that DNA damage-induced apoptosis are not only triggered by ATM-P53 signaling, 
it can also be triggered by P53-independent pathway (Figure 12) (Roos and Kaina, 2006). 
There are several strategies that cells employ to trigger P53-independent DNA damage-
induced apoptosis. The first one involves the P53 homologs P63 and P73 (Melino et al., 
2002). It has been proposed that activation of ATM and/or ATR by DNA damage recruit 
CHK1 and CHK2 to activate E2F1 by etoposide or camptothecin exposure (Urist et al., 
2004). E2F1 is a transcription factor that has unique ability to induce apoptosis. 
Chemotherapeutic drugs such as the topoisomerase II inhibitors, etoposide and adriamycin 
causes apoptosis through overexpression of E2F1 (Nip et al., 1997; Pruschy et al., 1999). 
The role of E2F1 is proposed by its over expression after DNA damage in the response to 
DNA damage (Blattner et al., 1999) by an ATM-induced phosphorylation (Lin et al., 2001). 
This in turn stimulates transcription of the p73 gene, giving rise to an increased level of P73 
protein (Urist et al., 2004). P53 requires P63 and P73 for triggering apoptosis (Flores et al., 
2002). However, P73 is pro-apoptotic even in the absence of P53. Up regulation of P73 
expression by p53 inactivation through E2F1 mediated transcription in human breast cancer 
cells (Tophkhane et al., 2012). P73-induced apoptosis was shown to be mediated by 
transcriptional upregulation of PUMA, which in turn provokes BAX mitochondrial 
translocation and CYCS release (Melino et al., 2004). P73 was also shown to activate the 
P53 target gene that encodes PMAIP1, which causes mitochondrial dysfunction (Flinterman 
et al., 2005).  
          Voltage-dependent anion channel (VDAC) is present at the external mitochondrial 
membrane, for transporting anions, cations, ATP, Ca
2+ 
and metabolites between 
mitochondria and other parts of the cell (Keinan et al.).  It is well established that VDAC is a 
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major permeability pathway for the transfer of Ca
2+
 across the outer mitochondrial membrane 
(Kroemer et al., 2008; Shelby, 2008). VDAC1 regulates the release of apoptotic proteins 
from mitochondria such as CYCS by oligomerization (Igosheva et al., 2010). The release of 
CYCS is also regulated by BCL-2 family protein BAX, which interacts with VDAC to 
increase pore size and promote CYCS release, while anti-apoptotic BCl-XL produces the 
exact opposite effect (Wu et al., 2010b). Chemotherapeutic agents interfere with BCL-XL 
mitochondrial binding by VDAC1-based peptides to induce apoptosis in cancer cells (Arbel 
et al., 2012). This key role in apoptosis suggests VDAC as a potential target for 
chemotherapeutic drugs. 
 
Summary 
          This literature review indicates that maintenance of ovarian follicular reserve is critical 
for normal reproductive function. Ovarian follicular viability and endowment are not only 
affected by chemical exposure but also obesity. Ovotoxicants can be bioactivated in ovarian 
tissue via CYP and mEH enzymes and interact with DNA to form DNA adducts, ultimately 
leading to DNA damage which is a potential upstream event of the chemical-induced ovarian 
follicle loss. The purpose of the studies described in this dissertation was to elucidate 
upstream mechanistic initiating events leading to ovotoxicity induced by PM and DMBA. In 
addition, the impact of altered central metabolism on ovarian susceptibility to the ovotoxic 
effects of PM and DMBA were evaluated. Our rationale for these studies was that these two 
ovotoxicants have been demonstrated to interact with DNA in extra-ovarian tissues.  
Additionally, ovaries from a progressive model of obesity had increased sensitivity to 
DMBA-induced ovotoxicity, and had basal levels of DNA damage (Nteeba et al., 2014). 
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Three models were used to assess the impacts of PM and DMBA exposure on DNA damage, 
DNA repair, GJ communication, and altered signaling pathways; a spontaneously 
immortalized granulosa cell line; use of a neonatal whole ovary culture system; as well as in 
vivo studies using the lethal yellow mouse model of progressive obesity. 
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Figure 1. Ovarian follicular development 
Folliculogenesis begins with the establishment of a finite pool of primordial follicles. 
Primordial follicles must grow to the primary, pre-antral and antral stages before they reach 
the pre-ovulatory stage and are capable of releasing an oocyte for fertilization. After 
ovulation, the remaining granulosa and theca cells differentiate into a structure known as the 
corpus luteum (CL). At the antral stage, however, 99.9% of antral follicles will undergo 
atresia (Barnett et al., 2006). 
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Figure 2. The arrangement of gap junction 
Each gap junction is composed of two connexins contributed by each cell. Individual 
connexins are made up of six protein subunits called connexons. Each connexin protein 
contains amino and carboxyl terminus in the cytoplasm. Four transmembrane domains in 
connexin are connected by two extracellular loops (E1 and E2) and one cytoplasmic loop 
(CL) (Tripathi, P and Tripathi, M; 2010). 
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Figure 3. Formation of hemichannels and intercellular channels 
(A) Six identical connexin subunits (green or orange) can oligomerize to form a homomeric 
hemichannel. Two co-expressed connexins may oligomerize with each other to form a 
heteromeric hemichannel. (B) Two hemichannels dock with each other to form a complete 
gap junction channel. Two hemichannels of similar composition form homotypic channels 
whereas two hemichannels of different composition form heterotypic channels (Beyer et al., 
2013).  
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Figure 4. The potential effects of reproductive toxicants on the reproductive life  
 
Exposure to reproductive toxicants can have long term impact on female reproductive 
capacity. The effect can vary depending upon whether the damage occurred during fetal 
development, childhood, regular adulthood or pregnancy. One possible result can be 
premature ovarian failure (menopause) (Hoyer P.B., Comprehensive Toxicology, Vol. 10, 
Elsevier Publishing, Oxford, 1997, p 253).  
 
 
 
 
55 
  
 
 
Figure 5. The human ovary and potential targets of chemotherapeutic agents 
A) Stages of follicle development and B) Potential targets of chemotherapeutic damage within the 
ovary (i) chemotherapeutic agents could be directly affecting the resting pool of primordial follicles 
or the growing follicle population. As growing follicles inhibit the recruitment of primordial follicles, 
the loss of this growing population will lead to increased activation of primordial follicles and so the 
loss of that reserve. (ii) Chemotherapeutic agents could be directly targeting the oocyte or the somatic 
cells. Oocyte death would result from death of the follicular somatic cells, as the oocyte is dependent 
on these for its survival (Morgan et al., 2012). 
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Figure 6. Cyclophosphamide metabolism and formation of DNA adducts 
Cyclophosphamide converted into acrolein and phosphoramide mustard with help of liver 
microsomes. Phosphoramide mustard bind with DNA at guanine position to form G-NOR, 
G-NOR-OH and G-NOR-G adducts (Johnson et al., 2011). 
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Figure 7. DMBA metabolic pathway 
The parent compound, DMBA, is bioactivated by CYP450 isoform 1B1 (CYP1B1) to a 
DMBA-3, 4-epoxide intermediate, which is hydrolyzed by mEH to form DMBA-3,4-diol. 
This compound further undergoes bioactivation by either CYP1B1 or 1A1 to form the 
ultimate carcinogenic and ovotoxic metabolite, DMBA-3,4-diol-1,2-epoxide (Miyata et al., 
1999). 
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Figure 8. DNA damage responses 
DNA damage is caused by a variety of sources. The cellular response to damage may involve 
activation of a cell cycle checkpoint, commencement of transcriptional programs, execution 
of DNA repair, or when the damage is severe, initiation of apoptosis (Friedberg et al., 1995). 
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Figure 9. Mammalian cell cycle checkpoint pathways 
In response to DNA damage, ATM and/or ATR trigger the activation of a checkpoint that 
leads to cell cycle arrest or delay. Checkpoint pathways are characterized by cascades of 
protein phosphorylation events (indicated with a "P") that alter the activity, stability, or 
localization of the modified proteins. A general overview of the G1, S, and G2 cell cycle 
checkpoint pathways is indicated (Bartek, J. & J. Lukas 2001). 
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Figure 10. Double strand break (DSB) repair 
Shown is an overview of the main steps and factor requirements for DNA DSB repair by 
homologous recombination (left) and non-homologous end-joining (right) (Jackson, S.P. 
2002).  
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Figure 11. Schematic representation of apoptotic events 
The two main pathways of apoptosis are extrinsic and intrinsic as well as a 
perforin/granzyme pathway. Each requires specific triggering signals to begin an energy-
dependent cascade of molecular events. Each pathways activates its own initiator caspase 
(8,9,10) which in turn will activate the executioner caspase-3. However, granzyme A works 
in a caspase-independent fashion. The execution pathway results in characteristic 
cytomorphological features including cell shrinkage, chromatin condensation, formation of 
cytoplasmic blebs and apoptotic bodies and finally phagocytosis of the apoptotic bodies by 
adjacent parenchymal cells, neoplastic cells or macrophages (Elmore, 2007). 
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Figure 12. Mechanism of P53-independent apoptosis 
DNA damage activates ATM or ATR, and this activates CHK1 or CHK2. CHK1 and CHK2 
activate E2F1 and the transcription factor E2F1 transcribes the P73 protein. P73 mediates 
apoptosis through either the transcription of NOXA, PUMA and BAX or via mitochondrial 
localization of these proteins (Roos et al., 2000). 
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Abstract 
          7,12-dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles at all stages of 
development. This study investigated DMBA-induced DNA double strand break (DSB) 
formation with subsequent activation of the ovarian DNA repair response in models of pre-
antral or pre-ovulatory follicle loss. Postnatal day (PND) 4 Fisher 344 (F344) rat ovaries 
were cultured for 4 days followed by single exposures of vehicle control (1% DMSO) or 
DMBA (12.5 nM or 75 nM) and maintained in culture for 4 or 8 days. Alternately, PND4 
F344 rat ovaries were exposed to 1 µM DMBA at the start of culture for 2 days. Total RNA 
or protein was isolated, followed by RT-PCR or Western blotting to quantify mRNA or 
protein level, respectively. γH2AX and phosphorylated ATM were localized and quantified 
using immunofluorescence staining. DMBA exposure increased CASP 3 and γH2AX protein.  
Additionally, DMBA (12.5 nM and 1 µM) increased levels of mRNA encoding Atm, Xrcc6, 
Brca1 and Rad51. In contrast, Parp1 mRNA was initially decreased (d4) but subsequently 
increased (d8), due to DMBA, and PARP1 protein was increased after 8 days of exposure. 
Total ATM increased in a concentration-dependent temporal pattern (75 nM d4; 12.5 nM 
d8), while pATM was localized in large primary and secondary follicles and increased after 8 
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days of 75 nM DMBA exposure compared to both control and 12.5 nM DMBA. These 
findings support that, despite some concentration effects, DMBA induces ovarian DNA 
damage and that DNA repair mechanisms are induced as a potential mechanism to prevent 
follicle loss.  
 
Introduction 
          The ovary is the ovum-producing female reproductive organ composed of follicles at 
different stages of development. The oocytes encased in primordial follicles are maintained 
in a dormant state until activation into the growing follicular pool where they subsequently 
go through a series of follicular developmental stages (McGee and Hsueh, 2000). 
Approximately 99% of ovarian follicles die by a process known as atresia (Borman et al., 
2000), and ovarian senescence (menopause) occurs when the finite pool of primordial 
follicles has become exhausted (Hoyer and Sipes, 1996; Broekmans et al., 2007; Hansen et 
al., 2008). Since primordial follicles cannot be regenerated (Hirshfield, 1991), their depletion 
leads to infertility and premature ovarian failure (POF). A number of chemical classes can 
deplete follicles causing ovotoxicity, including the polycyclic aromatic hydrocarbon, 7,12-
dimethylbenz[a]anthracene (DMBA) (Mattison, 1980; Hoyer et al., 2009; Igawa et al., 
2009). 
          DMBA causes destruction of all follicle types leading to POF in mice and rats 
(Mattison, 1980). Sources of environmental DMBA exposure come from burning of organic 
matter, including cigarette smoke, charred foods and car exhaust fumes (Gelboin, 1980). 
DMBA causes apoptosis in granulosa and theca cells of pre-ovulatory follicles through 
increased expression of pro-apoptotic BAX and activation of the executioner protein CASP3 
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(Tsai-Turton et al., 2007). Cigarette smoke exposure induces early menopause in female 
smokers compared to their non-smoking counterparts (Jick, 1979; Mattison et al., 1983; 
Harlow and Signorello, 2000). Also, the offspring of female smokers, are born with a 
decreased number of oocytes, potentially leading to abnormal ovarian function, decreased 
fertility, and/or early menopause, even if smoking was halted during pregnancy (Jurisicova et 
al., 2007). Chronic low dose DMBA exposure (0.35 mg/kg to 7.0 mg/kg intraperitoneal (i.p) 
daily for 15d), mimicking human DMBA exposure, resulted in more follicle loss compared 
to a single high dose (80mg/kg i.p) in rats (Borman et al., 2000). Use of a neonatal ovary 
culture system has determined that a single DMBA exposure depleted large primary follicles 
at concentrations of 12.5 and 75 nM, while secondary follicles were destroyed at the 12.5 nM 
concentration only (Madden et al., under review), further suggesting that single low dose 
DMBA exposures are of equal concern as high dose exposures for ovarian function.     
          DMBA can cause dose-dependent DNA damage in extra-ovarian tissues (peripheral 
lymphocytes, liver and skin cells) when exposed along with physical stress in rats (Muqbil et 
al., 2006). Double-strand breaks (DSB) in DNA are the most cytotoxic lesions, generated by 
ionizing radiation, man-made chemicals (van Gent et al., 2001) and chemotherapeutic drugs 
(Helleday et al., 2008). These DSB’s pose a serious threat to genome stability if either 
unrepaired or repaired incorrectly, and could potentially lead to permanent damage that could 
be a negative consequence for gamete health (Petrillo et al., 2011; Summers et al., 2011). 
DSB’s can be sensed by Ataxia telangiectasia mutated (ATM) protein, a 
phosphatidylinositol-3 kinase (PI3K) family member, with subsequent activation of cellular 
DNA damage responses (DDR) leading to cell cycle arrest, DNA damage repair, and 
subsequent cell cycle resumption (Norbury and Hickson, 2001; Shiloh, 2003; Yang et al., 
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2003; Giunta et al., 2010). One event downstream of ATM activation is phosphorylation of 
histone H2AX (termed γH2AX) which leads to recruitment of DNA repair molecules to the 
site of damage (Svetlova et al., 2010). 
          There are two major pathways that repair DNA DSB’s: Homologous Recombination 
(HR) and Non-Homologous End Joining (NHEJ). HR requires regions of extensive DNA 
homology and is most active in the S and G2 phases of the cell cycle in dividing cells 
(Chiruvella et al., 2012). During HR, breast cancer type 1 (BRCA1) is phosphorylated by 
ATM and co-localizes with RAD51 at the site of DNA damage to induce DSB repair (Scully 
et al., 1997). NHEJ, active at all phases of the cell cycle, can rejoin a DSB with or without 
processing of the ends (Chiruvella et al., 2012). Key signaling molecules involved in NHEJ 
repair include the KU70/80 heterodimer (XRCC6 and XRCC5) which recognize and bind to 
the DSB, recruiting DNA dependent-protein kinase (DNA-PKs) to the DSB ends (Calsou et 
al., 2003). In addition, Artemis, X-ray repair complementing defective repair in Chinese 
hamster cells 4 (XRCC4), DNA ligase IV, and XRCC4-like factor (XLF) are activated 
during NHEJ repair (Dobbs et al., 2010).   
          Little is known about whether DNA damage is induced in the ovary during DMBA 
exposure, and if so, which DNA repair pathway predominates. The objective of this study 
was therefore to investigate the DNA repair response induced by DMBA at concentrations 
that induce pre-antral (primordial and small primary; 1 µM DMBA) and pre-ovulatory (large 
primary and secondary; 12.5 and 75 nM DMBA) follicle depletion.   
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Methods and Materials 
Reagents 
          7,12-Dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), bovine serum albumin 
(BSA), ascorbic acid, transferrin, 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, 
ammonium persulphate, glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris 
base, Tris HCL, Sodium chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St 
Louis, MO). Dulbecco's Modified Eagle Medium:nutrient mixture F-12 (Ham) 1x 
(DMEM/Ham's F12), Albumax, penicillin (5000U/ml), Hanks' Balanced Salt Solution 
(without CaCl2, MgCl2 orMgSO4) from Invitrogen Co. (Carlsbad, CA). Millicell-CM filter 
inserts and 48 well cell culture plates were obtained from Millipore (Bedford, MA) and 
Corning Inc. (Corning, NY) respectively. RNeasy Mini kit, QIA shredder kit, RNeasy Min 
Elute kit, and Quantitect TM SYBR Green PCR kit were purchased from Qiagen Inc 
(Valencia, CA). All primers were purchased from the Iowa State University DNA facility. 
All primary antibodies were purchased from Abcam (Cambridge, MA). RNA later was 
obtained from Ambion Inc. (Austin, TX). Goat anti-mouse, goat anti-rabbit and rabbit anti-
goat secondary antibodies were obtained from Santa Cruz Biotechnology, (Santa Cruz, CA). 
Ponceau S was from Fisher Scientific. ECL plus chemical luminescence detection kit was 
obtained from GE Healthcare, Amersham (Buckinghamshire, UK). 
Ovary culture 
          Ovaries were collected from PND4 female F344 rats and cultured as described 
previously (Devine et al., 2002). Briefly, ovaries were removed, trimmed of oviduct and 
other excess tissues and placed onto membrane floating on 250 μl of DMEM/Ham's F12 
medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml 
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penicillin and 27.5 μg/ml transferrin per well in a 48 well plate that had previously been 
equilibrated to 37 °C. A drop of medium was placed on top of each ovary to prevent it from 
drying. Ovaries were cultured in control medium for four days to allow development of large 
primary and secondary follicles, and were then treated once with medium containing vehicle 
control (1% DMSO) ± DMBA (12.5 nM or 75 nM) and the culture was maintained for four 
or eight days (as described below) at 37 °C and 5% CO2. This exposure induces pre-
ovulatory follicle depletion after 8 days (Madden et al., under review). In addition, ovaries 
were exposed to vehicle control (1% DMSO) ± DMBA (1 µM) on alternate days from the 
start of culture (PND4) for 2 days. At this concentration, pre-antral follicle loss occurs from 
four days onward (Igawa et al., 2009). The medium was replaced every two days.  One ovary 
per animal was placed in control medium, while the contralateral ovary was exposed to the 
experimental treatment. All animal procedures were approved by the Institutional Animal 
Care and Use Committee at Iowa State University.  
RNA isolation and qRT-PCR 
          RNA was isolated using an RNeasy Mini kit (Qiagen) and the concentration was 
determined using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop technologies, 
Inc., Wilmington, DE) (n=3; 10 ovaries per pool). Total RNA (200 ng) was reverse 
transcribed to cDNA utilizing the Superscript III One-Step RT-PCR (Qiagen). cDNA was 
diluted (1:20) in RNase-free water. Diluted cDNA (2μl) were amplified on an Eppendorf 
PCR Master cycler using Quantitect SYBR Green PCR kit (Qiagen). Primers for Atm, Brca1, 
Parp1, Rad51, Xrcc6 and Gapdh were designed by Primer 3 Input Version (0.4.0) and are 
listed in Table 1. The regular cycling program consisted of a 15-min hold at 95
o
C and 45 
cycles of denaturing at 95
o
C for 15s, annealing at 58
o
C for 15s, and extension at 72
o
C for 20s 
69 
 
 
at which point data were acquired. There was no difference in Gapdh mRNA expression 
between treatments, thus each sample was normalized to Gapdh before quantification. 
Quantification of fold-change in gene expression was performed using the 2
-Ct 
method 
(Livak and Schmittgen, 2001; Pfaffl, 2001). 
Protein isolation and Western blotting 
          Protein was isolated from cultured ovaries (n=3; 10 ovaries per pool). Homogenates 
were prepared from cultured ovaries via homogenization in tissue lysis buffer containing 
protease and phosphatase inhibitors as previously described (Thompson et al., 2005). Briefly, 
homogenized samples were placed on ice for 30 min, followed by two rounds of 
centrifugation at 10,000 rpm for 15 min and protein concentration was measured using a 
BCA protocol. Protein was stored at -80 °C until further use. SDS-PAGE was used to 
separate protein homogenates which were then transferred to a nitrocellulose membrane. 
Membranes were blocked for 1 hour in 5 % milk in Tris-buffered saline containing tween 20, 
followed by incubation with anti-PARP1 antibody (1:200), anti-ATM antibody (1:100), anti-
RAD51 antibody (1:500), anti-γH2AX (1:200) or anti-caspase 3 antibody (1:50)  for 36 h at 
4
o
C. Following three washes in TTBS (1X), membranes were incubated with species-specific 
secondary antibodies (1:2000) for 1 h at room temperature. Membranes were washed 3X in 
TTBS and incubated in chemiluminescence detection substrate (ECL plus) for 5 min 
followed by X-ray film exposure. Densitometry of the appropriate bands was performed 
using ImageJ software (NCBI). Equal protein loading was confirmed by Ponceau S staining 
of membranes and protein level was normalized to Ponceau S densitometry values.  
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Immunofluorescence Staining  
          Ovaries were fixed in 4% paraformaldehyde for 2 h, transferred to 70% ethanol, 
embedded in paraffin, serially sectioned (5 µM thick), and every 10th section was mounted. 
Slides were deparaffinized in xylene and rehydrated with subsequent washes in ethanol. 
Antigen retrieval was carried out by microwaving sections for 7 min in sodium citrate buffer 
(1M, pH 6.1). Sections were then blocked in 5% BSA for 1 h at room temperature. Sections 
were incubated with primary antibodies directed against pATM (1:100) or γH2AX (1:50) 
overnight at 4°C. After washing in 1% PBS, sections were incubated with the appropriate 
goat anti-mouse IgG-FITC or donkey anti-rabbit IgG-FITC secondary antibodies for 1 h. 
Slides were then counterstained with 4-6-diamidino-2-phenylindole (DAPI) or Hoechst for 5 
min. Images were taken using a Leica fluorescent microscope and number of follicles with 
foci for pATM and γH2AX were analyzed using ImageJ software (NCBI). 5 large primary 
and 3 secondary follicles were quantified per slide (n=3 ovaries; 15 large primary and 9 
secondary follicles quantified per ovary).    
Statistical analysis 
          Raw data were analyzed by paired t-tests comparing treatment with control using 
Graphpad Prism 5.04 software. Values are expressed as mean ± SE; n=3 (10 ovaries per 
pool). Statistical significance was defined as * = P < 0.05. 
 
Results 
Effect of DMBA on Caspase-3 protein level 
          F344 female rat PND4 pup ovaries were cultured in medium containing vehicle control 
(DMSO) for four days, followed by a single exposure to vehicle control medium ± DMBA 
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(12.5 nM or 75 nM) and maintained in culture for a further 4 or 8 days. The effect of DMBA 
on the protein level of an apoptosis marker, caspase-3, was determined. Caspase-3 protein 
level (17 Kda) was increased (P < 0.05) by both DMBA treatments (CT - 1.0 ± 0.02; 12.5 
nM - 1.12 ± 0.03; 75 nM - 1.15 ± 0.03), after 8 days confirming that apoptosis was induced 
by DMBA exposure (Figure 1).  
Localization and quantification of DMBA-induced markers of DNA damage  
          F344 female rat PND4 pup ovaries were cultured in medium containing vehicle control 
(DMSO) for four days, followed by a single exposure to vehicle control medium +/- DMBA 
(12.5 nM or 75 nM) and maintained in culture for a further 4 or 8 days. Immunofluorescence 
staining was used to determine localization and staining intensity for pATM and γH2AX 
proteins. γH2AX protein was localized in granulosa cells of CT ovaries at both time points, 
but increased in the oocyte nucleus of large primary and secondary follicles following 
DMBA treatment (Figure 2A-C).  Furthermore, Western blotting demonstrated that γH2AX 
protein level was also increased (P < 0.05) after 2 days of 1 µM DMBA exposure (Figure 
2D).   
Ovarian DMBA exposure alters expression of genes involved in DNA repair 
          To determine the effect of DMBA on DNA repair gene mRNA expression, F344 
female rat PND4 pup ovaries were cultured in medium containing vehicle control (DMSO) 
for 4 days, followed by a single exposure to vehicle control medium +/- DMBA (12.5 nM or 
75 nM) and maintained in culture for a further 4 or 8 days. After exposure to DMBA, RNA 
was isolated and qRT-PCR was performed to determine mRNA expression of DNA repair 
genes. Relative to control treated ovaries, Atm (0.9-fold ± 0.1), Xrcc6 (1.6-fold ± 0.3), Brca1 
(1.4-fold ± 0.4) and Rad51 (0.6-fold ± 0.1) mRNA were increased (P < 0.05) by the 12.5 nM 
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DMBA treatment after 4 days of exposure. In contrast, Rad51 (0.7-fold ± 0.2) mRNA was 
decreased (P < 0.05) only by treatment with 75 nM DMBA.  Parp1 mRNA expression was 
decreased (P < 0.05) by both 12.5 (0.75-fold ± 0.04) and 75 nM (0.89-fold ± 0.06) DMBA 
concentrations after 4 days (Figure 3A). After 8 days of both DMBA treatments, mRNA 
encoding Atm (12.5 nM: 0.84-fold ± 0.2; 75 nM: 0.3-fold ± 0.03) and Parp1 (12.5 nM: 0.3-
fold ± 0.1; 75nM: 0.7-fold ± 0.3) were increased (P < 0.05) compared to control treated 
ovaries (Figure 3B). 
          To further confirm that the DNA repair response is activated prior to follicle depletion, 
F344 female rat PND4 pup ovaries were cultured in medium containing vehicle control 
(DMSO) or DMBA (1µM) for 2 days. At this concentration, DMBA induces primordial and 
small primary follicle loss from 4 days of exposure onwards (Igawa et al., 2009).  Relative to 
control treated ovaries, Atm (1.18-fold ± 0.4), Parp1 (0.78-fold ± 0.1), Brca1 (0.55-fold ± 
0.2) and Rad51 (3.07-fold ± 0.7) mRNA were increased (P < 0.05) by 1 µM DMBA (Figure 
3C). 
Ovarian DMBA exposure alters DNA repair protein level 
          F344 female rat PND4 ovaries were cultured in medium containing vehicle control 
(DMSO) for 4 days, followed by a single exposure to vehicle control medium ± DMBA (12.5 
nM or 75 nM) and maintained in culture for a further 4 or 8 days at which point total protein 
was isolated.  Total ATM protein was measured by Western blotting and was increased (P < 
0.05) after 4 days in ovaries treated with 75 nM DMBA (CT - 0.93 ± 0.03; 12.5 nM - 0.96 ± 
0.03; 75 nM - 1.17 ± 0.04; Figure 4A), and after 8 days in ovaries exposed to 12.5 nM 
DMBA (CT - 0.53 ± 0.01; 12.5 nM - 0.66 ± 0.01; 75 nM - 0.57 ± 0.03; Figure 4A). 
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          pATM protein was observed in the nucleus and cytoplasm of oocytes and in granulosa 
cells of all type of follicles (Figure 5A-C). There was no effect of 12.5 nM DMBA on pATM 
protein staining, relative to control.  However, pATM was increased (P < 0.05) by 75 nM 
DMBA in large primary (CT - 0.333 ± 0.33; 75 nM - 1.67 ± 0.33) and secondary follicles 
(CT - 2 ± 1.5; 75 nM - 9.33 ± 1.3) (Figure 5D).  
          Western blotting demonstrated that PARP1 protein level increased (P < 0.05) after 4 
days when exposed to 12.5 nM DMBA (CT - 1.14 ± 0.01; 12.5 nM - 1.44 ± 0.07; 75 nM - 
1.10 ± 0.002; Figure 6A), and was increased (P < 0.05) by both DMBA exposures after 8 
days (CT - 0.94 ± 0.02; 12.5 nM - 1.03 ± 0.03; 75 nM - 1.01 ± 0.01; Figure 6A). 
 
Discussion 
          DMBA causes depletion of follicles at all stages of development (Rajapaksa et al., 
2007; Igawa et al., 2009). Our previous work established that a single exposure to 12.5 or 75 
nM DMBA caused loss of large primary and/or secondary follicles (Madden et al., under 
review), and thereby established a model to study pre-ovulatory follicle loss. In the current 
study, we first confirmed that DMBA induced apoptosis at these concentrations by 
evaluating the level of caspase-3 in the ovary, which increased during DMBA exposure. 
Having established that atresia is ongoing in the ovary 8 days after DMBA exposure, we 
determined the impact of DMBA on DNA repair proteins as a proxy for DNA damage. 
          DMBA directly or indirectly causes DNA damage in extra-ovarian tissues 
(Rajasekaran et al., 2011), which can induce different cell fates such as DNA repair, cell 
cycle arrest and apoptosis (Norbury and Hickson, 2001). While DMBA-induced DNA 
damage has been characterized in many cell types (Bolognesi et al., 1991; Muqbil et al., 
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2006; Rajasekaran et al., 2011), the ovarian mechanisms are not well understood. DNA DSB 
is highly cytotoxic lesions, generated by DMBA (Muqbil et al., 2006) and DSB’s are one of 
the mechanisms that cause phosphoramide mustard-induced follicle loss in ovaries (Petrillo 
et al., 2011). We localized γH2AX protein to the nucleus and granulosa cells of large primary 
and secondary follicles after both DMBA exposures; however this staining was negligible in 
the oocyte nucleus of control-treated ovaries. Additionally, we demonstrated that γH2AX 
protein is increased in ovaries exposed for two days to a concentration of DMBA that causes 
primordial and small primary depletion after 4 days. Since, detection of γH2AX is considered 
the gold standard for localization of DNA DSBs (Svetlova et al., 2010; Petrillo et al., 2011) 
these data indicate that DNA damage is occurring in ovaries exposed to DMBA.  
          The PI3K family member ATM is described as a critical sensor to initiate the cellular 
genotoxic response after the occurrence of DSBs (Shiloh, 2003; Yang et al., 2003; Gao et al., 
2008). In this study, we determined an increase in the level of mRNA encoding Atm by 
exposure to both DMBA treatments. Total ATM protein was also increased by DMBA 
exposure, thus potentially also serving as a sensor of DNA DSB occurrence in the ovary. 
Interestingly, there was a temporal pattern of ATM protein induction, with the 75 nM DMBA 
concentration demonstrating induction of ATM after 4 days, while the 12.5 nM DMBA 
exposure took a longer time for ATM induction to occur. Whether the 12.5 nM exposure 
caused DNA damage prior to the induction of ATM cannot be confirmed from the data 
herein but is possible. These data are consistent with a previous study that demonstrated 
increased ATM in WT female mice spleen cells exposed to 50 mg/kg DMBA (Gao et al., 
2008). ATM has been localized to the cytoplasm of growing follicles in the mouse ovary 
(Barlow et al., 1998). We also observed localization of pATM to the oocyte cytoplasm and 
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nucleus of large primary and secondary follicles further supporting that DMBA induces DNA 
damage in the rat ovary. The ATM pathway regulates cell survival by either inducing 
apoptosis or preventing cell progression and activating DNA repair (Lavin and Kozlov, 
2007). ATM can initiate the action of the HR or the NHEJ DNA repair machinery 
components in the mice embryo (Chiruvella et al., 2012) and in MCF7 cells after exposure to 
ionizing radiation (Paull et al., 2000; Summers et al., 2011), respectively. In this study, 
Xrrc6, Brca1 and Rad51 mRNA were increased by exposure to the concentration of DMBA 
at which both large primary and secondary follicles are depleted, and Brca1 and Rad51 
mRNA were increased by 1 µM DMBA exposure after 2 days. Since these are components 
of the HR pathway that predominates in actively dividing cells, these data could suggest that 
the DMBA-induced DNA repair response occurs in granulosa cells. However, it has also 
been recently shown that genes involved in HR are expressed in the oocyte of mice and 
humans, and that their expression levels decline as the female ages (Titus et al., 2013).      
          In response to DNA damage, cells can also activate PARP1, an enzyme that catalyzes 
poly-ADP-ribosylation of a variety of proteins (D'Amours et al., 1999). Activation of PARP1 
can also increase the accessibility of DNA repair enzymes and transcription factors to 
chromatin (Dantzer et al., 2006). In this study, Parp1 mRNA and protein were increased by 
both concentrations of DMBA. Also, Parp1 mRNA was observed to be increased prior to 
follicle loss in the ovaries exposed to 1 µM DMBA. There has been controversy concerning 
the role of PARP1 in the regulation of cell survival/death in response to DNA damage. Some 
studies have implicated PARP1 in the regulation of DNA repair and cell survival (Wang et 
al., 1997; Ziegler and Oei, 2001; De Vos et al., 2012) whereas others have implicated 
PARP1 in initiating cell death by either apoptosis (Yu et al., 2002; Muñoz-Gámez et al., 
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2009) or necrosis (Ha and Snyder, 1999). The data reported herein may indicate PARP1 
activation may stimulate cell death after DMBA exposure.  
          In summary, this study indicates that exposure to DMBA causes ovotoxicity through 
DSB formation, and that the ovary mounts a protective response in order to repair this 
damage. The response to DSB’s however is not sufficient to completely prevent pre-
ovulatory follicle loss at the DMBA levels investigated however it is possible that this is the 
case at lower exposure levels. Taken together these data raise concern about the fertility 
impacts of low level DMBA exposure to females.   
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Table 1. Primer sequence used for qRT-PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genes Forward primer Reverse primer 
Atm TCAGCAGCACCTCTGATTCTT AGACAGACATGCTGCCTCCT 
Brca1 CCCTCTTAGTCTGCTGAGCT CCTTTGGGTGGCTGTACTGA 
Parp1 AAGTGCCAGTGTCAAGGAGA ACAGGGAGCAAAAGGGAAGA 
Prkdc GCCACAGACCCCAATATCCT TATCTGACCATCTCGCCAGC 
Rad51 ATCCCTGCATGCTTGTTCTC CTGCAGCTGACCATAACGAA 
Xrcc6 GATCTGACACTGCCCAAGGT  TGCTTCTTCGGTCCACTCTT 
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Figure 1. Effect of DMBA exposure on casepase-3 protein expression 
Following 8 d of culture, total protein was isolated from PND4 rat ovaries exposed to control 
(CT), 12.5 or 75 nM DMBA. Caspase-3 protein was measured by Western blotting. (A) 
Densitometry data was normalized to Ponceau S and expressed as mean raw data ± SE; n=3 
(10 ovaries per pool). Statistical significance was defined as * = P < 0.05. (B) Western 
blotting of caspase-3. DMBA increases Caspase 3 protein level during follicle loss. 
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Figure 2. Localization and quantification of γH2AX protein  
Paraffin embedded ovarian sections from PND4 rat ovaries exposed to (A) control (CT), (B) 
12.5 or (C) 75 nM DMBA were used to perform immunohistochemistry to determine 
localization of γH2AX protein after 4 d.  (D) Quantification of γH2AX loci in large primary 
and secondary follicles; Data is expressed as number of follicles positive for γH2AX ± SE; 
n=3; Statistical significance was defined as * = P < 0.05.  (E) Western blot to detect γH2AX 
in vehicle control (C) or 1 µM DMBA (D) treated ovaries and expressed as mean raw data ± 
SE; n=3 (10 ovaries per pool). Statistical significance was defined as * = P < 0.05.  γH2AX 
staining increases at 75 nM DMBA at 4 days. 
84 
 
 
Figure 3. Effect of DMBA exposure on DNA repair gene mRNA expression 
Following (A) 4 or (B) 8d of culture, RNA was isolated from PND4 rat ovaries exposed to 
control (CT), 12.5 or 75 nM DMBA and qRT-PCR performed. Additionally, RNA was 
isolated from ovaries exposed to (C) control (CT) or 1 µM DMBA for qRT-PCR.  Values are 
expressed as mean fold change ± SE; n=3 (10 ovaries per pool). Statistical significance was 
defined as * = P < 0.05. DMBA alters DNA repair gene expressions. 
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Figure 4. Effect of DMBA exposure on total ATM protein level 
Following 4 or 8d of culture, total protein was isolated from PND4 rat ovaries exposed to 
control (CT), 12.5 or 75 nM DMBA. ATM protein was measured by Western blotting. (A) 
Results were normalized to Ponceau S and expressed as mean raw data ± SE; n=3 (10 ovaries 
per pool). Statistical significance was defined as * = P < 0.05. (B) Representative western 
blot for ATM. DMBA alters ATM protein level. 
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Figure 5. Localization and quantification of pATM protein 
Following 8d of culture, paraffin embedded ovarian sections from PND4 rat ovaries exposed 
to (A) control (CT), (B) 12.5 or (C) 75 nM DMBA were used to perform 
immunohistochemistry to determine localization and (D) quantification of pATM protein.  
Data is expressed as number of follicles positive for pATM ± SE; n=3; Statistical 
significance was defined as * = P < 0.05. pATM staining increases at higher concentration in 
pre-antral follicles. 
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Figure 6. Effect of DMBA exposure on PARP1 protein level 
Following 4 or 8d of culture, total protein was isolated from PND4 rat ovaries exposed to 
control (CT), 12.5 or 75 nM DMBA. PARP1 protein was measured by Western blotting. (A) 
Results were normalized to Ponceau S and expressed as mean raw data ± SE; n=3 (10 ovaries 
per pool). Statistical significance was defined as * = P < 0.05. (B) Representative Western 
blot for PARP1. PARP1 protein increases by DMBA exposure. 
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Abstract 
          7,12-dimethylbenz[a]anthracene (DMBA) reduces ovarian follicle number, and 
induces DNA damage in extra-ovarian tissues, thus, this study investigated ovarian DMBA-
induced DNA damage. Additionally, since obesity is associated with increased incidence of 
offspring birth defects, we hypothesized that a DMBA-induced DNA damage response 
(DDR) might be compromised in ovarian tissue from obese females. Wild type (lean) non 
agouti (a/a) and KK.Cg-Ay/J heterozygote (obese) mice were dosed with sesame oil or 
DMBA (1mg/kg; intraperitoneal injection) at 18 wks of age, for 14 days. Total ovarian RNA 
and protein were isolated and abundance of Ataxia telangiectasia mutated (Atm), X-ray repair 
complementing defective repair in chinese hamster cells 6 (Xrcc6), Breast cancer type 1 
(Brca1), Rad 51 homolog (Rad51), Poly [ADP-ribose] polymerase 1 (Parp1) and Protein 
kinase, DNA-activated, catalytic polypeptide (Prkdc) quantified by RT-PCR or Western blot, 
respectively.  Phosphorylated histone H2AX (γH2AX) level was also determined by Western 
blotting. Basal protein abundance of PRKDC and BRCA1 proteins were decreased (P < 0.05) 
but γH2AX and PARP1 proteins increased (P < 0.05) in ovaries from obese females. Ovarian 
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ATM, XRCC6, PRKDC, RAD51 and PARP1 proteins were increased (P < 0.05) by DMBA 
exposure in lean mice. A blunted DMBA-induced increase (P < 0.05) in XRCC6, PRKDC, 
RAD51 and BRCA1 was observed in ovaries from obese mice, relative to lean counterparts. 
Taken together, DMBA exposure induced γH2AX as well as the ovarian DDR, supporting 
that DMBA causes ovarian DNA damage as an ovotoxic insult.  Additionally, the ovarian 
DDR was partially attenuated in obese females raising concern that obesity may be an 
additive factor during chemical-induced ovotoxicity.    
 
Introduction 
          7,12-dimethylbenz[a]anthracene (DMBA) is a polycyclic aromatic hydrocarbon 
liberated through cigarette smoke and car exhaust fumes (Gelboin, 1980). DMBA destroys 
all follicle types leading to ovarian failure in mice and rats (Mattison and Schulman, 1980). 
In addition, it is recognized that female smokers experience ovarian senescence at an earlier 
age than their non-smoking counterparts (Jick and Porter, 1977). DMBA requires the action 
of ovarian enzymes cytochromes p450 (Cyp) isoforms 1A1 and 1B1 (Shimada et al., 2003) 
and microsomal epoxide hydrolase (mEH) (Rajapaksa et al., 2007; Igawa et al., 2009; 
Madden et al., 2014) for biotransformation to the ovotoxic metabolite, DMBA 3,4-diol, 1,2-
epoxide, which is both carcinogenic and has the potential to form DNA adducts (Miyata et 
al., 1999). DMBA exposure also induces the DNA damage response (DDR) in cultured 
neonatal rat ovaries, indicating that DNA damage is a potential mechanism by which DMBA 
induces its ovotoxic effects (Ganesan et al., 2013).   
          Double-strand breaks (DSBs) in DNA are cytotoxic lesions, generated by ionizing 
radiation and man-made chemicals (van Gent et al., 2001). DSB’s can be sensed by a PI3K 
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family member Ataxia telangiectasia mutated (ATM) protein (Norbury and Hickson, 2001; 
Yang et al., 2003; Giunta et al., 2010). ATM phosphorylates histone H2AX (γH2AX) which 
leads to recruitment of DNA repair molecules to the site of DSBs (Svetlova et al., 2010), thus 
γH2AX become a gold standard marker for localizing DSBs. DNA DSB’s pose a serious 
threat to both cell viability and genome stability if left unrepaired or repaired incorrectly, and 
could potentially lead to permanent damage with resulting negative consequences for gamete 
health (Petrillo et al., 2011; Summers et al., 2011). Two major pathways can repair DNA 
DSB’s: Non-Homologous End Joining (NHEJ) and Homologous Recombination (HR). Key 
signaling molecules involved in NHEJ repair include the X-ray repair complementing 
defective repair in Chinese hamster cells 6 and 5 (XRCC6 and XRCC5) heterodimer which 
recognizes and binds to the DSB, recruiting protein kinase DNA-activated, catalytic 
polypeptide (PRKDC) to the DSB ends. During HR, breast cancer type 1 (BRCA1) can be 
phosphorylated by ATM and co-localizes with RAD51 recombinase (RAD51) at the site of 
DNA damage to induce DSB repair (Petrillo et al., 2011). 
          Approximately 65% of women in the United States are overweight or obese (Flegal 
Km et al., 2010) and the associated reproductive complications include menstrual cycle 
disturbances, ovulatory dysfunction, infertility, decreased conception, early pregnancy loss 
and congenital abnormalities in offspring (Cardozo et al., 2012; Sauber-Schatz et al., 2012).  
Obesity has been associated with altered insulin and insulin growth factor (IGF) signaling 
(Qatanani and Lazar, 2007). Insulin serves as a regulator of enzymes involved in the 
metabolism of xenobiotics (Woodcroft and Novak, 1999), mediated, at least partly, through 
activation of phosphatidylinositol-3 kinase (PI3K) and variety of downstream effectors 
including protein kinase B (Akt) (Niswender et al., 2003; Kim and Novak, 2007). Insulin 
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increases mEH protein expression in primary cultured rat hepatocytes (Kim et al., 2003). 
Also, increased ovarian PI3K signaling and mEH have been demonstrated in mice fed a high 
fat diet until obese (Nteeba et al., 2013). The lethal yellow mouse, which develops 
progressive obesity, was found to have both higher basal levels of mEH and greater mEH 
induction in response to DMBA exposure (Nteeba et al., 2014). These data suggest that 
ovarian tissue from obese females could have potentially greater exposure to the ovotoxic 
metabolite of DMBA, due to higher levels of ovarian mEH, and thus greater DMBA 
bioactivation to a metabolite that interacts with DNA (Miyata et al., 1999). The objective of 
this study was therefore to investigate ovarian DMBA-induced DNA damage as evidenced 
by phosphorylation of H2AX and induction of the DDR in both lean and obese mice.  
 
Methods and Materials 
Reagents 
          7,12-dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), sesame oil (CAS # 8008-
74-0), 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, ammonium persulphate, 
glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris base, Tris HCL, Sodium 
chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St Louis, MO).  RNeasy Mini 
kit, QIA shredder kit, RNeasy Min Elute kit, and Quantitect TM SYBR Green PCR kit were 
purchased from Qiagen Inc (Valencia, CA). All primers were purchased from the Iowa State 
University DNA facility. All primary antibodies were purchased from Abcam (Cambridge, 
MA) with the exception of the BRCA1(C-20) primary antibody which was from Santa Cruz 
Biotechnology (Santa Cruz, CA). RNA later was obtained from Ambion Inc. (Austin, TX). 
Goat anti-mouse and anti-rabbit secondary antibodies were obtained from Santa Cruz 
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Biotechnology (Santa Cruz, CA). Ponceau S was from Fisher Scientific. ECL plus chemical 
luminescence detection kit was obtained from GE Healthcare, Amersham (Buckinghamshire, 
UK). 
Animals 
          Ovarian tissue was obtained as part of a larger study by our group (Nteeba et al., 
2014).  Briefly, four week old female wild type normal non-agouti (a/a; designated lean; n = 
10) and agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 10) were purchased from 
Jackson laboratories (Bar Harbor, ME 002468). All animals were housed in cages under a 12 
h light/dark photoperiod with the temperature between 70-73
o
F and humidity approximately 
20-30%. The animals were provided with a standard diet (Teklad 2014 global 14% protein 
rodent maintenance diet) with ad libitum access to food and water until 18 weeks of age. All 
animal experimental procedures were approved by the Iowa State University Animal Care 
and Use Committee.  
In vivo DMBA exposure  
           Both lean and obese mice were intraperitoneally (i.p) dosed with sesame oil (SO) or 
DMBA (95%; 1mg/kg) for 14 days. This dose was chosen based on the literature (Mattison 
and Thorgeirsson, 1979). Mice were euthanized 3 days after the end of dosing in their pro-
estrus phase. One ovary from each mouse was fixed in 4% paraformaldehyde and one ovary 
was preserved in RNA later at -80ºC for RNA and protein isolation. No difference in body 
weight due to DMBA exposure was observed and the lethal yellow mice had higher body 
weights (Nteeba et al., 2014). DMBA reduced ovarian weight and volume in both lean and 
obese mice, relative to vehicle treated mice, and ovarian weight and volume was lower in 
obese DMBA-treated relative to lean DMBA-treated mice (Nteeba et al., 2014). 
93 
 
 
RNA isolation and qRT-PCR 
          RNA was isolated using an RNeasy Mini kit (Qiagen) and the concentration was 
determined using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop technologies, 
Inc., Wilmington, DE) (n=3). Total RNA (200 ng) was reverse transcribed to cDNA utilizing 
the Superscript III One-Step RT-PCR (Qiagen). cDNA was diluted (1:20) in RNase-free 
water. Diluted cDNA (2 μl) were amplified on an Eppendorf PCR Master cycler using 
Quantitect SYBR Green PCR kit (Qiagen). Primers for Atm, Brca1, Prkdc, Parp1, Rad51, 
Xrcc6 and Gapdh were designed by Primer 3 Input Version (0.4.0) and are listed in Table 1. 
The regular cycling program consisted of a 15-min hold at 95
o
C and 45 cycles of denaturing 
at 95
o
C for 15s, annealing at 58
o
C for 15s, and extension at 72
o
C for 20s at which point data 
were acquired. There was no difference in Gapdh mRNA expression between treatments, 
thus each sample was normalized to Gapdh before quantification. Quantification of fold-
change in gene expression was performed using the 2
-Ct 
method (Livak and Schmittgen, 
2001; Pfaffl, 2001). 
Protein isolation and western blotting 
           Protein was isolated from whole ovaries (n=3) by homogenization in tissue lysis 
buffer containing protease and phosphatase inhibitors as previously described (Thompson et 
al., 2005). Briefly, homogenized samples were placed on ice for 30 min, followed by two 
rounds of centrifugation at 10,000 rpm for 15 min and protein concentration was measured 
using a standard BCA protocol. SDS-PAGE was used to separate protein homogenates which 
were then transferred to a nitrocellulose membrane. Membranes were blocked for 1 hour in 5 
% milk in Tris-buffered saline containing tween 20, followed by incubation with one of: anti-
rabbit PARP1 antibody (1:200), anti-rabbit phosphorylated H2AX antibody (γH2AX; 1:100), 
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anti-mouse ATM antibody (1:100), anti-mouse RAD51 antibody (1:500), anti-mouse 
XRCC6 antibody (1:100), anti-rabbit BRCA1 antibody (1:500), or anti-rabbit PRKDC 
antibody (1:100) for 36 h at 4
o
C. Following three washes in TTBS (1X), membranes were 
incubated with species-specific secondary antibodies (1:2000) for 1h at room temperature. 
Membranes were washed 3X in TTBS and incubated in chemiluminescence detection 
substrate (ECL plus) for 5 min followed by X-ray film exposure. Densitometry of the 
appropriate bands was performed using ImageJ software (NCBI). Equal protein loading was 
confirmed by Ponceau S staining of membranes and protein level was normalized to Ponceau 
S densitometry values. Chemical exposures can impact traditional housekeeping protein 
abundance (our unpublished data), thus equal protein loading was confirmed by Ponceau S 
staining of total protein and protein level was normalized to Ponceau S densitometry values.  
Statistical analysis 
          Raw data were analyzed by unpaired t-test (comparison of two samples) or one-way 
ANOVA (comparison of multiple samples) analysis with the Tukey pairwise comparison 
using Graphpad Prism 5.04 software. Values are expressed as mean ± SE; n=3. A P-value < 
0.05 was considered a significant difference between treatments, while P < 0.1 was 
considered a trend towards a difference. 
 
Results 
Effect of DMBA on ovarian H2AX phosphorylation in lean and obese mice  
          Phosphorylation of H2AX occurs within seconds of a DNA DSB and is considered the 
gold standard marker for DSB detection. γH2AX protein was absent in lean control-treated 
ovaries but was evident (P < 0.05) in obese ovaries that had received sesame oil. γH2AX 
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protein level was increased (P < 0.05) by DMBA exposure in both lean and obese mice  
compared to their respective control-treated ovaries (Figure 1A). Relative to lean mice, the 
DMBA-induced increase in γH2AX protein was lower in ovaries from obese mice (Figure 
1B).   
Impact of DMBA exposure on ovarian Atm abundance in lean and obese mice 
          ATM is the cellular sensor of DNA DSBs. Basal Atm mRNA levels were lower (P < 
0.05) in ovaries from obese relative to lean mice. In lean mice, ovarian Atm mRNA levels 
were decreased (P < 0.05) by DMBA exposure compared to control-treated animals. In 
contrast, in obese mice, DMBA exposure increased (P < 0.05) ovarian Atm mRNA levels 
relative to control-treated obese mice (Figure 2A). There was no difference in basal ovarian 
ATM protein levels between lean and obese mice. Additionally, DMBA increased (P < 0.05) 
ATM protein levels in both lean and obese mice to the same extent (Figure 2B, C). 
DMBA-induction of ovarian Xrcc6 mRNA and protein in lean and obese mice  
          Xrcc6 is a member of the NHEJ pathways recruited by γH2AX. Basal levels of Xrcc6 
mRNA were lower (P < 0.05) in obese compared to lean mouse ovaries. In lean mice, levels 
of Xrcc6 mRNA were increased by DMBA exposure while, in contrast, DMBA exposure did 
not impact Xrcc6 in obese ovaries (Figure 3A). There was no impact of obesity on ovarian 
XRCC6 protein. In lean and obese mice, relative to control-treated animals, levels of ovarian 
XRCC6 protein were increased (P < 0.05) by DMBA exposure. Interestingly, relative to lean 
DMBA-treated ovaries, DMBA-induced XRCC6 protein expression was lower (P < 0.05) in 
obese ovaries (Figure 3B, C). 
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Response of ovarian Prkdc mRNA and protein to DMBA exposure in lean and obese 
mice 
 
          The NHEJ member, PRKDC, is recruited by γH2AX [20] upon DSB formation. Basal 
levels of Prkdc mRNA were lower (P < 0.05) in obese compared to lean ovaries. In lean 
mice, levels of Prkdc mRNA were decreased (P < 0.05) by DMBA exposure compared to 
control-treated ovaries. In contrast, DMBA exposure increased (P < 0.05) Prkdc mRNA level 
in ovaries from obese mice, compared to obese control-treated animals (Figure 4A). Basal 
PRKDC protein levels were also lowers (P < 0.05) in obese relative to lean ovaries. In both 
lean and obese mice, relative to control-treated animals, levels of ovarian PRKDC protein 
were increased (P < 0.05) by DMBA exposure (Figure 4B, C). 
Impact of DMBA exposure on ovarian Brca1 mRNA and protein in lean and obese mice 
          BRCA1 is phosphorylated by ATM during HR. Lower (P < 0.05) levels of basal Brca1 
mRNA were observed in obese ovaries relative to lean ovaries. In both lean and obese mice, 
levels of Brca1 mRNA were increased (P < 0.05) by DMBA exposure compared to control 
treatments, however, obesity resulted in a blunted DMBA-induced Brca1 mRNA increase 
(Figure 5A). Basal BRCA1 protein levels were lower (P < 0.05) in obese relative to lean 
ovaries. In obese mice, relative to control-treated animals, levels of ovarian BRCA1 protein 
were increased (P < 0.05) by DMBA exposure while no BRCA1 induction was observed in 
lean mice (Figure 5B, C). 
Ovarian DMBA-induced Rad51 mRNA and protein in lean and obese mice  
           RAD51 is also part of HR and activated upon DSB formation. There was a trend (P = 
0.07) for reduced Rad51 mRNA in obese relative to lean ovaries. In lean and obese mice, 
levels of Rad51 mRNA were increased by DMBA exposure compared to control treatments, 
however, the DMBA-induced increased in Rad51 mRNA level was reduced (P < 0.05) in 
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ovaries, relative to the response in lean ovaries (Figure 6A). There was no difference in basal 
RAD51 protein levels between lean and obese ovaries. In lean and obese mice, RAD51 
protein levels were increased (P < 0.05) by DMBA exposure compared to control treatments, 
however, the DMBA-induced RAD51 protein level was lower (P < 0.05) in obese relative to 
lean ovaries (Figure 6B, C). 
DMBA-induction of ovarian Parp1 mRNA and protein in lean and obese mice 
          PARP1 is another protein involved in the response to DSB. Higher basal levels of 
Parp1 mRNA were noted in obese compared to lean ovaries. In lean and obese mice, levels 
of Parp1 mRNA were increased (P < 0.05) by DMBA exposure compared to control 
treatments (Figure 7A). Basal PARP1 protein levels were higher in obese relative to lean 
ovaries. DMBA increased (P < 0.05) PARP1 protein in both lean and obese mice (Figure 7B, 
C).   
 
Discussion 
          Increased bioactivation of DMBA by elevated ovarian mEH during obesity (Nteeba et 
al., 2014) could induce DNA damage since DMBA activation is mediated through mEH, 
reulting in generation of an ovotoxic alkylating metabilite containing two epoxide groups 
(Miyata et al., 1999).  Thus, we assessed the formation of DSBs as well as the DDR in the 
ovaries of DMBA-exposed mice. The dose and route of DMBA exposure was chosen based 
on a previous study (Mattison and Thorgeirsson, 1979) which was shown to be effective in 
destroying approximately 50% of the primordial follicle pool. Female cigarette smokers are 
known to undergo ovarian failure earlier than their non-smoking counterparts (Jick and 
Porter, 1977), however, since it is difficult to extrapolate human ovarian exposure to DMBA 
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due to differences in individual hepatic xenobiotic biotransformation a physiological 
endpoint provides a bioassay approach for measurement of ovarian impacts. This 
physiological endpoint of approximately 50% primordial follicle depletion allows for the 
study of changes to the ovary in the absence of complete depletion of the follicular reserve.  
          Obesity is a detrimental physiological state for oocyte quality and fertility (Wittemer et 
al., 2000; Brewer and Balen, 2010). Maternal obesity increases the risk of offspring birth 
defects (Watkins et al., 2003). Interestingly,  poor quality oocytes (Cardozo et al., 2012) and 
birth defects are also caused by DNA damage in germ cells (Flegal Km et al., 2010; Sauber-
Schatz et al., 2012). The obese mice had elevated basal glucose and had a compromised 
response to a glucose tolerance test (data not shown; (Nteeba et al., 2014). DMBA depleted 
healthy follicles of all types in both lean and obese treated females compared to sesame-
treated females, and ovarian weight was lower in the obese DMBA relative to the lean 
DMBA treated mice, indicating greater levels of ovotoxicity (Nteeba et al., 2014). Since 
DMBA potentially causes ovarian DNA damage and because we observed lower ovarian 
weights in DMBA exposed ovarias from obese mice, relative to their lean counterparts 
(Nteeba et al., 2014), we determined whether obesity has any additive impact on DMBA-
induced ovotoxicity.      
          ATM is recruited upon DSB formation to phosphorylate downstream cellular effector 
molecules resulting in either cell cycle arrest to accomodate DNA repair (Canman et al., 
1998; Lee and Paull, 2007) or apoptosis (Stankovic et al., 2002) (Waster and Ollinger, 2009). 
DMBA exposure decreased Atm mRNA level in lean ovaries while the opposite was the case 
in obese ovaries. Despite this, increased ATM protein was observed in both lean and obese 
ovaries upon DMBA exposure indicating that ovarian DNA damage is imparted by DMBA 
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exposure. Activation of ATM, associated with apoptotic oocyte death, has been previously 
observed during doxorubicin exposure in embryonic stem cells (Soleimani et al., 2011). 
While it is difficult to conclude whether our conflicting effects of DMBA exposure in lean 
and obese ovaries on Atm mRNA levels indicate different mechanisms of regulation during 
obesity, it is clear that DMBA exposure increased ovarian ATM protein regardless of 
metabolic status, supporting that DMBA induces ovarian DNA damage.     
          When a DSB occurs, ATM phosphorylates H2AX (γH2AX), a sensitive marker of 
DSBs (Bouquet et al., 2006; Mah et al., 2010). We demonstrate increased γH2AX protein 
due to DMBA exposure regardless of the presence of obesity. This data are in agreement 
with our previous study that found activated γH2AX protein in neonatal rat ovaries that had 
been exposure to DMBA (Ganesan et al., 2013). Interestingly, low levels of γH2AX protein 
were observed during obesity, independent of DMBA exposure, which may indicate that low 
level DNA damage is present in ovarian tissue of obese females. DNA damage in peripheral 
lymphocytes of obese and overweight italian children has been demonstrated (Jungheim et 
al., 2010), thus our data is in agreement with these studies. Taken together, this data further 
supports that DMBA exposure induces ovarian DNA damage, and that the ovary is 
responsive to such an insult.  
          γH2AX recruits XRCC6 and PRKDC to repair DNA by the NHEJ pathway (Summers 
et al., 2011). Xrcc6 mRNA was increased by DMBA exposure in lean ovaries but no change 
was observed with obesity, though a lower basal level was present. In contrast to mRNA 
data, XRCC6 protein was increased by DMBA in both lean and obese ovaries but this 
increase appeared to be blunted due to obesity. This lowered response could be due to basal 
DNA damage that is seemingly present in ovarian tissue during obesity as suggested by the 
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observed γH2AX. Defective DNA repair and chromosomal instability due to decreased 
XRCC6 have been reported in embryonic cells (Gu et al., 1997). In addition, suppressed 
XRCC6 leads to DNA damage and reactive oxygen species-induced endoplasmic reticulum 
stress in Toll like receptor (TLR) 4 mutant liver cells, ultimately leading to induction of the 
ATM-PRKDC protein complex as well as induction of PARP1, resulting in apoptosis of 
precancerous hepatocytes (Wang et al., 2013). Prkdc mRNA expression was decreased by 
DMBA exposure in lean but increased in obese ovaries. In contrast, despite their being 
reduced basal levels of PRKDC protein in obese relative to lean mice, PRKDC protein 
induction by DMBA exposure was observed in both lean and obese mice. Inhibition of 
PRKDC reduces H2AX phosphorylation and the HR repair mechanism in a medaka 
embryonic cell line (Urushihara et al., 2012). Thus, our data suggest that increased PRKDC 
by DMBA exposure might play a pro-apoptotic role in ovarian tissue.  
          PARP1 is involved in DNA damage-induced cell apoptosis (D'Amours et al., 1999) 
and DMBA has been shown to increase PARP1 expression prior to follicle loss in neonatal 
rat ovaries (Ganesan et al., 2013). DMBA increased both Parp1 mRNA and protein in lean 
and obese ovaries, with ovaries from obese mice having higher basal levels of Parp1. 
Elevated Parp1 could play a role in DMBA-induced ovotoxicity, since PARP1 inhibition 
previously protected against cisplastin-induced renal damage and inflammation (Kim et al., 
2012). Interestingly, the mitochondrial apoptotic pathway mediated by caspase 9 is 
constitutively activated in oocytes and contibutes to the elimination of oocytes with meiotic 
errors through the cleavage and activation of PARP1 (Ene et al., 2013). Thus, increased 
PARP1 observed in our study could mediate increased DMBA-induced ovotoxicity.   
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          RAD51 interacts with BRCA1 during DDR and DMBA exposure increased RAD51 
protein abundance in both prostate tissue (Xu et al., 2002) and in cultured neonatal ovaries  
from rats (Ganesan et al., 2013). In this study, DMBA exposure increased Rad51 mRNA 
levels in lean but not obese mice. Furthermore, ovarian RAD51 protein was upregulated by 
DMBA in the lean females but a reduced response was observed in ovaries from obese 
females. DMBA has been shown to induce ROS generation and DNA damage in Brca1 
knock down MCF10A cells (Kang et al., 2013). In agreement with our previpous study 
demonstrating increased Brca1 in neonatal rat ovaries exposure to DMBA (Ganesan et al., 
2013), we found increased DMBA-induced Brca1 mRNA in ovaries of lean mice but this 
response was partly attentuated in ovaries from obese mice. In contrast, BRCA1 protein was 
increased in ovaries from obese but not lean ovaries due to DMBA exposure. Interestingly, 
and in contrast to increased γH2AX, we noted that basal Brca1 mRNA and protein 
abundance was lower due to obesity. Reduced Brca1 is associated with an increased risk of 
hereditary breast and ovarian cancer (Robson et al., 1998; Kauff et al., 2002). BRCA1 
controls the mitotic checkpoint complex, and loss of this control can lead to mitotic errors 
contributing to neoplasia in ovarian cystadenoma cells (Yu et al., 2012). Further, women 
with Brca1 mutations can experience earlier ovarian senescence and develop ovarian cancer 
at younger ages (Rzepka-Górska et al., 2006). Impairment of BRCA1-related DNA DSB 
repair has been associated with accelerated loss of the ovarian follicular reserve and with 
accumulation of DSB in human oocytes, suggesting that DNA DSB repair efficiency is an 
important determinant of oocyte aging in women (Titus et al., 2013). Thus, any impact of 
DMBA on Brca1 levels could indicate potential negative female fertility consequences.   
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          In summary, our results support that DMBA exposure induces DSB formation in the 
ovary and the DDR is activated in ovarian tissue of exposed mice. Interestingly, we found a 
disconnect between mRNA and protein levels, perhaps indicating that a delay in transcript 
processing occurs in ovaries from obese mice, or that other regulators of gene expression are 
affected potentially including microRNA as we have previously noted in a high fat feeding-
induced obesity mouse model (Nteeba et al., 2013), underscoring the importance of 
investigating translational as well as transcriptional effects of obesity. It is important to note 
that this study represents a snapshot in time of the DMBA-induced ovarian DDR, however, it 
is concerning that the ovaries from obese female mice were observed to have a low level of 
γH2AX protein therein, indicating that DNA damage, outside of ovotoxicant exposure, may 
be present. Also, the ovarian DDR was blunted due to obesity, indicating a reduced ability to 
respond to stress-induced DNA damage. Taken together, the observations reported in this 
study could imply a higher sensitivity to and suceptibility for DMBA-induced ovotoxicity 
effects in obese females.  
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Table 1. Primer sequences used for qRT-PCR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genes Forward primer Reverse primer 
Atm TCAGCAGCACCTCTGATTCTT AGACAGACATGCTGCCTCCT 
Brca1 CCCTCTTAGTCTGCTGAGCT CCTTTGGGTGGCTGTACTGA 
Parp1 AAGTGCCAGTGTCAAGGAGA ACAGGGAGCAAAAGGGAAGA 
Prkdc GCCACAGACCCCAATATCCT TATCTGACCATCTCGCCAGC 
Rad51 ATCCCTGCATGCTTGTTCTC CTGCAGCTGACCATAACGAA 
Xrcc6 GATCTGACACTGCCCAAGGT  TGCTTCTTCGGTCCACTCTT 
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Figure 1. Effect of DMBA on H2AX phosphorylation in lean and obese mice 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by (A) Western blotting to detect γH2AX. Protein abundance was quantified using 
ImageJ software.  Values are expressed as raw data mean ± SE; n=3. Different letters 
indicate P < 0.05. Both DMBA and obesity increase DNA damage formation. 
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Figure 2. Impact of DMBA exposure on ovarian Atm abundance in mice 
 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Atm (A) mRNA or (B,C) protein abundance. (A) Atm was normalized to Gapdh for 
quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries (set 
at 1). (B) Protein abundance was quantified using ImageJ software.  Values are expressed as 
raw data mean ± SE; n=3. Different letters indicate P < 0.05. DMBA increases ATM protein 
levels. 
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Figure 3. DMBA-induction of ovarian Xrcc6 mRNA and protein in mice 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Xrcc6 (A) mRNA or (B,C) protein abundance. (A) Xrcc6 was normalized to Gapdh 
for quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries 
(set at 1). (B) Protein abundance was quantified using ImageJ software. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05. DMBA increases XRCC6 
protein levels. 
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Figure 4. DMBA-induction ovarian Prkdc mRNA and protein in mice 
 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Prkdc (A) mRNA or (B,C) protein abundance.  (A) Prkdc was normalized to Gapdh 
for quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries 
(set at 1). (B) Protein abundance was quantified using ImageJ software. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05. Obesity blunted DMBA 
induced PRKDC protein levels. 
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Figure 5. Impact of DMBA exposure on ovarian Brca1 mRNA and protein in mice 
 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Brca1 (A) mRNA or (B,C) protein abundance. (A) Brca1 was normalized to Gapdh 
for quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries 
(set at 1). (B) Protein abundance was quantified using ImageJ software. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05. Obesity decreases BRCA1 
protein levels. 
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Figure 6. Ovarian DMBA-induced Rad51 mRNA and protein in mice 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Rad51 (A) mRNA or (B,C) protein abundance. (A) Rad51 was normalized to Gapdh 
for quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries 
(set at 1). (B) Protein abundance was quantified using ImageJ software. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05. DMBA increases RAD 51 
protein levels. 
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Figure 7. DMBA-induction of ovarian Parp1 mRNA and protein in mice 
Lean and obese mice were dosed with sesame oil (CT) or DMBA (1 mg/kg; i.p.) for 14 days, 
followed by RNA or protein isolation. qRT-PCR or Western blotting were performed to 
quantify Parp1 (A) mRNA or (B,C) protein abundance. (A) Parp1 was normalized to Gapdh 
for quantification, and values are reported as fold-change (n = 3) relative to lean CT ovaries 
(set at 1). (B) Protein abundance was quantified using ImageJ software. Values are expressed 
as raw data mean ± SE; n=3. Different letters indicate P < 0.05. Both obesity and DMBA 
increase PARP1 protein levels. 
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Abstract 
          7,12-dimethylbenz[a]anthracene (DMBA) destroys ovarian follicles in a concentration-
dependent manner. The impact of DMBA on connexin (CX) proteins that mediate 
communication between follicular cell types was investigated. Postnatal day (PND) 4 Fisher 
344 rat ovaries were cultured for 4 days in vehicle medium (1% DMSO) followed by a single 
exposure to vehicle control (1% DMSO) or DMBA (12.5 nM or 75 nM) and cultured for 4 or 
8 days. RT-PCR or Western blotting was performed to quantify Cx37 or Cx43 mRNA or 
protein level, respectively. Immunofluorescence staining determined CX37 or CX43 level 
and localization. Cx37 mRNA and protein increased (P < 0.05) at 4 days of DMBA exposure. 
Relative to vehicle control-treated ovaries, mRNA encoding Cx43 decreased (P < 0.05) but 
CX43 protein increased (P < 0.05) at 4 days by both DMBA exposures. mRNA expression of 
pro-apoptotic p53 was decreased (P < 0.05) but no changes in Bax expression were observed 
after 4 days of DMBA exposures. In contrast, after 8 days, DMBA decreased Cx37 and Cx43 
mRNA and protein but increased both p53 and Bax mRNA levels. CX43 protein was located 
between granulosa cells, while CX37 was located at the oocyte cell surface of all follicle 
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stages. These findings support that DMBA exposure impacts ovarian Cx37 and Cx43 mRNA 
and protein prior to and at the time of follicle loss. It is possible that such interference in 
follicular cell communication is detrimental to follicle viability, and may play a role in 
DMBA-induced follicular atresia.   
 
Introduction 
          The female gamete, the oocyte, is encased in a follicular structure surrounded by 
granulosa cells and, as the follicle matures, also by theca cells. Primordial follicles are 
maintained in a dormant state until activation into the growing follicular pool (Hirshfield, 
1991). In women, nearly 99% of ovarian follicles undergo degenerative changes by a process 
known as atresia (Hirshfield, 1991) and ovarian senescence (menopause) occurs when the 
finite pool of primordial follicles has become exhausted (Mattison and Nightingale, 1982; 
Broekmans et al., 2007; Hansen et al., 2008). Since primordial follicles cannot be 
regenerated (Hirshfield, 1991), chemical-induced depletion of this follicle pool can lead to 
infertility and premature ovarian failure (POF). A number of chemical classes can deplete 
follicles causing ovotoxicity, including the polycyclic aromatic hydrocarbon, 7,12-
dimethylbenz[a]anthracene (DMBA) (Mattison, 1980; Hoyer et al., 2009; Igawa et al., 
2009). 
          DMBA causes DNA double strand breaks (DSBs) damage in oocytes and granulosa 
cells to cause follicle loss (Ganesan et al., 2013). DSBs activate ataxia-telangiectasia mutated 
(ATM) protein which phosphorylates P53, a tumor suppressor protein. P53 can then activate 
DNA repair proteins, induce cell cycle arrest or initiate apoptosis if the DNA damage proves 
to be irreparable. Phosphorylated P53 activates a number of downstream pro-apoptotic 
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molecules including Bax (Lane, 1992). BAX promotes apoptosis by binding to and 
antagonizing the action BCL-2 protein, resulting in release of cytochrome c and activation of 
caspases to induce apoptosis (Weng et al., 2005). We and others have previously 
demonstrated that ovaries exposed to DMBA have increased levels of caspase 3 protein 
(Tsai-Turton et al., 2007; Ganesan et al., 2013). Additionally, BAX-deficient mice ovaries 
are resistant to DMBA-induced primordial follicle destruction (Matikainen et al., 2001).   
          Granulosa:granulosa and granulosa:oocyte cell to cell communication are necessary for 
maintenance of follicular viability. Communication between these cells occurs through gap 
junction intra-cellular channels, which directly connect the cytoplasmic compartments of 
neighboring cells and allow exchange of ions, metabolites and second messenger such as 
Ca
2+
 and inositol phosphates (Goldberg et al., 2004). Gap junctions are involved in 
regulation of cellular growth, metabolism and differentiation (Sohl and Willecke, 2003; Wei 
et al., 2004) and ovarian folliculogenesis (Simon et al., 2006). The major ovarian gap 
junction proteins are connexin (CX) 37 and 43 (Kidder and Mhawi, 2002a). CX37 
communicates from the oocyte to granulosa cell (Simon et al., 1997), while CX43 functions 
in intra-granulosa cell communication (Granot et al., 2002; Kidder and Mhawi, 2002a). 
CX37 is thought to be involved in follicular development and ovulation as well as luteal 
tissue growth, differentiation, and regression (Borowczyk et al., 2006). Cx37-null mouse 
oocytes suffer growth retardation and do not survive to become meiotically competent 
(Carabatsos et al., 2000). Follicle growth is also interrupted: Cx37
-/-
 granulosa cells form 
structures resembling corpora lutea in the absence of ovulation. CX43 levels are increased in 
granulosa cells following activation of follicular growth and maturation (Melton et al., 2001), 
while reduced granulosa cell expression of CX43 is linked to elevated apoptosis in porcine, 
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bovine (Johnson et al., 1999; Cheng et al., 2005) and avian (Krysko et al., 2004) species. 
Thus, CX37 and CX43 play important roles in the ovary to maintain follicular and oocyte 
viability and quality.   
          Little is known about the impact of ovotoxicant exposures on ovarian function, thus in 
this study we investigated any impact of DMBA on ovarian gap junction genes Cx37 and 
Cx43. We utilized a neonatal rat whole ovary culture method to determine the effect of a 
single DMBA exposure at two concentrations: 12.5 nM and 75 nM on Cx37 and Cx43 
mRNA and protein level. These exposures have previously been shown to cause large 
primary and secondary follicle loss (Madden et al., under review). In addition, we have 
previously shown that these concentrations induce DNA damage and increased caspase 3 
levels after 8 days of exposure. Our hypothesis was that altered Cx37 and Cx43 at timepoints 
prior to observed follicle loss may support that they are targets for DMBA as part of 
DMBA’s mechanism of ovotoxicity.    
 
Methods and Materials 
Reagents 
          7,12-Dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), bovine serum albumin 
(BSA), ascorbic acid, transferrin, 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, 
ammonium persulphate, glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris 
base, Tris HCL, Sodium chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St 
Louis, MO). Dulbecco's Modified Eagle Medium:nutrient mixture F-12 (Ham) 1x 
(DMEM/Ham's F12), Albumax, penicillin (5000U/ml), Hanks' Balanced Salt Solution 
(without CaCl2, MgCl2 orMgSO4) from Invitrogen Co. (Carlsbad, CA). Millicell-CM filter 
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inserts and 48 well cell culture plates were obtained from Millipore (Bedford, MA) and 
Corning Inc. (Corning, NY) respectively. RNeasy Mini kit, QIA shredder kit, RNeasy Min 
Elute kit, and Quantitect TM SYBR Green PCR kit were purchased from Qiagen Inc 
(Valencia, CA). All primers were purchased from the Iowa State University DNA facility. 
All primary antibodies were purchased from Abcam (Cambridge, MA). RNA later was 
obtained from Ambion Inc. (Austin, TX). Goat anti-rabbit secondary antibodies were 
obtained from Santa Cruz Biotechnology, (Santa Cruz, CA). Ponceau S was from Fisher 
Scientific. ECL plus chemical luminescence detection kit was obtained from GE Healthcare, 
Amersham (Buckinghamshire, UK). 
Ovary culture  
          Ovaries were collected from PND4 Fisher 344 female rats and cultured as described 
previously (Devine et al., 2002). Briefly, PND4 female F344 rat pups were euthanized by 
CO2 inhalation followed by decapitation. Ovaries were removed, trimmed of oviduct and 
other excess tissues and placed onto membrane floating on 250 μl of DMEM/Ham's F12 
medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml 
penicillin and 27.5 μg/ml transferrin per well in a 48 well plate that had previously been 
equilibrated to 37 °C. A drop of medium was placed on top of each ovary to prevent it from 
drying. Ovaries were cultured for 4 days in control medium to allow development of large 
primary and secondary follicles, and were then treated once with medium containing vehicle 
control (1% DMSO) ± DMBA (12.5 nM or 75 nM) and the culture was maintained for four 
or eight days at 37 °C and 5% CO2. This exposure induces pre-ovulatory follicle depletion 
after 8 days (Madden et al., under review). The medium was replaced every two days.  
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RNA isolation and qRT-PCR 
          RNA was isolated using an RNeasy Mini kit (Qiagen) and the concentration was 
determined using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop technologies, 
Inc., Wilmington, DE) (n=3; 10 ovaries per pool). Total RNA (200 ng) was reverse 
transcribed to cDNA utilizing the Superscript III One-Step RT-PCR (Qiagen). cDNA was 
diluted (1:20) in RNase-free water. Diluted cDNA (2μl) were amplified on an Eppendorf 
PCR Master cycler using Quantitect SYBR Green PCR kit (Qiagen).  Primers for Cx37, Cx43 
and Gapdh were designed by Primer 3 Input Version (0.4.0); Cx37 forward - 
tgatcacaggtggttctgga; Cx37 reverse - aggagaagtggggtgtgatg: Cx43 forward - 
gagcgaggtttcaacagtgc; Cx43 reverse - ccgaacacgacagcagttta: Gapdh forward - 
gtggacctcatggcctacat; Gapdh reverse – ggatggaattgtgagggaga: p53 forward – 
tggtccagcaaatcctatc; p53 reverse – gagtggaggaaatgggtcct: Bax forward – 
cgagctgatcagaaccatca; Bax reverse – ctcagcccatcttcttccag.  The regular cycling program 
consisted of a 15-min hold at 95
o
C and 45 cycles of denaturing at 95
o
C for 15s, annealing at 
58
o
C for 15s, and extension at 72
o
C for 20s at which point data were acquired. There was no 
difference in Gapdh mRNA expression between treatments, thus each sample was 
normalized to Gapdh before quantification. Quantification of fold-change in gene expression 
was performed using the 2
-Ct 
method (Livak and Schmittgen, 2001; Pfaffl, 2001).  
Protein isolation and Western blotting 
          Protein was isolated from cultured ovaries (n=3; 10 ovaries per pool). Homogenates 
were prepared from cultured ovaries via homogenization in tissue lysis buffer containing 
protease and phosphatase inhibitors as previously described (Thompson et al., 2005). Briefly, 
homogenized samples were placed on ice for 30 min, followed by two rounds of 
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centrifugation at 10,000 rpm for 15 min and protein concentration was measured using a 
BCA protocol. Protein was stored at -80 °C until further use. SDS-PAGE was used to 
separate protein homogenates which were then transferred to a nitrocellulose membrane. 
Membranes were blocked for 1 hour in 5 % milk in Tris-buffered saline containing tween 20, 
followed by incubation with anti-rabbit CX37 or CX43 antibody (1:100) for 36 h at 4
o
C. 
Following three washes in TTBS (1X), membranes were incubated with species-specific 
secondary antibodies (1:2000) for 1 h at room temperature. Membranes were washed 3X in 
TTBS and incubated in chemiluminescence detection substrate (ECL plus) for 5 min 
followed by X-ray film exposure. Densitometry of the appropriate bands was performed 
using ImageJ software (NCBI). Equal protein loading was confirmed by Ponceau S staining 
of membranes and protein level was normalized to Ponceau S densitometry values.     
Immunofluorescence Staining  
          Ovaries were fixed in 4% paraformaldehyde for 2 h, transferred to 70% ethanol, 
embedded in paraffin, serially sectioned (5 µM thick), and every 10th section was mounted. 
Slides were deparaffinized in xylene and rehydrated with subsequent washes in ethanol. 
Antigen retrieval was carried out by microwaving sections for 7 min in sodium citrate buffer 
(1M, pH 6.1). Sections were then blocked in 5% BSA for 1 h at room temperature. Sections 
were incubated with primary antibody CX37 (1:200) and CX43 (1:200) overnight at 4°C. 
After washing in 1% PBS, sections were incubated with the appropriate goat anti-rabbit IgG-
FITC secondary antibodies for 1 h. Slides were then counterstained with 4-6-diamidino-2-
phenylindole (DAPI) or Hoechst for 5 min. Images were taken using a Leica fluorescent 
microscope and protein expression were analyzed using ImageJ software (NCBI). 10-15 
follicles per ovary (n=3) were analyzed for CX37 protein quantification and 3 ovaries were 
123 
 
 
used to quantify CX 43 protein level by counting the number of CX43 positive foci in each 
ovary. 
Statistical analysis 
          Raw data were analyzed by paired t-tests where two treatments were compared or 
ANOVA for comparison of more than two treatments, comparing treatment with control 
using Graphpad Prism 5.04 software. Values are expressed as mean ± SE; n=3 (10 ovaries 
per pool). Statistical significance was defined as * = P < 0.05. 
  
Results 
Effect of DMBA exposure on Cx37 and Cx43 mRNA expression  
          DMBA exposure increased (P < 0.05) Cx37 mRNA (12.5 nM: 3.4-fold ± 0.9;75 nM: 
1.4-fold ± 0.9) at 4 days of exposure. In contrast, DMBA decreased (P < 0.05) Cx43 mRNA 
(12.5nM:0.5-fold ± 0.004; 75 nM: 0.7-fold ± 0.2), compared to vehicle-treated ovaries at 4 
days of exposure (Figure 1A).  At 8 days, both Cx37 and Cx43 mRNA expression were 
decreased (P < 0.05) by 12.5 nM (Cx37: 0.9-fold ± 0.007; Cx43: 0.85-fold ± 0.008) and 75 
nM (Cx37: 0.95-fold ± 0.04; Cx43: 0.95-fold ± 0.06) DMBA compared to vehicle-treated 
ovaries (Figure 1B). 
DMBA alters CX37 and CX43 protein level 
          CX37 protein level was increased (P < 0.05) by 12.5 nM (1.91 ± 0.006) and decreased 
(P < 0.05) by 75 nM DMBA (1.67 ± 0.05) at 4 days, relative to vehicle-treated ovaries (1.88 
± 0.06). CX43 protein level was increased (P < 0.05) by 12.5 nM (2.16 ± 0.03) and by 75 nM 
DMBA (1.62 ± 0.12) at 4 days, relative to vehicle-treated ovaries (0.84 ± 0.08) (Figure 2A). 
At 8 days, CX37 was decreased (P < 0.05) by 12.5 nM (0.95 ± 0.01) compared to vehicle-
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treated ovaries (1.09 ± 0.02), but there was no impact of 75 nM DMBA on CX37.  CX43 
protein level was decreased (P < 0.05) by 12.5 nM (0.93 ± 0.02) and by 75 nM DMBA (0.78 
± 0.05) compared to vehicle-treated ovaries (1.01 ± 0.02) (Figure 2B). 
DMBA affects localization and amount of ovarian CX37 and CX43 proteins  
          CX37 (Figure 3A-C) was localized to the oocyte cell surface. At 8 days, CX37 protein 
staining was increased (P < 0.05) in small primary follicles by 12.5 nM (45.58 ± 1.9) 
compared to 75 nM DMBA (34.35 ± 2.4) and vehicle-treated (37.33 ± 1.9) ovaries and in 
large primary and secondary follicles, CX37 was decreased (P < 0.05) by 12.5 nM (38.1 ± 
0.73 and 31.04 ± 2.9) and by 75 nM (32.74 ± 0.7 and 21.01 ± 2.1) DMBA exposures, relative 
to vehicle-treated (43.17 ± 1.5 and 41.39 ± 1.7) ovaries, respectively (Figure 3H). CX43 
(Figure 3D-F) was localized to the granulosa cells of all follicular stages. CX43 total protein 
staining was decreased (P < 0.05) by 12.5 nM (2708 ± 390) and 75 nM DMBA (3671 ± 
1017) exposures compared to vehicle-treated (6648 ± 920) ovaries at 8 days (Figure 3G). In 
follicles that were devoid of oocytes, CX43 protein localization was absent or negligible.  
DMBA alters p53 and Bax mRNA level 
          Relative to vehicle-treated ovaries, DMBA exposure decreased (P < 0.05) p53 mRNA 
(12.5 nM: 0.7-fold ± 0.04; 75 nM: 0.6-fold ± 0.1) after 4 days of exposure (Figure 4A). In 
contrast, DMBA increased (P < 0.05) p53 mRNA (12.5nM:0.6-fold ± 0.1; 75 nM: 0.4-fold ± 
0.09), compared to vehicle-treated ovaries after 8 days of exposure (Figure 4B). DMBA 
exposure did not affect Bax mRNA (12.5 nM: 0.2-fold ± 0.2; 75 nM: 0.2-fold ± 0.2) after 4 
days of exposure (Figure 4C). In contrast, DMBA increased (P < 0.05) Bax mRNA (12.5nM: 
0.9-fold ± 0.08; 75 nM: 0.8-fold ± 0.1), compared to vehicle-treated ovaries after 8 days of 
exposure (Figure 4D) 
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Discussion 
          DMBA is an ovotoxicant that depletes follicles at various stages of development 
(Rajapaksa et al., 2007; Igawa et al., 2009; Madden et al., under review). The initiating event 
in DMBA-induced follicle destruction remains unclear; however, since cell to cell 
communication is vital for follicular viability, it is possible that perturbation to 
communication within the follicle could have detrimental consequences for the oocyte. CX37 
and CX43 are the major ovarian gap junction proteins, shown to be essential for 
folliculogenesis and production of fertilizable oocytes (Granot et al., 2002; Kidder and 
Mhawi, 2002b; Teilmann, 2005). There is little information on whether ovotoxic chemicals 
target CX proteins and communication within the follicle, thus, we investigated whether 
DMBA had any impact on Cx37 and Cx43. Prior to DMBA-induced follicle loss, Cx37 
mRNA and protein was increased and although Cx43 protein was elevated, mRNA encoding 
the Cx43 gene was decreased. These data indicate that DMBA may target Cx43 at the 
transcriptional level initially, and that increased Cx37 mRNA and protein and CX43 protein 
may be part of the ovarian protective response to DMBA exposure. Both Cx37 and Cx43 
mRNA and protein were decreased by DMBA exposures at 8 days. This time coincides with 
DMBA-induced follicle depletion (Madden et al., under review) and therefore may simply be 
a consequence of reduced follicle number.  
          Cx37-null mice display retarded oocyte growth (Carabatsos et al., 2000) due to lack of 
nutrient intake from extracellular environment (Eppig, 1991). We found that CX37 protein 
was localized to the oocyte cell surface, in agreement with a previous report in the mouse 
ovary (Teilmann, 2005; Simon et al., 2006). Lack of organized CX37 localization around the 
oocyte perimeter has been reported as an early sign of follicular atresia (Teilmann, 2005), 
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thus, the perturbations to Cx37 mRNA and protein could impact follicular viability during 
DMBA-induced ovotoxicity. Interestingly, increased CX37 protein was evident in the small 
primary follicles at 12.5 nM DMBA. Since small primary follicle numbers are not impacted 
by DMBA at this concentration (Madden et al., under review), it is possible that increased 
CX37 is protective against DMBA-induced follicle loss. 
          Cx43 mRNA and protein level are correlated with follicular development in immature 
rats (Granot and Dekel, 1997). In extra-ovarian tissues, CX43 is inversely correlated with 
apoptosis, acting as a survival factor (Lin et al., 2003). The increase in Cx43 mRNA level 
after 4 days of DMBA exposure potentially indicates an anti-apoptotic role for ovarian 
CX43. Consistent with this posit, at the time point when follicle loss was observed (Madden 
et al., under review), Cx43 mRNA and protein were decreased by DMBA exposure which is 
consistent with lower expression of Cx43 mRNA and protein expression in cryopreserved 
apoptotic mouse ovarian tissue (Lee et al., 2008). This decrease in Cx43 mRNA and protein 
is also associated with increased caspase 3 protein in ovaries treated with the same DMBA 
concentrations (Ganesan et al., 2013). An elevated level of apoptosis associated with low 
expression of CX43 has also been reported in avian granulosa cells (Krysko et al., 2004).  
CX43 protein was localized between the granulosa cells in all stage follicles, consistent with 
a previous study that reported CX43 localization in the gap junctions connecting rat ovarian 
granulosa cells, with highest expression in pre-mature and pre-ovulatory antral follicles 
(Okuma et al., 1996; Gittens and Kidder, 2005). Interestingly, in large primary and secondary 
follicles that were devoid of oocytes, CX43 protein was either absent or negligible, implying 
that some oocyte-derived factor may be involved in CX43 protein maintenance. Despite our 
observed reduction of CX43 protein from total protein homogenates, the number of CX43 
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positive foci was increased. This may be representative of an attempt to increase gap junction 
communication and promote survival.   
           We also found increased levels of pro-apoptotic p53 and Bax at the time of follicle 
loss (8 days) but not before the time of follicle loss (4 days). Decreased p53 prior to follicle 
loss, could be due to interaction of p53 with mdm2, resulting in p53 inhibition (Lakin and 
Jackson, 1999). Additionally, there was no induction of Bax until the time-point at which 
follicle loss was observed (day 8). These results are in agreement with another study that 
demonstrated increased pro-apoptotic BAX and caspase-3 in granulosa cells of DMBA-
exposed pre-ovulatory follicles (Tsai-Turton et al., 2007).  
            In summary, DMBA alters ovarian Cx37 and Cx43 at the transcriptional and post-
transcriptional levels. The initial increase in CX37 and CX43 proteins in response to DMBA 
exposure demonstrates the capacity of ovarian tissue to mount a compensatory response to an 
ovotoxic insult.  
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Figure 1. Effect of DMBA exposure on Cx37 and Cx43 mRNA expression 
Total RNA was isolated from PND4 rat ovaries that were cultured in control medium for 4 
days followed by a single exposure to control (CT), 12.5 or 75 nM DMBA for (A) 4 or (B) 8 
days. qRT-PCR was performed to amplify Cx37 or Cx43 mRNA. Values are expressed as 
mean fold change ± SE; n=3 (10 ovaries per pool). Statistical significance was defined as * = 
P < 0.05. DMBA alters connexins gene expression. 
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Figure 2. Effect of DMBA exposure on CX37 and CX43 protein level 
Total protein was isolated from PND4 rat ovaries that were cultured in control medium for 4 
days followed by a single exposure to control (CT), 12.5 or 75 nM DMBA for (A) 4 or (B) 8 
days. (C) Western blotting was performed to quantify CX37 or CX43 protein level (day 8).  
Values are expressed as densitometric mean ± SE; n=3 (10 ovaries per pool). Statistical 
significance was defined as * = P < 0.05. DMBA alters connexins protein levels. 
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Figure 3. Impact of DMBA exposure on ovarian CX37 and CX43 protein level 
PND4 rat ovaries were cultured in control medium for 4 days followed by a single exposure 
to control (CT), 12.5 or 75 nM DMBA for 8 days. Ovarian sections were immunostained 
using primary (A-C) CX37 (green stain) or (D-F) CX43 (red stain) antibodies to check the 
localization and intensity of staining. Blue staining represents nuclear DNA staining. Thin 
arrows indicate primordial/small primary follicles; thick arrows indicate large 
primary/secondary follicles; chevron indicates follicle lacking an oocyte. ImageJ software 
was used to analyze the intensity of staining. 10-15 follicles per ovary (n=3) were used for 
(G) CX37 quantification and 3 ovaries were used for (H) CX43 positive foci quantification. 
Values are expressed as densitometric mean ± SE.  *= P< 0.05; different from control. 
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Figure 4. Effect of DMBA exposure on p53 and Bax mRNA expression 
 
Total RNA was isolated from PND4 rat ovaries that were cultured in control medium for 4 
days followed by a single exposure to vehicle control (CT), 12.5 or 75 nM DMBA for (A, C) 
4 or (B, D) 8 days. qRT-PCR was performed to amplify (A, B) p53 or (C, D) Bax mRNA. 
Values are expressed as mean fold change ± SE; n=3 (10 ovaries per pool). Statistical 
significance was defined as * = P < 0.05. DMBA increase apoptotic genes during follicle 
loss. 
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Abstract 
          The ovarian gap junction proteins connexin 37, 43 and 45 are involved in cell 
communication and folliculogenesis. 7,12-dimethylbenz[a]anthracene (DMBA) alters CX37 
and CX43 expression in cultured neonatal rat ovaries. Additionally, obesity has an additive 
effect on DMBA-induced ovotoxicity, thus, we investigated any impacts of obesity and 
DMBA on gap junction protein levels using an in vivo model. Ovaries were collected from 
lean and obese mice aged 6, 12, 18, or 24 wks.  A subset of 18 wk old mice (lean and obese) 
was dosed with sesame oil or DMBA (1 mg/kg; i.p) for 14 days and ovaries collected 3 days 
thereafter. Cx43, Cx45 mRNA and protein levels were decreased (P < 0.05) after 18 wks 
while Cx37 mRNA and protein levels were decreased (P < 0.05) after 24 wks in obese 
ovaries. Cx37 mRNA and antral follicle protein staining intensity were reduced (P < 0.05) by 
obesity while total CX37 protein was reduced (P < 0.05) in DMBA exposed obese ovaries. 
Cx43 mRNA and total protein levels were decreased (P < 0.05) by DMBA in both lean and 
obese ovaries while basal protein staining intensity was reduced (P < 0.05) in obese controls. 
Cx45 mRNA, total protein and protein staining intensity level were decreased (P < 0.05) by 
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obesity. These data support that obesity temporally alters gap junction protein expression and 
that DMBA-induced ovotoxicity may involve reduced gap junction protein function.  
 
Introduction 
          The ovary is the major female reproductive organ composed of follicles at different 
developmental stages from primordial to antral. Follicles contain a single oocyte, arrested in 
the diplotene stage of meiosis, which are surrounded by single to multiple layers of granulosa 
cells dependent on the stage of development. Granulosa cells are the somatic follicular cells 
and their functions include production of sex steroid hormones and growth factors which are 
essential for fertile reproductive life of women. Granulosa cell death by apoptosis is 
reportedly involved in the process of follicular atresia in the mammalian ovary (Tilly, 1997; 
Jiang et al., 2003). 
          Connexins (CX) are a family of transmembrane proteins that connect to form gap 
junctions; channels which allow direct exchange of ions and small molecules between 
adjacent cells and which are involved in cell proliferation, differentiation, cell survival, 
oocyte maturation, meiotic resumption and death (Gershon et al., 2008; Conti et al., 2012; 
Kar et al., 2012). Eight CX proteins are expressed in ovaries encoded by the Cx26, Cx30.3, 
Cx32, Cx37, Cx40, Cx43, Cx45 and Cx57 genes (Grazul-Bilska et al., 1997; Kidder and 
Mhawi, 2002). The most abundant gap junction proteins expressed in the mice ovaries are 
CX37, CX43 and CX45 (Simon et al., 1997; Ackert et al., 2001; Wright et al., 2001). CX37 
is present between the oocyte and granulosa cell (Simon et al., 1997) while CX43 
(Valdimarsson et al., 1993; Gittens, 2003) and CX45 (Okuma et al., 1996; Alcoléa et al., 
1999; Wright et al., 2001) co-localize between granulosa cells. CX proteins are expressed in 
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a temporal pattern during follicular development and maturation in mouse ovaries (Wright et 
al., 2001), and defects in oocyte and follicular development have been identified in CX37 
deficient mice in which heterologous oocyte-granulosa cell gap junctions were under 
developed (Carabatsos et al., 2000). CX43 protein expression was also reduced in ovarian 
granulosa cells during follicular atresia in pigs and swamp buffaloes (Cheng et al., 2005; 
Feranil et al., 2005). These studies indicate that CXs are important for completion of oocyte 
growth, acquisition of cytoplasmic meiotic competence and follicular survivability.  
          CX proteins are targeted by chemicals including retinoids, carotinoids, 
chemotherapeutic agents (King and Bertram, 2005), cigarette components (McKarns et al., 
2000) and polycyclic aromatic hydrocarbons including 7,12-dimethylbenz[a]anthracene 
(DMBA) (Sharovskaya et al., 2006; Ganesan and Keating, 2014). DMBA, liberated from 
burning of organic matter incineration, destroys all type of follicles in the ovaries of exposed 
mice and rats leading to ovarian failure (Gelboin, 1980; Mattison and Schulman, 1980).  
Cigarette smoke causes premature menopause onset in female smokers compared to their age 
matched non-smoking counterparts (Mattison et al., 1983; Alcoléa et al., 1999; Harlow and 
Signorello, 2000) and the offspring of female smokers have decreased numbers of oocytes, 
potentially leading to infertility (Jurisicova et al., 2007). DMBA destroys follicles by 
inducing apoptosis through increased expression of pro-apoptotic BAX and activation of the 
executioner protein caspase 3 (Tilly et al., 1991; Tsai-Turton et al., 2007). Additionally, 
DMBA alters the connexin gap junction protein expression when neonatal cultured rat 
ovaries were exposed in vitro (Ganesan and Keating, 2014).  
          Approximately one-third of adults in the USA are obese (Flegal Km et al., 2010; 
Meeker et al., 2010), and negative female phenotypic associations include polycystic ovarian 
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syndrome, menstrual disorders, intrauterine fetal death and infertility (Haslam and James; 
Cardozo et al., 2012). Obesity also detrimentally affects pregnancy rates in natural and 
assisted conception potentially by reducing oocyte quality (Wu et al., 2011). Primordial and 
small primary follicle numbers were reduced in ovaries from obese mice with a concomitant 
increase in number of secondary and pre-ovulatory follicles relative to lean mouse ovaries 
(Nteeba et al., 2014a). Additionally, ovaries from mice fed a high fat diet showed increased 
accumulation of endoplasmic reticulum stress, decreased mitochondrial activity and 
increased apoptosis of cumulus oocyte complexes and ovarian cells (Wu et al., 2010).  
Interestingly, a high fat diet also reduced cardiovascular connexin expression in female rats 
resulting in increased risk of ventricular arrhythmia (Aubin et al., 2010). Taken together, 
both DMBA and obesity have separately been shown to affect Cx gene mRNA and protein 
levels, thus this study investigated both the impact of obesity and DMBA exposure on 
ovarian Cx mRNA and protein levels using the lethal yellow mouse model of progressive 
obesity.   
 
Methods and Materials 
Reagents 
          7,12-dimethylbenz[a]anthracene (DMBA; CAS # 57-97-6), sesame oil (CAS # 8008-
74-0), 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, ammonium persulphate, 
glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris base, Tris HCL, Sodium 
chloride, Tween-20 were purchased from Sigma-Aldrich Inc. (St Louis, MO).  RNeasy Mini 
kit, QIA shredder kit, RNeasy Min Elute kit, and Quantitect TM SYBR Green PCR kit were 
purchased from Qiagen Inc (Valencia, CA). All primers were purchased from the Iowa State 
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University DNA facility. All primary antibodies were purchased from Abcam (Cambridge, 
MA). RNA later was obtained from Ambion Inc. (Austin, TX). Goat anti-rabbit secondary 
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Ponceau S was 
from Fisher Scientific. ECL plus chemical luminescence detection kit was obtained from GE 
Healthcare, Amersham (Buckinghamshire, UK). 
Animals 
          The ovarian tissues utilized in this study were obtained as part of a larger study in our 
laboratory (Nteeba et al., 2014a; Nteeba et al., 2014b). Briefly, four week old female wild 
type normal non-agouti (a/a; designated lean; n = 10) and agouti lethal yellow (KK.Cg-Ay/J; 
designated obese; n = 10) were purchased from Jackson laboratories (Bar Harbor, ME 
002468). All animals were housed in cages under a 12 h light/dark photoperiod with the 
temperature between 70-73
o
F and humidity approximately 20-30%. The animals were 
provided with a standard diet (Teklad 2014 global 14% protein rodent maintenance diet) with 
ad libitum access to food and water until 6, 12, 18 or 24 wks of age. Also, a subset of 18 wk 
old mice were dosed with sesame oil (vehicle control; n = 5 lean; n = 5 obese) or DMBA 
(1mg/kg; intraperitoneal injection; n = 5 lean; n = 5 obese) for 14 days and ovaries collected 
3 days after the end of exposure. This DMBA dose was chosen based on the literature to 
induce approximately 50% primordial follicle loss (Borman et al., 2000). All procedures 
were approved by the Iowa State University Animal Care and Use Committee.  
Tissue collection  
          At the end of each experimental time point, mice were euthanized in their pro-estrus 
phase of cyclicity by CO2 asphyxiation. Ovaries were collected and cleaned off excess fat and 
stored in RNAlater at -80
0
C or fixed in 4% paraformaldehyde. 
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RNA isolation and qRT-PCR 
          RNA was isolated using an RNeasy Mini kit (Qiagen) and the concentration 
determined using an ND-1000 Spectrophotometer (λ = 260/280nm; NanoDrop technologies, 
Inc., Wilmington, DE) (n=3).  Total RNA (200 ng) was reverse transcribed to cDNA utilizing 
the Superscript III One-Step RT-PCR (Qiagen). Diluted (1:20) cDNA (2 μl) were amplified 
on an Eppendorf PCR Master cycler using Quantitect SYBR Green PCR kit (Qiagen).  
Primers for Cx37, Cx43 and Cx45 and Gapdh were designed by Primer 3 Input Version 
(0.4.0) (Table 3). The regular cycling program consisted of a 15 min hold at 95
o
C and 45 
cycles of denaturing at 95
o
C for 15 s, annealing at 58
o
C for 15 s, and extension at 72
o
C for 20 
s at which point data were acquired. There was no difference in Gapdh mRNA expression 
between treatments, thus each sample was normalized to Gapdh before quantification. 
Quantification of fold-change in gene expression was performed using the 2
-Ct 
method 
(Livak and Schmittgen, 2001; Pfaffl, 2001). 
Protein isolation and western blotting 
          Protein was isolated from whole ovaries (n=3) by homogenization in tissue lysis buffer 
containing protease and phosphatase inhibitors as previously described (Ganesan and 
Keating, 2014). Briefly, homogenized samples were placed on ice for 30 min, followed by 
two rounds of centrifugation at 10,000 rpm for 15 min and protein concentration was 
measured using a standard BCA protocol. SDS-PAGE was used to separate protein 
homogenates which were then transferred to a nitrocellulose membrane. Membranes were 
blocked for 1 hour in 5 % milk in Tris-buffered saline containing tween 20, followed by 
incubation in anti-rabbit CX37, CX43 and CX45 primary antibodies (1:100) for 36 h at 4
o
C. 
Following three washes in TTBS (1X), membranes were incubated with species-specific 
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secondary antibodies (1:3000) for 1 h at room temperature. Membranes were washed 3X in 
TTBS and incubated in enhanced chemiluminescence detection substrate (ECL plus) for 5 
min followed by X-ray film exposure. Densitometry of the appropriate bands was performed 
using ImageJ software (NCBI). Equal protein loading was confirmed by Ponceau S staining 
of membranes and protein level was normalized to Ponceau S densitometry values.    
 Immunofluorescence staining  
          Ovaries were fixed in 4% paraformaldehyde for 2 h, transferred to 70% ethanol, 
embedded in paraffin, serially sectioned (5 µM thickness), and every 10th section was 
mounted. Slides were deparaffinized in xylene and rehydrated with subsequent washes in 
ethanol. Antigen retrieval was carried out by microwaving sections for 7 min in sodium 
citrate buffer (1M, pH 6.1). Sections were then blocked in 5% BSA for 1 h at room 
temperature. Sections were incubated with primary antibody directed against CX37 (1:200), 
CX43 (1:200) or CX45 (1:100) overnight at 4°C. After washing in 1% PBS, sections were 
incubated with the appropriate goat anti-rabbit IgG-FITC secondary antibody for 1 h. Slides 
were then counterstained with 4-6-diamidino-2-phenylindole (DAPI) for 5 min. Images were 
taken using a Leica fluorescent microscope and protein expression were analyzed using 
ImageJ software (NCBI). 10 antral follicles per ovary and 3 ovaries were used for protein 
analysis. 
Statistical analysis 
          Raw data were analyzed by unpaired t-test using Graphpad Prism 5.04 software. 
Values are expressed as fold change ± SE for mRNA expression and raw data mean ± SE for 
total protein and protein, n=3. Different letters or asterisk (*) indicate statistical significance 
at P < 0.05. 
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Results 
Effect of progressive obesity on Cx37 mRNA and protein abundance  
          In lean mice, Cx37 mRNA levels were increased (P < 0.05) at 24 wks compared to 
earlier time points (Figure 1A) while no changes in obese ovaries across time points (Figure 
1B). At 24 wks of age, obese mice had lower (P < 0.05) ovarian Cx37 mRNA abundance 
relative to their lean counterparts (Figure 1C). CX37 protein levels were decreased (P < 0.05) 
in ovaries from lean mice at both 18 and 24 wks, relative to 6 and 12 wks of age, however, 
the level of CX37 was greater (P < 0.05) at 24 wks than 18 wks (Figure 1D). A similar 
pattern was observed in CX37 protein in obese ovaries; however the 24 wk rebound did not 
occur (Figure 1E). Comparison of lean to obese ovarian CX37 levels revealed that obese 
ovaries had higher (P < 0.05) CX37 levels at 12 wks but lower (P < 0.05) levels at 24 wks, 
relative to lean ovaries (Figure 1F, G).   
Progressive obesity impact on Cx43 mRNA and protein level  
          A temporal pattern of increased (P < 0.05) Cx43 mRNA was observed in both lean and 
obese mice (Figure 2A, B). Comparison of Cx43 mRNA between ovaries from lean and 
obese mice demonstrated increased (P < 0.05) Cx43 mRNA at the 12 wk time point, however 
Cx43 mRNA was reduced (P < 0.05) in the 18 and 24 wk aged mice (Figure 2C) in obese 
relative to lean ovaries. Ovarian CX43 protein levels were increased (P < 0.05) over time in 
lean mice (Figure 2D). Progressive obesity resulted in reduced (P < 0.05) ovarian CX43 
(Figure 2E) and this reduction was reflected in decreased (P < 0.05) CX43 in obese relative 
to lean ovaries at the 18 and 24 wks time points (Figure 2F,G).   
 
 
143 
 
 
Effect of obesity on ovarian Cx45 mRNA and protein abundance 
          There was a dramatic decrease (P < 0.05) in Cx45 mRNA over time in both lean and 
obese ovaries (Figures 3A, B). Interestingly, Cx45 mRNA abundance was greater (P < 0.05) 
in obese relative to lean ovaries at the 12 wk time point; however this effect was reversed (P 
< 0.05) at 18 and 24 wks of age (Figure 3C). CX45 protein level was decreased over time in 
both lean and obese ovaries (Figure 3D, E). In a similar manner to Cx45 mRNA, protein 
levels were greater (P < 0.05) in ovaries from obese mice at 12 wks of age, and a reduction 
(P < 0.05) was observed at both the 18 and 24 wk aged mice (Figure 3F, G).   
DMBA effects on Cx37 mRNA and protein level 
          At the end of DMBA dosing and tissue collection, animals were 20.5 wks of age.  
Basal levels of Cx37 mRNA were decreased (P < 0.05) in obese compared to lean ovaries.  
In both lean and obese mice, levels of Cx37 mRNA were not changed by DMBA exposure 
compared to their control counterparts, however, Cx37 mRNA levels were decreased (P < 
0.05) in obese relative to lean ovaries after DMBA exposure (Figure 4A). CX37 total protein 
basal levels were not changed in obese compared to lean ovaries. In lean mice, levels of 
CX37 total protein were not affected by DMBA exposure compared to control-treated 
ovaries. In contrast, DMBA exposure decreased (P < 0.05) CX37 total protein level in 
ovaries from obese mice, compared to obese control-treated animals (Figure 4B, C). 
Impact of DMBA exposure on ovarian Cx43 mRNA and protein  
          Basal levels of Cx43 mRNA were not changed in obese compared to lean ovaries.  In 
both lean and obese mice, levels of Cx43 mRNA were decreased (P < 0.05) by DMBA 
exposure compared to control-treated ovaries. Cx43 mRNA level was decreased to a greater 
extent (P < 0.05) in ovaries from obese mice relative to their lean littermates after DMBA 
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exposure (Figure 5A). CX43 total protein basal levels were not changed (P < 0.05) in obese 
compared to lean ovaries. In both lean and obese mice, levels of CX43 protein were 
decreased (P < 0.05) by DMBA exposure compared to control-treated ovaries. There was no 
difference in CX43 protein level between obese and lean ovaries after DMBA exposure 
(Figure 5B, C). 
Consequence of DMBA exposure on Cx45 mRNA and protein expression 
          Basal levels of Cx45 mRNA were decreased (P < 0.05) in obese compared to lean 
ovaries.  In both lean and obese mice, levels of Cx45 mRNA were not changed (P < 0.05) by 
DMBA exposure compared to their respective control-treated ovaries (Figure 6A). CX45 
protein abundance was decreased (P < 0.05) in obese compared to lean ovaries. In lean mice, 
levels of CX45 total protein were not changed by DMBA exposure compared to control-
treated ovaries. In contrast, DMBA exposure increased (P < 0.05) CX45 total protein level in 
ovaries from obese mice, compared to obese control-treated animals (Figure B, C). 
Localization and quantification of obesity and DMBA effects on CX proteins 
          CX37 was localized to the oocyte cytoplasm of the oocyte and between the granulosa 
cells (Figure 7A-D). CX37 protein basal levels were lower (P < 0.05) in obese relative to 
lean ovaries. Similar to the western blotting data, in both lean and obese mice, levels of 
CX37 protein were unchanged by DMBA exposure compared to control-treated ovaries.  
CX37 protein level was decreased in obese ovaries compared to lean ovaries after DMBA 
exposure (Figure 7M). CX43 was localized between the granulosa cells (Figure 7E-H).  
CX43 protein levels were lower (P < 0.05) in antral follicles of obese relative to lean ovaries.  
In both lean and obese mice, levels of CX43 protein were decreased (P < 0.05) by DMBA 
exposure compared to control-treated ovaries. CX43 protein level was decreased to a greater 
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extent in obese ovaries compared to lean ovaries after DMBA exposure (Figure 7N). CX45 
proteins were localized between the granulosa cells (Figure 7I-L). CX45 protein levels were 
lower (P < 0.05) in obese relative to lean ovaries. In both lean and obese mice, levels of 
CX45 protein were unchanged by DMBA exposure compared to control-treated ovaries.  
CX45 protein level was lower in obese than in lean ovaries after DMBA exposure (Figure 
7O). 
 
Discussion 
          High fat diet fed mice have increased levels of apoptosis in cumulus oocyte complexes 
and granulosa cells (Wu et al., 2010) and reduced connexin expression in hearts of female 
rats (Aubin et al., 2010), potentially supporting that obesity alters connexin protein 
abundance.  DMBA altered connexin gene expression in neonatal ovaries (Ganesan and 
Keating, 2014), however, the effect of DMBA on connexin level in adult mouse ovaries has 
not yet been studied. Also, our previous work has demonstrated that the level of an enzyme 
required for DMBA bioactivation is higher in ovaries of obese mice, potentially predisposing 
them to increased DMBA-induced ovotoxicity (Nteeba et al., 2014a). Thus, this study 
investigated the impacts of both progressive obesity and DMBA exposure on ovarian 
connexin mRNA and protein abundance. 
          CX37 is essential for follicular development, ovulation as well as luteal tissue growth, 
differentiation, and regression (Simon et al., 1997). Ovarian Cx37 mRNA level was 
increased in 24 wk old mice however total protein was decreased after 18 wks in lean mice 
ovaries potentially indicating that CX37 protein levels decline with ovarian aging. Cx37 
mRNA was previously shown to be reduced in the mesenteric arteries of 25 wk old insulin 
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resistant obese compared to lean littermate control rats (Young et al., 2008). CX37 total 
protein was decreased after 18 wks in obese mice ovaries. Ovaries from obese mice had 
lower levels of Cx37 mRNA and protein after 24 wks compared to lean ovaries, but in a 
similar manner to the lean mice, Cx37 mRNA declined with aging in obese females. This 
observed decline in Cx37 mRNA with progressive obesity could also be due to altered 
folliculogenesis as observed from 12 wks onwards (Nteeba et al., 2014b).     
          In a similar manner to our previous study in neonatal cultured rat ovaries (Ganesan and 
Keating, 2014), DMBA decreased CX37 total protein levels. Further, obesity had a greater 
impact on the DMBA-induced decrease in CX37; suggesting DMBA may accelerate the 
decrease in CX37 protein levels during obesity, further contributing to ovotoxicity. CX37 
protein was localized in the cytoplasm of oocyte (oolemma) and in the granulosa cells of 
large follicles, consistent with our previous study (Ganesan and Keating, 2014) and others 
who showed that CX37 is present on the oocyte surface of pre-antral follicles and between 
the granulosa cells of large antral follicles in mouse ovaries (Wright et al., 2001; Teilmann, 
2005; Simon et al., 2006). Loss of organized CX37 localization around the oocyte perimeter 
is an early sign of follicular atresia (Teilmann, 2005), and suggests that intact cellular 
communication between the oocyte and the somatic cells is mandatory for follicular health.  
CX37 antral follicle protein staining intensity was reduced in both the obese control and 
DMBA treated ovaries compared to lean ovaries, in agreement with our previous work 
demonstrating that CX37 protein was decreased in cultured neonatal rat ovaries after DMBA 
exposure (Ganesan and Keating, 2014). Reduced CX37 has also been shown in denuded 
oocytes of diabetic mice compared to non-diabetic mice (Ratchford et al., 2008). Our results 
indicate that CX37 protein levels are reduced by aging, progressive obesity and DMBA 
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exposure, potentially interfering with the role of CX37 during follicular development, 
maintenance of germinal vesicle and ovulation.  
          CX43 forms channels between granulosa cells, which are required for their 
proliferation (Gittens, 2003). Granulosa cells recovered from Cx43
-/-
 mice fail to show 
electrical coupling (Tong et al., 2005). In the present study, Cx43 mRNA and protein levels 
were increased in lean ovaries after 18 wks which was similar to previous study that CX43 
protein expression was increased in wild-type littermates compared to Gja1
Jrt/+
 mutant mice 
after 11 wks of age in ovaries (Flenniken et al., 2005). However, Cx43 mRNA and protein 
levels were decreased in obese ovaries compared to lean ovaries in agreement with another 
study demonstrating that a high fat diet induced low CX43 protein levels, restorable by 
pharmacological intervention in cardiac tissues of 32 wk old mice (Noyan-Ashraf et al., 
2013). Decreased CX43 levels in autopsied uterine tissue were also demonstrated in rats fed 
a high fat and high cholesterol diet for approximately 8.5 wks (Elmes et al., 2011). These 
data further support that CX43 protein levels are decreased during progressive obesity.  
          DMBA exposure decreased Cx43 mRNA and total protein levels both in lean and 
obese mice ovaries consistent with our previous study in neonatal female rat pups ovaries 
which indicated that DMBA reduced Cx43 mRNA and protein levels prior to follicle loss 
(Ganesan and Keating, 2014). Since DMBA is a component of cigarette smoke these results 
are consistent with previous studies that cigarette smoke reduced CX43 expression in the 
corporal cavernosum of male rats (Liu et al., 2011) and in human pancreatic ductal epithelial 
cells (Tai et al., 2007). Cx43 mRNA and protein were also decreased in atretic follicles in rat 
ovaries (Wiesen and Midgley, 1994). Immunohistochemistry staining in our study localized 
CX43 protein between the granulosa cells and CX43 protein staining intensity was reduced 
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in obese ovaries. The intensity of CX43 protein staining was also reduced by DMBA 
exposure in lean and obese ovaries. An increase in apoptotic follicles associated with a 
decrease in the ovarian CX43 expression was recently shown in acute hyperglycemia and 
chronic diabetic female mice (Chang et al., 2005). The reduced amount of CX43 protein 
staining by DMBA exposure and by obesity indicates that antral follicles could be 
undergoing atresia. 
          CX45 is localized between granulosa cells and expressed throughout follicular 
development (Okuma et al., 1996). Cx45 mRNA and protein were decreased in both lean and 
obese ovaries after 12 wks of age but CX45 protein increased after 18 wks of age in lean 
ovaries. In contrast, the level of Cx45 mRNA and protein were both reduced after 18 wks of 
age in obese relative to lean ovaries. Also, Cx45 mRNA and total protein levels were reduced 
in obese ovaries compared to lean ovaries after DMBA exposure. Since this is the first study 
to explore the level of CX45 protein levels after chemical exposure, the results indicate that 
CX45 is responsive to both DMBA exposure and progressive obesity. CX45 staining was 
found to be restricted to gap junctions between granulosa cells of large antral follicles 
(Wright et al., 2001). We also found that CX45 protein was present between the granulosa 
cells of antral follicles and the intensity of protein staining was reduced by obesity in antral 
follicles of obese mice. Additionally, CX45 is reported to co-localize with CX43 protein in 
rat ovaries (Okuma et al., 1996). Our results suggest that both CX43 and CX45 protein 
staining intensity were reduced by obesity and that CX43 is more sensitive to DMBA 
exposure than CX45.  
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          In summary, we report that ovarian aging, obesity and DMBA exposure each alter 
connexin gap junction protein expression in ovaries in a manner that could contribute to 
compromised reproduction observed during each one of these physiological paradigms.  
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Table 1. Primer sequences used for qRT-PCR 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Forward primer Reverse primer 
Cx37 TGATCACAGGTGGTTCTGGA AGGAGAAGTGGGGTGTGATG 
Cx43 TGCAAGTGTGTAAGCGTGTG TTGCACGGCAGGAATTCTAT 
Cx45 TGGTTGGGCTTAAAACTTGG CAGCTCCACCTTCAGAGTCC 
Gapdh GTGGACCTCATGGCCTACAT GGATGGAATTGTGAGGGAGA 
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Figure 1. Effect of progressive obesity on Cx37 mRNA and protein abundance 
Ovaries were collected from 6, 12, 18 or 24 wks aged mice to isolate RNA and protein to 
perform qRT-PCR (A-C) and western blot (D-G). Analysis between lean alone (A, D), obese 
alone (B, E) and between lean and obese or interaction (C, F) and values are expressed as 
fold change ± SE for mRNA expression and raw data mean ± SE for protein expression; n=3. 
Different letters or asterisk (*) indicate the statistical significance P < 0.05. Connexin 37 
decreases during aging and during progressive obesity. 
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Figure 2. Progressive obesity impact on Cx43 mRNA and protein level 
Ovaries were collected from 6, 12, 18 and 24 wks of age to isolate RNA and protein to 
perform qRT-PCR (A-C) and western blot (D-G). Analysis between lean alone (A, D), obese 
alone (B, E) and between lean and obese or interaction (C, F) and values are expressed as 
fold change ± SE for mRNA expression and raw data mean ± SE for protein expression; n=3. 
Different letters or asterisk (*) indicate the statistical significance P < 0.05. Connexin 43 
increases after24 wks while decreases by progressive obesity. 
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Figure 3. Effect of obesity on ovarian Cx45 mRNA and protein abundance 
Ovaries were collected from 6, 12, 18 and 24 wks of age to isolate RNA and protein to 
perform qRT-PCR (A-C) and western blot (D-G). Analysis between lean alone (A, D), obese 
alone (B, E) and between lean and obese interaction (C, F) and values are expressed as fold 
change ± SE for mRNA expression and raw data mean ± SE for protein expression; n=3. 
Different letters or asterisk (*) indicate statistical significance P < 0.05. Connexin 45  
increases after 24 wks while decreases by progressive obesity. 
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Figure 4. DMBA effects on Cx37 mRNA and protein level 
Following exposure to DMBA at 1mg/kg for 14 days, total mRNA and protein were isolated 
to perform qRT-PCR (A) and western blot analysis (B, C). Values are expressed as fold 
change ± SE for mRNA expression and raw data mean ± SE for total protein; n=3. Different 
letters indicate the statistical significance P < 0.05. DMBA alters CX 37 protein during 
obesity. 
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Figure 5. Impact of DMBA exposure on ovarian Cx43 mRNA and protein 
Following exposure of DMBA at 1mg/kg for 14 days, total mRNA and protein were isolated 
to perform qRT-PCR (A) and western blot analysis (B, C). Values are expressed as fold 
change ± SE for mRNA expression and raw data mean ± SE for total protein; n=3. Different 
letters indicate the statistical significance P < 0.05. DMBA reduces CX 43 proteins in both 
lean and obese ovaries. 
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Figure 6. Consequence of DMBA exposure on Cx45 mRNA and protein expression 
Following exposure of DMBA at 1mg/kg for 14 days, total mRNA and protein were isolated 
to perform qRT-PCR (A) and western blot (B,C) analysis. Values are expressed as fold 
change ± SE for mRNA expression and raw data mean ± SE for total protein; n=3. Different 
letters indicate the statistical significance P < 0.05. Obesity reduces CX 45 protein levels 
compared to lean ovaries. 
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Figure 7. Obesity and DMBA impacts on CX proteins 
Following exposure of DMBA at 1mg/kg for 14 days, paraffin embedded ovarian sections 
were immunostained using primary CX37 (A-D), CX43(E-H) and CX45 (I-L) antibodies to 
check the localization and intensity of staining for CX37 (M); CX43 (N) and CX45 (O). 
ImageJ software was used to analyze the intensity of staining (M-O). 10-large follicles per 
ovary and 3 ovaries were used for protein analysis. Values are expressed as mean ± SE.  
Different letters indicate the statistical significance P < 0.05. CX37 and CX45 protein 
staining decreases by obesity while CX 43 decreases by DMBA. 
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Abstract 
          Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent 
cyclophosphamide (CPA), destroys rapidly dividing cells by forming NOR-G-OH, NOR-G 
and G-NOR-G adducts with DNA, potentially leading to DNA damage. A previous study 
demonstrated that PM induces ovarian DNA damage in rat ovaries. To investigate whether 
PM induces DNA adduct formation, DNA damage and induction of the DNA repair 
response, rat spontaneously immortalized granulosa cells (SIGC) were treated with vehicle 
control (1% DMSO) or PM (3 or 6 µM) for 24 or 48 h. Cell viability was reduced (P < 0.05) 
after 48 h of exposure to 3 or 6 µM PM. The NOR-G-OH DNA adduct was detected after 24 
h of 6 µM PM exposure, while the more cytotoxic G-NOR-G DNA adduct was formed after 
48 h by exposure to both PM concentrations. Phosphorylated H2AX (γH2AX), a marker of 
DNA double stranded break occurrence, was also increased by PM exposure, coincident with 
DNA adduct formation. Additionally, induction of genes and proteins involved in DNA 
repair were observed in both a time- and dose-dependent manner. These data support that PM 
induces DNA adduct formation in ovarian granulosa cells, induces DNA damage and elicits 
the ovarian DNA repair response. 
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Introduction 
          Infertility is a side effect of female cancer treatment. Female cancer treatment 
survivors have reduced fecundity, relative to their non-treated counterparts (Hudson, 2010).  
In addition, cancer treatment can reduce the ovarian follicular reserve, resulting in premature 
ovarian failure (POF) (Hudson, 2010). Fewer primordial follicles have been demonstrated in 
autopsied ovarian samples (Himelstein-Braw et al., 1977) and fewer antral follicles detected 
by ultrasound (Larsen et al., 2003) in females that received anti-neoplastic treatment 
compared to their age-matched control subjects.  
          Cyclophosphamide (CPA) is an alkylating agent used to treat both cancer and 
autoimmune disorders. CPA causes acute ovarian failure in childhood cancer survivors 
(Chemaitilly et al., 2006) and rapid amenorrhea in women undergoing adjuvant treatment for 
breast cancer (Minton and Munster, 2002). CPA is a pro-drug requiring hepatic 
biotransformation by cytochrome P-450 enzymes, to generate an active cytotoxic metabolite, 
phosphoramide mustard (PM) (Plowchalk and Mattison, 1991; Madden et al., 2014). PM is 
the anti-neoplastic as well as the ovotoxic metabolite of CPA (Desmeules and Devine, 2006; 
Petrillo et al., 2011). PM causes primordial and small primary follicle loss (Petrillo et al., 
2011) and a volatile metabolite of PM, chloroethylaziridine (CEZ) is also likely involved in 
PM-induced ovotoxicity (Madden et al., 2014). PM induces DNA or chromosomal damage 
in mammalian cells, important genotoxicity markers (Anderson et al., 1995). PM is also an 
alkylating agent, known to cause cytotoxicity though forming cross-linked DNA adducts 
which inhibit DNA strand separation during replication (Phillips et al., 2000). DNA 
alkylation by PM occurs primarily at the N-7 position of guanine (Mehta et al., 1980) giving 
rise to the first product, a guanosine-PM adduct, which is unstable with a half-life of ~2-3 h 
164 
 
 
(Mehta and Ludlum, 1982). PM forms a mono-functional DNA adduct; N-(2-chloroethyl)-N-
[2-(7-guaninyl)ethyl]amine (NOR-G) and a bi-functional DNA adduct; N-(2-hydroxyethyl)-
N-[2-(N7-guaninyl)ethyl]-amine (NOR-G-OH) and  N,N-bis[2-(N7-guaniny1)ethyl]amine 
(G-NOR-G), DNA adduct both in vitro (Cushnir et al., 1990) and in vivo (Malayappan et al., 
2010) (Figure 1). The cross-linked adduct G-NOR-G is responsible for the cytotoxicity and 
teratological effects of CPA/PM (Little and Mirkes, 1987). PM has been shown to induce 
DNA damage in exposed ovaries of mice and rats (Petrillo et al., 2011).   
          Upon DSB induction, cells activate DNA damage responses (DDR) that comprise of 
cell cycle arrest, DNA damage repair, and subsequent cell cycle resumption or cell death 
(Giunta et al., 2010). One of the most immediate DDR events is phosphorylation of histone 
H2AX (γH2AX), considered the gold standard for localizing DSBs since it recruits and 
maintains DNA repair molecules at damage sites until repair is completed (Svetlova et al., 
2010). Some DDR proteins activated due to DSBs include ataxia-telangiectasia mutated 
(ATM), ATM related (ATR) and DNA-dependent protein kinases (DNA-PKcs) (Svetlova et 
al., 2010).  DNA DSBs can be repaired by both the non-homologous end joining (NHEJ) and 
homologous recombination (HR) pathways.  
          The granulosa cell is the somatic cell component of the oocyte-containing follicle, and 
close association between the granulosa cell and oocyte is required for follicular 
development. Some functions of granulosa cells include the production of sex steroids 
(Bjersing and Carstensen, 1967) and a myriad of growth factors that interact with the oocyte 
during development (Forde et al., 2008). Loss of granulosa cells during pre-antral and antral 
stages of follicular development leads to a premature reduction in female fecundity through 
reduced follicle health and oocyte viability (Walters et al., 2012). An in vivo study 
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demonstrated that the destruction of granulosa cells by CPA potentially occurs through 
apoptosis in rats (Lopez and Luderer, 2004). Since PM-induced DNA damage could 
predispose the follicle towards atresia, this study investigated whether PM exposure to 
granulosa cells results in PM-DNA adducts formation and subsequent DDR induction.   
 
Methods and Materials 
Reagents  
          Phosphoramide mustard (PM) was obtained from the National Cancer Institute 
(Bethesda, MD). 2-β-mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, Ammonium 
persulphate, Glycerol, N′N′N′N′-Tetramethylethylenediamine (TEMED), Tris base, Tris 
HCL, Sodium chloride, Tween-20, Bis- 2-chloroethylamine hydrochloride, 2′-
deoxyguanosine and sodium acetate were purchased from Sigma-Aldrich Inc. (St Louis, 
MO). Dulbecco's Modified Eagle Medium (D-MEM)/F-12 (1x), 0.25% Trypsin-
Ethylenediaminetetraacetic acid (EDTA), Pen Strep and Fetal Bovine Serum (FBS) from 
Gibco by Life Technologies (Grand Island, NY). Millicell-EZ slides were from Millipore 
(Bedford, MA). Corning Vacuum Filter/Storage System and cell culture flasks were 
purchased from Corning Inc. (Corning, NY). RNeasy Mini kit, QIA shredder kit, RNeasy 
Min Elute kit, QuantitectTM SYBR Green PCR kit and Blood and cell culture DNA mini kit 
were purchased from Qiagen Inc (Valencia, CA). All primers were purchased from the Iowa 
State University DNA facility. All primary antibodies were purchased from Abcam 
(Cambridge, MA). RNA later was obtained from Ambion Inc. (Austin, TX). The polyclonal 
goat anti-rabbit secondary were obtained from Pierce Biotechnology (Rockford, IL). Ponceau 
S was from Fisher Scientific.  
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Rat spontaneously immortalized granulosa cell culture 
          A spontaneously immortalized clonal granulosa cell line (SIGC) derived from primary 
rat ovarian granulosa cell cultures were obtained as a gift from Dr. Burghardt at Texas A&M 
University. SIGC cells (2.5× 10
4
 cells) were cultured in 25-cm
2
 flasks in media (DMEM/F12 
plus 5% FBS and 50mg/ml of Pen Strep) at 37°C and 5% CO2 until 80% confluent.   
Cell viability 
          SIGC cells were treated with DMSO and/or PM (0.5 µM, 1 µM, 3 µM or 6µM) for 48 
h to perform cell viability measurements. Cells were harvested by trypsinization and 100 µl 
of the cell suspension was stained with Trypan blue (1:1). Trypan blue selectively penetrates 
cell membranes of dead cells, coloring them blue, whereas it is not absorbed by membranes 
of live cells, thus excluding live cells from staining. Cell counting was performed using a 
hemocytometer and the percentage of viable cells calculated. 
DNA isolation and mass spectrometry 
          Cells were harvested by trypsinization and pelleted by centrifugation at 1200 RPM for 
5 min, washed twice in phosphate buffer saline (PBS) and resuspended in cold PBS (4°C).  
DNA was isolated from cells using a Qiagen blood and cell culture DNA kit according to the 
manufacturer’s protocol. DNA concentration was determined using NanoDrop (λ = 260/280 
nm; ND 1000; Nanodrop technologies Inc., Wilmington, DE). Internal standards of G-NOR-
G and NOR-G-OH were prepared according to a modified procedure (Hemminki, 1985; 
Malayappan et al., 2010). DNA samples from cell lines (10-50 μg in 200 μL of buffer) were 
used to perform Agilent QTOF6540 LC/MS analysis at the Iowa State University Chemical 
Instrumentation Facility. Each sample (1 µl) was injected into the Jet stream ESI ion source 
and water/MeOH (20/80) was used as effluent solvent. The LC column used in this 
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experiment was C18, 4.6*150 mm, 1.8 µm and accurate mass measurement was achieved by 
constantly infusing a calibrant (masses: 121.0508 and 922.0098). 
Immunofluorescence 
         Cells (1 x 10
5 
cells/well) were transferred to a Millicell-EZ slide wells (Millipore, 
Bedford, MA) and treated with DMSO ± PM (3 or 6 µM) for 24 or 48 h. Cells were washed 
with PBS three times and fixed with 95% ethanol for 5 min on ice, followed by incubation in 
0.25-0.5% Triton X-100 containing PBS for 10 minutes to permeabilize the membranes. 
After washing, slides were blocked with 5% normal serum in PBS for 1 h and washed again 
with PBS. Slides were incubated with a primary antibody directed against γH2AX (1:50) 
overnight at 4°C. After washing in PBS, slides were incubated with a donkey anti-rabbit IgG-
FITC secondary antibody (1:3000) for 1 h. Slides were then counterstained with 4-6-
diamidino-2-phenylindole (DAPI). Images were taken using a Leica fluorescent microscope 
and the percentage of cells with foci for γH2AX was calculated (n=3 slides/treatment).  
RNA isolation and qRT-PCR 
          SIGC cells were treated with DMSO ± PM (3 or 6µM) for 24 or 48 h. RNA was 
isolated using an RNeasy Mini kit and the concentration was determined using a NanoDrop 
(λ = 260/280 nm; ND 1000; Nanodrop technologies Inc., Wilmington, DE). Total RNA (1 
μg) was reverse transcribed to cDNA utilizing the Superscript III One-Step qRT-PCR. 
Diluted cDNA (2 μl; 1:20) were amplified on an Eppendorf PCR Master cycler using 
Quantitect SYBR Green PCR kit. Primers for Atm, Prkdc, Xrcc6, Parp1, Rad51, Brca1 and 
Gapdh were designed by Primer 3 Input Version (0.4.0) (Table 3). The regular cycling 
program consisted of a 15 min hold at 95
o
C and 45 cycles of denaturing at 95
o
C for 15 s, 
annealing at 58
o
C for 15 s, and extension at 72
o
C for 20 s at which point data were acquired. 
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Each sample was normalized to Gapdh before quantification using the 2
-Ct 
method (Livak 
and Schmittgen, 2001; Pfaffl, 2001) 
Protein isolation and western blot  
          SIGC cells were treated with DMSO ± PM (3 or 6 µM) for 24 or 48 h and protein 
isolated using lysis buffer containing protease and phosphatase inhibitors as previously 
described (Ganesan et al., 2013). Briefly, cells were placed on ice for 10 min, followed by 
two rounds of centrifugation at 10,000 rpm for 15 min and protein concentration was 
measured using a BCA protocol. Protein was stored at -80 °C until further use.  SDS-PAGE 
was used to separate the proteins and then transferred to nitrocellulose membrane. 
Membranes were blocked for 1 h in 5 % milk in Tris-buffered saline containing tween 20. 
Membrane were incubated in one of: anti-PARP1 antibody (1:200), anti-ATM antibody 
(1:100), anti-rabbit phosphorylated H2AX antibody (γH2AX; 1:100), anti-rabbit BRCA1 
antibody (1:500), anti-rabbit PRKDC antibody (1:100), anti-RAD 51 antibody (1:500) and 
anti-mouse XRCC6 antibody (1:100) for 36 h at 4°C. Following three washes in TTBS (1X), 
membranes were incubated with a species specific secondary antibody (1:2000) for 1 h at 
room temperature. Membrane were washed three times in TTBS and one time in TBS and 
then incubated in enhanced chemiluminescence (ECL) detection substrate for 5 min and 
exposed to X-ray film. Densitometry of the appropriate bands was performed using ImageJ 
software (NCBI). All proteins were normalized to Ponceau S densitometry values. 
Statistical analysis 
          Data were analyzed by unpaired t-tests comparing treatment with control raw data at 
each individual time-point using Prism 5.04 software (Graph Pad Software). Statistical 
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significance was defined as P< 0.05. For graphical purposes, protein expression is presented 
as a mean ± SE of the respective control. 
 
Results 
Cell viability was impacted by PM exposure 
          SIGC cells were treated with DMSO or PM (0.5, 1, 3 or 6 µM) for 48 h and cell 
viability quantified using Trypan blue staining. PM reduced (P < 0.05) cell viability at 
concentrations of 3 µM and higher. Relative to control, the percentage of viable cells was 
91% and 83.6% after exposure to 3 µM and 6 µM PM, respectively (Figure 2). 
PM exposure induces DNA adduct formation 
          SIGC cells were treated with DMSO or PM (3 or 6 µM) for 12, 24 or 48 h and LC/MS 
analysis performed. A NOR-G-OH (Figure 3A, B) DNA adduct was observed after 24 h of 
exposure to 6 µM PM, while the G-NOR-G (Figure 3C, D) DNA adduct was formed after 48 
h with both the 3 and 6 µM PM exposures.  
DNA damage was induced by PM exposure as determined by localization of γH2AX 
          SIGC cells were treated with DMSO or PM (3 or 6 µM) for 24 or 48 h to perform 
γH2AX protein localization (Figure 4A-C) using immunofluorescence. The percentage of 
cells with positive γH2AX foci were increased (P < 0.05) by the 6 µM PM exposure after 24 
h, relative to control treated cells. After 48 h of PM exposure (both concentrations) increased 
levels of γH2AX foci were observed (Figure 4D). 
PM exposure increases DDR gene mRNA expression level 
          Following 24 h of PM exposure, the DDR genes Atm (2.2 fold ± 0.5), Parp1 (2.2 fold 
± 0.4), Prkdc (2.2 fold ± 0.2), Xrcc6 (2.1 fold ± 0.4), Brca1 (2.0 fold ± 0.3) and Rad51 (3.3 
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fold ± 0.7) mRNA expression were increased (P < 0.05) after 6 µM concentration compared 
to both control and cells exposed to 3 µM PM. Atm (0.5 fold ± 0.09), Parp1 (0.4 fold ± 0.01), 
Prkdc (0.4 fold ± 0.07), Xrcc6 (0.4 fold ± 0.06), Brca1 (0.6 fold ± 0.07) and Rad51 (0.4 fold 
± 0.04) mRNA expression were decreased (P < 0.05) by 3 µM PM exposure after 24 h 
compared to both control and 6 µM PM treated cells (Figure 5A). 
          After PM exposure for 48 h, mRNA abundance of the DNA repair response genes Atm 
(3.1 fold ± 0.6), Parp1 (4.9 fold ± 1.1), Prkdc (4.1 fold ± 0.6), Brca1 (3.4 fold ± 0.4) and 
Rad51 (8.6 fold ± 2.4) mRNA expression were increased (P < 0.05) at 3 µM concentration 
while no changes in Xrcc6 (1.5 fold ± 0.4) mRNA expression were observed compared to 
control and 6 µM PM. At the same time Atm (2.3 fold ± 0.3), Parp1 (2.2 fold ± 0.4), Brca1 
(2.1 fold ± 0.6) were increased at the 6 µM PM concentration compared to control and 3 µM 
PM. No changes were detected in Prkdc (1.4 fold ± 0.3), Xrcc6 (0.4 fold ± 0.01), or Rad51 
(1.4 fold ± 0.3) mRNA expression at 3 µM compared to control and 6 µM PM exposure 
(Figure 5B).  
DDR proteins were increased in response to PM exposure 
          Following 24 h of PM exposure, the DDR proteins γH2AX (0.8 ± 0.03), ATM (1.05 ± 
0.07), PRKDC (0.9 ± 0.02), XRCC6 (1.2 ± 0.02) and RAD51 (1.2 ± 0.01) were increased (P 
< 0.05) by exposure to 6µM PM.  BRCA1 (3 µM: 1.3 ± 0.009; 6 µM: 1.5 ± 0.03) and PARP1 
(3 µM: 1.2 ± 0.02; 6µM: 1.4 ± 0.09) were increased (P < 0.05) by both concentrations of PM 
compared to control. In contrast, PRKDC (0.8 ± 0.01) and RAD51 (0.9 ± 0.02) were 
decreased (P < 0.05) by 3 µM PM compared to both control and 6 µM PM treatments (Figure 
6A). 
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          After 48 h of PM exposure, the DDR proteins γH2AX (3 µM: 0.4 ± 0.006; 6 µM: 0.4 ± 
0.007), ATM (3 µM: 4 ± 0.02; 6 µM: 0.4 ± 0.009), PARP1 (3 µM: 0.8 ± 0.01; 6 µM: 0.7 ± 
0.03), PRKDC (3 µM: 0.8 ± 0.01; 6 µM: 0.7 ± 0.03) and BRCA1 (3 µM: 0.9 ± 0.01; 6 µM: 
0.9 ± 0.03) were increased (P < 0.05) at both PM concentrations compared to control while 
XRCC6 (3 µM: 0.9 ± 0.04; 6 µM: 0.8 ± 0.03) protein was decreased (P < 0.05) by 6 µM, but 
not 3 µM, PM concentration.  RAD51 (3 µM: 0.7 ± 0.01; 6 µM: 0.8 ± 0.05) protein was not 
altered by either concentration of PM compared to control (Figure 6B). 
 
Discussion 
          CPA has been reported to destroy ovarian follicles by targeting granulosa cells in mice 
and rats (Desmeules and Devine, 2006). PM-induced DNA damage not only presents in the 
nucleus of oocyte and also occurs in granulosa cells (Petrillo et al., 2011). Since PM induces 
DNA damage in granulosa cells, we assessed whether DNA adduct formation occurs and if 
there is a subsequent DDR due to PM exposure in the rat ovarian SIGC line. It is known that 
the cytotoxic properties of PM occur by formation of DNA adducts, thereby preventing cell 
division by inhibiting DNA strand separation (Cushnir et al., 1990).  In addition, the cross-
linked adduct G-NOR-G is responsible for the cytotoxicity and teratological effects of CPA 
(Little and Mirkes, 1987) and these events are required for tumor destruction. PM formed the 
G-NOR-G adduct in exposed rat embryos (Mirkes et al., 1992) as well as in white blood cells 
of cancer patients (Malayappan et al., 2010). PM-induced cell death was observed in our 
SIGC cells after 48 h. We found that PM binds to DNA to first form a NOR-G-OH (m.wt: 
239) adduct followed rapidly by formation of the G-NOR-G (m.wt: 372) adduct. These data 
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support that DNA adducts formation is involved in the ovotoxic, in addition to the anti-
neoplastic properties of PM.   
         ATM is a protein kinase that is recruited and activated by DNA DSBs. Various 
chemicals including CPA activate ATM signaling eventually resulting in apoptosis in 
mammalian cells (Ganesan et al., 2013; Toulany et al., 2014). ATM phosphorylates histone 
H2AX in response to DNA DSBs (Burma et al., 2001) and γH2AX protein was previously 
localized within oocyte and granulosa cell of PM exposed mouse ovaries (Petrillo et al., 
2011). Both ATM activation and γH2AX appearance serve as proxy markers of cellular DNA 
damage (Tanaka et al., 2006). Increased Atm mRNA and protein were observed after 24 h of 
exposure to 6 µM PM, and by both PM concentrations after 48 h, indicating a dose- and 
time-dependent impact of PM on Atm induction. We report herein that PM increased the 
percentage of γH2AX-positive cells containing and also increased γH2AX protein in total 
ovarian protein homogenates in both a dose- and time-dependent manner. These results 
indicate that DNA damage is induced by PM exposure after DNA adducts formation in rat 
ovarian granulosa cells. 
          Poly(ADP-ribose) polymerase-1 (PARP-1) is rapidly activated by DNA DSBs, and 
involved in the posttranslational modification of nuclear proteins during DNA damage and 
activates cellular process like DNA replication, DNA repair, apoptosis and genome stability 
(Yu et al., 2002). In the current study, Parp1 mRNA and protein were increased in a similar 
manner to that observed in Atm - by 6 µM PM after 24 h of PM exposure and by both PM 
concentrations after 48 h. A link between ATM and PARP-1 has been previously found; 
PARP-1 deficient mice were extremely sensitive to low doses of γ-radiation, and this 
phenotype could be ascribed to a deficient ATM-kinase activation in tissues such as the 
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intestine epithelium (de Murcia et al., 1997). In our current study, ATM protein level was 
coincident with PARP-1 protein level after PM exposure.   
          PARP-1 competes with XRCC6 to repair a DSB as part of the NHEJ pathway but, in 
contrast, PARP-1 is also recruited to a DSB in the absence of XRCC6 when the classical 
pathway of NHEJ is absent (Wang et al., 2006). XRCC6 is a KU protein which forms a 
heterodimer with XRCC5. Deficiency of XRCC6 protein causes genomic instability and 
malignant formation (Wang et al., 2013). We found that Xrcc6 mRNA was reduced by the 
lower PM exposure after 24 h, but increased by the 6 µM PM concentration at the same time 
point. Subsequently, Xrcc6 mRNA in 3 µM PM-treated cells returned to control levels, while 
it was reduced at the higher PM concentration. XRCC6 protein levels were initially increased 
by the 6 µM PM exposure, but subsequently decreased. These results indicate that there is a 
dynamic response of Xrcc6 mRNA in response to PM exposure, and may suggest that 
XRCC6 is involved in the earlier DDR via the NHEJ repair pathway, but at later times of 
exposure, that PARP-1 could potentially compete with XRCC6 to repair DNA damage 
through an XRCC6-independent DNA repair pathway, however, these possibilities cannot be 
confirmed by the current study. 
          PRKDC is a DNA-dependent protein kinase recruited and activated at the site of DNA 
damage by KU proteins to repair DSBs repair by NHEJ pathways. Interestingly, capsaicin-
induced autophagy of MCF-7 cells was shown to occur via activation of the PRKDC, ATM 
and PARP-1 DDR proteins (Yoon et al., 2012). Further, increased ionizing radiation-induced 
Prkdc mRNA was observed in mouse leukaemic monocyte macrophage cell line RAW264.7 
and was thought to be involved in prevention of cell death (Dhariwala et al., 2012). We 
found a dose-dependent temporal pattern of Prkdc mRNA and protein increased expression 
174 
 
 
in response to PM exposure in SIGC cells. Our study also indicates that PM could induce 
PRKDC as part of the mechanism to repair DNA damage and improve the survivability of 
SIGC cells by preventing cell death.  
          BRCA1 is breast cancer protein required for repair of DSBs via the HR pathway.  
Previously, we have found that Brca1 mRNA and protein was increased in response to a 
chemical exposure (7,12-dimethylbenz[a]anthracene) that induced DSBs in rat ovaries 
(Ganesan et al., 2013). Activation of ATM and BRCA1 inhibited apoptosis induced by 5-
azacytidine by repairing DNA damage in cells that were resistant to 5-azacytidine and this 
activation was absent in the parental 5-azacytidine-sensitive leukemia cell line U937 and HL-
60 (Imanishi et al., 2014). In this study, we observed a temporal pattern of increased Brca1 
mRNA and protein due to PM exposure, supporting that the HR DDR pathway is induced 
and that ovarian Brca1 is responsive to PM exposure.  
          BRCA1 can interact with RAD 51 during HR to regulate the function of RAD51 in 
response to DSBs and block sister chromatid replication slippage (Cousineau et al., 2005). 
Down regulation of RAD51 previously indicated failure of the HR pathway in hypoxic 
cancer cells (Bindra et al., 2004). Also, Rad51 mRNA was elevated in tumor cells, 
suggesting that it plays a role in repair of DNA damage (Raderschall et al., 2002). We found 
that PM increased Rad51 mRNA and protein at the 6 µM concentration and that a similar 
response occurred with the 3 µM PM exposure, but this lagged that of the higher 
concentration, again indicating a dynamic, temporal pattern of the DDR to PM exposure.   
          In conclusion, PM exposure to an SIGC line caused formation of both NOR-G-OH and 
G-NOR-G DNA adducts. In addition, loss of cell viability and induction of the DDR, in a 
time- and dose-dependent manner was observed. Taken together, PM, the active metabolite 
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of CPA, may induce ovarian cell death via formation of DNA adducts and the ovarian 
granulosa cells induce mechanisms to respond to this genotoxic insult likely in order to 
protect the ovarian granulosa cells.    
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Table 1. Primer sequences used for qRT-PCR 
Genes Forward primer Reverse primer 
Atm TCAGCAGCACCTCTGATTCTT AGACAGACATGCTGCCTCCT 
Brca1 CCCTCTTAGTCTGCTGAGCT CCTTTGGGTGGCTGTACTGA 
Parp1 AAGTGCCAGTGTCAAGGAGA ACAGGGAGCAAAAGGGAAGA 
Prkdc GCCACAGACCCCAATATCCT TATCTGACCATCTCGCCAGC 
Rad51 ATCCCTGCATGCTTGTTCTC CTGCAGCTGACCATAACGAA 
Xrcc6 GATCTGACACTGCCCAAGGT TGCTTCTTCGGTCCACTCTT 
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Figure 1. Formation of Phosphoramide mustard-induced DNA adducts 
PM undergoes nonenzymatic degradation to produce nornitrogen mustard (NOR). Both PM 
and NOR alkylate guanine bases within DNA to form guanine monoadducts, N-[2-(N7-
guaninyl)ethyl]-N-[2-hydroxyethyl]-amine (G-NOR-OH), and DNA-DNA cross-links, N,N-
bis[2-(N7-guaninyl) ethyl] amine (GNOR-G), although PM is considered the major DNA 
reactive metabolite (Malayappan et al., 2010). 
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Figure 2. PM decreases % of cell viability  
SIGC cells were treated with DMSO or PM (0.5, 1, 3 or 6 µM) for 48h. Trypan blue staining 
was used to determine the cell viability. Values represent % of viable cells ± SE. * = P < 
0.05; different from control. 
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Figure 3. PM exposure induces DNA adduct formation 
SIGC cells were treated with DMSO or PM (3 or 6 µM) for 12, 24 or 48h for DNA isolation. 
Agilent QTOF6540 LC/MS analysis was performed to determine the DNA adducts 
formation. The (A,B) NOR-G-OH was observed after 24h of exposure to 6 µM PM, while 
(C,D) G-NOR-G was formed after 48h at both the 3 and 6 µM  concentrations. Values 
represent the relative abundance of DNA adduct /10
5 
nucleotides).
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Figure 4. PM induces DNA damage formation 
SIGC cells were treated with DMSO or PM (3 or 6 µM) for 24 or 48h and γH2AX protein 
localized using immunofluorescence (A-C). Blue staining represents DNA; Red staining 
indicates γH2AX. (D) Values represent % of γH2AX positive cells ± SE. Different letters 
difference from CT; P < 0.05. 
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Figure 5. PM exposure increases DDR gene mRNA expression levels 
RNA was isolated from SIGC cells treated with DMSO or PM (3 or 6 µM) for (A) 24 h or 
(B) 48 h, followed by qRT-PCR. Genes were normalized with Gapdh and values reported as 
fold change relative to a control value of 1 ± SEM. Different letters difference from CT; P < 
0.05. 
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Figure 6. DDR proteins are increased in response to PM exposure 
Total protein was isolated from SIGC cells treated with DMSO or PM (3 or 6 µM) for (A) 24 
h or (B) 48 h, followed by Western blotting.  Ponceau S was used for normalization with 
protein of interest and values reported as raw mean value ± SEM. Different letters difference 
from CT; P < 0.05. 
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CHAPTER 7. THE OVARIAN DNA DAMAGE REPAIR RESPONSE IS INCREASED 
PRIOR TO PHOSPHORAMIDE MUSTARD-INDUCED FOLLICLE DEPLETION, 
WHICH IS PREVENTABLE BY INHIBITION OF ATAXIA TELANGIECTASIA 
MUTATED 
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Abstract 
          Phosphoramide mustard (PM) is an ovotoxic metabolite of cyclophosphamide and 
destroys primordial and primary follicles potentially by DNA damage induction. The 
temporal pattern by which PM induces DNA damage and initiation of the ovarian DNA 
damage response has not yet been characterized. This study investigated DNA damage 
initiation, the DNA repair response, as well as induction of follicular demise using a neonatal 
rat ovarian culture system. Additionally, to delineate specific mechanisms involved in the 
ovarian response to PM exposure, utility was made of PKC delta (PKCδ) deficient mice as 
well as an ATM inhibitor (KU-55933; AI). Fisher 344 PND4 rat ovaries were cultured for 
12, 24, 48 or 96 h in medium containing DMSO ± 60 µM PM or KU-55933 (10 nM). PKCδ 
WT and KO mice were cultured with DMSO ± 10 µM PM for 144 h. PM-induced activation 
of DNA damage repair genes was observed as early as 12 h post-exposure. The abundance of 
ATM, PARP1, E2F1, P73 and CASP3 were increased but RAD51 and BCL2 protein 
decreased after 96 h of PM exposure. PKCδ deficiency reduced numbers of all follicular 
stages, but did not have an additive impact on PM-induced ovotoxicity. ATM inhibition 
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protected all follicle stages from PM-induced depletion in number. In conclusion, the 
induction of ovarian DNA damage repair response post-PM exposure, suggest that DNA 
damage is involved in PM-induced ovotoxicity. 
 
Introduction 
          The female gamete, the oocyte, is produced by the ovary, wherein they become 
integrated into follicular structures. Females are born with a finite number of oocytes, which 
once depleted, cannot be replaced (Hirshfield et at., 1991). Approximately 10% of women 
suffer infertility due to premature depletion of their oocyte pool (Nikolaou and Templeton, 
2003). There are a number of environmental exposures, including cigarette smoke, 
occupational chemicals, pesticides and chemotherapeutic agents that can destroy oocytes, 
potentially hastening entry into premature ovarian senescence (Hoyer and Sipes, 1996).  
Those chemotherapeutic chemicals that are alkylating or DNA damaging agents reduce 
follicle number and fertility with concomitant induction of amenorrhea (Hudson, 2010).  
Moreover, chemotherapeutic agents may potentially have adverse effects on the offspring of 
the treated individual; that is, early embryonic mortality resulting from genetic effects, such 
as chromosomal aberrations that are induced in exposed oocytes (Gonfloni et al., 2009). 
         Cyclophosphamide (CPA) is used to treat cancer and autoimmune diseases, and causes 
premature ovarian failure and rapid amenorrhea in treated individuals by follicular 
destruction (Hudson, 2010). In rodents, CPA targets primordial follicles in mice (Plowchalk 
and Mattison, 1992) and antral follicles in rats (Ataya et al., 1990). Phosphoramide Mustard 
(PM), an ovotoxic metabolite of CPA, destroys rapidly dividing cells by covalently binding 
to DNA, inducing DNA-DNA, DNA-protein cross links and DNA double strand breaks 
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(DSB) (Helleday et al., 2008; Ganesan and Keating, Under Review). PM caused dose- and 
time-dependent primordial and primary ovarian follicle loss following DNA damage in mice 
and rat oocytes (Petrillo et al., 2011). If DNA repair fails, or the cell is overwhelmed by too 
many DNA lesions, cellular sensors initiate apoptosis (Friedberg, 2003).  The main players of 
DNA damage recognition are ataxia telangiectasia mutated (ATM), ATM related (ATR) and 
DNA-dependent protein kinases (DNA-PKcs), which phosphorylate a multitude of proteins 
and thereby induce the DNA damage response (DDR), in which P53 and BRCA1/2 play 
important roles (Roos and Kaina, 2006). ATM is mainly activated by DSBs formed either 
directly by ionizing radiation (IR), or indirectly by methylating agents or cisplatin exposure 
(Caporali et al., 2004). ATM is implicated in three crucial functions: regulation and 
stimulation of DSB repair, activation of cell cycle checkpoints, and signaling for apoptosis 
induction; three key nodes in making the decision between cellular survival and death 
following genotoxin exposure (Roos and Kaina, 2012).  
          Protein kinase c (PKC) is a serine-threonine kinase that is activated by diverse stimuli 
and which participates in cellular processes such as growth, differentiation and apoptosis 
(Hug and Sarre, 1993). PKC delta (PKCδ) represents a subfamily of novel PKC isoforms, is 
widely expressed in the rat ovary and regulated by estrogen (Peters et al., 2000). The 
catalytic fragment of PKCδ interacts with P73β and phosphorylates the transactivation and 
DNA binding domains of P73β to induce its apoptotic function (Ren et al., 2002). However, 
PKCδ also enhances proliferation and survival of murine mammary cells (Grossoni et al., 
2007), thus indicating that PKCδ has both pro- and anti-apoptotic properties. 
          DNA damage can activates the extrinsic death receptor apoptosis pathway (Fas) and/or 
the intrinsic mitochondrial apoptosis pathway (Roos and Kaina, 2006). In the mitochondrial 
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apoptotic pathway, voltage-dependent anion channel (VDAC) regulates the release of 
apoptotic proteins, such as cytochrome c (CYCS), from mitochondria by oligomerization 
(Igosheva et al., 2010). CYCS release is also regulated by the BCL-2 family protein BAX, 
which interacts with VDAC to increase pore size and promote CYCS release, while the anti-
apoptotic protein BCL-XL has the opposite effect (Wu et al., 2010).   
          Although it is recognized that infertility ensues from PM treatment, little is known 
about the earliest mechanistic events that contribute to ovotoxicity or that could provide 
protection from PM exposure. Our previous evidence using spontaneously immortalized 
granulosa cells indicated that PM exposure results in DNA adduct formation, followed by 
increased expression of members of the DNA repair response, thus we hypothesized that 
ATM and PKCδ could be important cellular sensors of ovarian DNA damage. This study was 
designed to investigate the temporal pattern of ovarian cellular signaling events post-PM 
exposure, using a whole neonatal ovarian culture method, with inclusion of an ATM inhibitor 
and use of a mouse strain that was deficient in PKCδ.   
 
Methods and Materials 
Reagents 
          Phosphoramide Mustard  (National Cancer Institute, Bethesda, MD), Bovine serum 
albumin (BSA), Ascorbic acid, Transferrin, 2- β-mercaptoethanol, 30% acrylamide/0.8% 
bisacrylamide, Ammonium persulphate, Glycerol, N′N′N′N′-Tetramethylethylenediamine 
(TEMED), Tris base, Tris HCL, Sodium chloride and KU-55933, Tween-20 were purchased 
from Sigma-Aldrich Inc. (St Louis, MO). Dulbecco's Modified Eagle Medium: nutrient 
mixture F-12 (Ham) 1x (DMEM/Ham's F12), Albumax, Penicillin (5000U/ml), Hanks' 
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Balanced Salt Solution (without CaCl2, MgCl2 or MgSO4) from Invitrogen Co. (Carlsbad, 
CA). Millicell-CM filter inserts and 48 well cell culture plates were obtained from Millipore 
(Bedford, MA) and Corning Inc. (Corning, NY) respectively. RNeasy Mini kit, QIA shredder 
kit, RNeasy Min Elute kit, RT
2
 First Strand Kit, RT
2
 SYBR Green Mastermix, QuantitectTM 
SYBR Green PCR kit and DNA damage RT
2
 profiler PCR array kit for rats were purchased 
from Qiagen Inc (Valencia, CA). All primers were purchased from Iowa State University 
DNA facilities. All primary antibodies were purchased from Abcam (Cambridge, MA). RNA 
later was obtained from Ambion Inc. (Austin, TX). The polyclonal goat anti-rabbit secondary 
were obtained from Pierce Biotechnology (Rockford, IL). Ponceau S was from Fisher 
Scientific. ECL plus chemical luminescence detection kit was obtained from GE Healthcare, 
Amersham (Buckinghamshire, UK). 
Ovary culture  
          Ovaries were collected from PND4 female F344 rats or PKCδ wild type and deficient 
mice and cultured as described by Devine, et al., 2002. Briefly, PND4 female pups were 
euthanized, ovaries removed, trimmed of excess tissue and placed onto a membrane floating 
on 250 μl of DMEM/Ham's F12 medium containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 
μg/ml ascorbic acid, 5 U/ml penicillin and 27.5 μg/ml transferrin per well in a 48 well plate 
previously equilibrated to 37 °C. Ovaries were cultured in medium containing vehicle control 
(DMSO) +/- PM 60 or 10 µM) and maintained at 37 °C with 5% CO2 for 12, 24, 48, 96 or 
144 h and medium replaced every two days. A drop of medium was placed on top of each 
ovary to prevent it from drying. Ovaries exposed to PM treatments (60 µM) were cultured in 
a separate incubator from other treatments to eliminate contamination from an ovotoxic, PM-
generated volatile metabolite (Madden et al., 2014).  
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Ovarian follicle counts 
          PND4 female F344 rats ovaries were cultured in medium containing vehicle control 
(DMSO) ± PM (60 µM) ± KU-55933 (10 nM) and maintained at 37 °C with 5% CO2 for 96 
h. The ATM inhibitor KU-55933 concentration was chosen based on our observations that 
primordial follicular viability was unaffected (data not presented). Ovaries from PKCδ wild 
type and deficient mice (Gift from Dr. Kanthasamy, Iowa State University) were cultured in 
vehicle control (DMSO) ± PM (10 µM) for 144 h. The chosen PM concentration of 10 µM 
was previously characterized to cause follicle depletion from day 2 onward after a single 
exposure in CD-1 mouse ovaries (Desmeules and Devine, 2006). Following incubation, 
ovaries were placed in 4% paraformaldehyde for 2 h and transferred to 70% ethanol. Ovaries 
were embedded in paraffin following standard histological procedures. Tissue sections (5 
μM) were cut and stained with haematoxylin and eosin and every 6th section were mounted 
as described previously (Igawa et al., 2009). Healthy follicles were counted (n=5 / group) 
and follicle population was classified according to the procedure adopted from (Devine et al., 
2004). 
RNA isolation and RT
2 
profiler
 
PCR Array 
          RNA was isolated (n = 3; 10 ovaries per pool) using an RNeasy Mini kit and the 
concentration determined using a NanoDrop (λ = 260/280 nm; ND 1000; Nanodrop 
technologies Inc., Wilmington, DE). Three biological replicates were used to perform a RT
2
 
profiler DNA damage PCR array. The PCR array contained 96-wells, each containing a 
gene-specific primer set; therefore one plate tested 96 genes per biological sample. Total 
ovarian RNA (1 μg) was reverse transcribed to cDNA using an RT2 first-strand Kit, 
combined with an appropriate RT
2
 SYBR Green Mastermix before being aliquoted into the 
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wells of the RT
2
 Profiler PCR Array. The regular cycling program consisted of a 10 min hold 
at 95
o
C and 40 cycles of denaturing at 95
o
C for 15 s and a combined annealing and extension 
for 1 min at 60
o
C. Each gene was normalized to a housekeeping genes on the array; 
ribosomal protein, large, P1 (Rplp1), as recommended by the company-provided analysis 
software. There was no effect of PM exposure on ovarian mRNA levels of this housekeeping 
gene. The SA Biosciences RT
2
 Profiler PCR Array Data Analysis software quantified the 
changes in mRNA levels using the 2
−ΔΔCt
 method. 
qRT-PCR 
          Total RNA (1 μg) was reverse transcribed to cDNA utilizing the Superscript III One-
Step qRT-PCR kit. cDNA was diluted (1:20) in RNase-free water and amplified on an 
Eppendorf PCR Master cycler using a Quantitect SYBR Green PCR kit. Primers for Atm, 
Prkdc, Xrcc6, Parp1, Rad51, Brca1 and Gapdh were designed by Primer 3 Input Version 
(0.4.0) (Ganesan and Keating, 2014). The regular cycling program consisted of a 15-min 
hold at 95
o
C and 45 cycles of denaturing at 95
o
C for 15 s, annealing at 58
o
C for 15 s, and 
extension at 72
o
C for 20 s at which point data were acquired. Each sample was normalized to 
Gapdh before quantification. Quantification of fold-change in gene expression was 
performed using the 2
-Ct 
method (Livak and Schmittgen, 2001; Pfaffl, 2001). 
Protein isolation and Western blotting  
          Total protein was isolated from cultured ovaries (n=3; 10 ovaries per pool via 
homogenization in tissue lysis buffer containing protease and phosphatase inhibitors as 
previously described (Ganesan et al., 2013). Briefly, homogenized samples were placed on 
ice for 30 min, followed by two rounds of centrifugation at 10,000 rpm for 15 min and 
protein concentration was measured using a BCA protocol. Protein was stored at -80 °C until 
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use. SDS-PAGE was used to separate proteins which were then transferred to nitrocellulose 
membrane. Membranes were blocked for 1 h in 5 % milk in Tris- buffered saline containing 
tween 20, followed by incubation with anti-PARP1 antibody (1:200), anti-ATM antibody 
(1:100), anti-RAD 51 antibody (1:500), anti-E2F1 antibody (1:100), anti-P73 antbody 
(1:200), anti-BCl2 antibody (1:200) and anti-Caspase 3 antibody  (1:50) overnight at 4°C. 
Following three washes in TTBS (1X) membranes were incubated with an appropriate 
species-specific secondary antibody (1:2000) for 1 h at room temperature. Membranes were 
washed three times in TTBS, once in TBS and then incubated in enhanced 
chemiluninescence detection substrate for 5 min and exposed to X-ray film. Densitometry of 
the appropriate bands was performed using ImageJ software (NCBI). All proteins were 
normalized to Ponceau S densitometry values. 
Statistical analysis 
          Treatment comparisons for follicle count experiments were performed using one-way 
analysis of variance. Quantitative RT-PCR and Western blot data were analyzed by t-test 
comparing treatment with control raw data at each individual time point. RT
2
 Profiler PCR 
array data were analyzed using the online SA Biosciences software which quantified the 
changes in mRNA levels using the 2
−ΔΔCt
 method. All other statistical analysis was 
performed using Prism 5.04 software (GraphPad Software). Statistical significance was 
defined as P < 0.05, with a trend for a difference considered at P < 0.1. For graphical 
purposes, protein expression is presented as a mean ± SE, relative to the respective control. 
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Results 
Impact of PM exposure on abundance of genes encoding proteins involved in the 
ovarian response to DNA damage  
 
         After 24 h of PM (60 µM) exposure, of the 89 genes tested, fourteen genes had 
increased (P < 0.05) gene expression, and four genes were trending toward being increased 
(P < 0.10) compared with the controls. After 48 h of PM exposure, of the 89 genes tested, 
five genes had increased (P < 0.05) gene expression, and six genes were trending toward 
being increased (P < 0.10) and two genes were trending toward being decreased (P < 0.10) 
compared to control-treated ovaries (Table 1).  
          In addition to genes present on the PCR array, primers were designed to quantify 
changes in genes that were of interest and were not either present on the array or the array 
was not performed at the time point of interest. Following 12 h of PM exposure, Atm (3.4-
fold ± 0.7); Parp1 (1.6-fold ± 0.5); Prkdc (0.9-fold ± 0.3); Xrcc6 (1.4-fold ± 0.3); Rad51 
(1.9-fold ± 0.5) and Brca1 (1.9-fold ± 0.6) mRNA abundance were increased (P < 0.05) 
compared to control (Figure 1). 
          Following 24 h of PM exposure, E2f1 (1.65-fold ±0.15) and p73 (3.06-fold ± 0.7) 
mRNA levels were increased (P < 0.05) compared to control. In contrast, PM exposure 
decreased (P < 0.05) Vdca1 (0.4-fold ± 0.1) mRNA abundance relative to control. There was 
no impact of PM exposure on Cycs mRNA level (Figure 2A). After 48 h of PM exposure, 
E2f1 (1.4-fold ± 0.2); p73 (90-fold ± 1); Mdm2 (0.7-fold ± 0.2); Vdca1 (0.4-fold ± 0.2) and 
Cycs (2.5-fold ± 0.5) mRNA levels were increased (P < 0.05) compared to control-treated 
ovaries (Figure 2B). After 96 h of PM exposure, increased (P < 0.05) levels of E2f 1 (1.3-
fold ± 0.2); p73 (1.4-fold ± 0.5); Mdm2 (1-fold ± 0.07); Vdca1 (0.3-fold ± 0.06) and Cycs 
(0.7-fold ± 0.1) mRNA were observed compared to control (Figure 2C).  
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 Effect of exposure to PM on abundance of DNA damage response proteins  
         The DNA damage repair proteins ATM (PM: 1.6 ± 0.3; CT: 1.4 ± 0.02) and PARP1 
(PM: 1.8 ± 0.03; CT: 1.5± 0.02) were increased (P < 0.05) compared to ovaries cultured in 
control media. In contrast, RAD51 (PM: 1.4 ± 0.02; CT: 1.5 ± 0.02) protein abundance was 
decreased (P < 0.05) after PM exposure (Figure 3A). The transcription factors E2F1 (PM: 1.5 
± 0.06; CT: 0.8 ± 0.04); P73 (PM: 1.9 ± 0.1; CT: 1.3 ± 0.03) (Figure 3B) and apoptotic 
proteins CASP3 (PM: 1.5 ± 0.02); CT: 1.3 ± 0.01) (Figure 3C) were increased (P < 0.05) 
after PM exposure, relative to control-treated ovaries. In contrast, the anti-apoptotic protein 
BCL2 (PM: 0.9 ± 0.05; CT: 1.2 ± 0.02) was decreased (P < 0.05) after PM exposure 
compared to control ovaries (Figure 3D). 
Involvement of ATM protein in ovotoxicity induced by PM exposure  
          Primordial follicle number (PM: 279.7 ± 7.8; CT: 568 ± 26.2; AI: 578 ± 49.1; PM+AI: 
536 ± 9.5) were reduced (P < 0.05) after PM treatment. There was no impact of ATM 
inhibition on primordial follicle number.  Interestingly, in the presence of ATM inhibition, 
primordial follicles were protected from PM-induced depletion (Figure 4A). 
          PM exposure reduced (P < 0.05) small primary follicle number (PM: 40.3 ± 8; CT: 
128.7 ± 5.8; AI: 124 ± 4.7; PM + AI: 69 ± 7.2), compared to all other groups. There was no 
impact of ATM inhibition on small primary follicle number, however, ATM inhibition 
partially prevented (P < 0.05) PM-induced destruction of small primary follicles (PM + AI: 
69 ± 7.2; PM: 40.3 ± 8) (Figure 4B). 
          A similar pattern was observed for both large primary and secondary follicles.  PM 
exposure depleted (P < 0.05) large primary follicle number (PM: 13 ± 3.2; CT: 32.6 ± 2.3; 
AI: 51.6 ± 2.9; PM + AI: 32.3 ± 4.4). Interestingly, ATM inhibition increased large primary 
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follicle numbers (AI: 51.6 ± 2.9; PM: 13 ± 3.2; CT: 32.6 ± 2.3; PM + AI: 32.3 ± 4.4), 
compared to all other groups (Figure 4C), and ATM inhibition prevented PM-induced 
depletion of large primary follicles (PM + AI: 32.3 ± 4.4; PM: 13 ± 3.2).  
          Secondary follicles numbers were reduced (P < 0.05) by PM exposure (PM: 2.6 ± 1.4; 
CT: 20.6 ± 3.8; AI: 18.6 ± 2.1). ATM inhibition alone did not impact secondary follicle 
number (CT: 20.6 ± 3.8; AI: 18.6 ± 2.1), and ATM inhibition partially protected secondary 
follicles from PM-induced ovotoxicity (PM: 2.6 ± 1.4; PM+ AI 12.3 ± 1.7) (Figure 4D). 
Impact of PKCδ deficiency on PM-induced ovotoxicity  
         PKC delta (PKCδ) wild type (WT) and deficient (KO) mouse ovaries were cultured 
with vehicle control (DMSO) ± PM (10 µM) for 144 h. PKCδ deficiency (KO) alone reduced 
(P < 0.05) ovarian follicle number, relative to the WT mice; primordial (WT: 193 ± 39.4; 
KO: 84 ± 22.3), small primary (WT: 59.2 ± 14.2; KO: 24 ± 3.9), large primary (WT: 28 ± 
4.6; KO: 18.4 ± 5.1) and secondary (WT: 6.6 ± 1.4; KO: 0.4 ± 0.4) follicles were all lower 
than those contained in ovaries from WT mice. PM reduced number of healthy follicles in 
both WT and KO mice ovaries (Figure 5A). The percentage of PM-induced follicle loss was 
calculated for both genotypes and no impact of PKCδ deficiency on PM-induced follicle loss 
was observed (Figure 5B).   
 
Discussion 
          Cells continuously experience multiple types of DNA modifications that occur due to 
external sources or exposures and DNA is the main victim of environmental genotoxins 
including alkylating compounds, ultraviolet (UV) light and ionizing radiation. PM, an 
alkylating agent causes both dose- and time-dependent ovarian primordial and primary 
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follicle loss following DNA damage to mice and rat oocytes (Petrillo et al., 2011). No 
mechanistic studies have been performed on the ovarian response to PM-induced DNA 
damage thus; we explored a potential mechanism of PM-induced ovarian follicle loss in 
neonatal cultured rat ovaries. Using this system, we previously demonstrated that PM causes 
depletion of all follicle types from day 4 onwards (Madden et al., 2014).   
          Two approaches were employed to determine transcriptional effects of PM exposure 
on genes involved in the ovarian response to DNA damage. We first used a commercially 
available PCR array to survey a wide number of genes at either 24 or 48 h post-exposure. A 
dynamic response in terms of gene activation was observed, in that genes that were altered 
after 24 h included Atm, Bax, Bbc3, Cdkn1a, Ddit3, Ercc2, Exo1, Fancc, Gadd45g, Lig1, 
Mgmt, Nthl1, Pold3, Rad21, Rpa1, Topbp1,Ung and Xrcc2.  After 48 h of exposure, genes 
that remained elevated included Atm, Bbc3, Cdkn1a, Nthl1, Mgmt and Pold3, however, a 
number of genes returned to control levels and genes that were increased at 48 h but not 24 h 
were Bard1, Gadd45a, Mif, Mpg, Rad18 and Terf1. We chose to also examine a number of 
genes after 12 h of PM exposure by traditional qPCR and found that Atm, Parp1, Prkdc, 
Xrcc6, Rad51 and Brca1 were elevated in mRNA abundance, and with the exception of Atm, 
all were returned to control level by the 24 h time point. Thus, a temporal ovarian response to 
PM exposure was evident and increased PM-induced Atm was sustained.  Activation of these 
genes support that DNA DSBs were induced by PM exposure as seen in other experimental 
paradigms (Durocher and Jackson, 2001; Ganesan and Keating, Under Review) and indicate 
that PM-induced DNA damage was occurring prior to activation of the ovarian DNA repair 
mechanism. These data also support that PM induces DNA damage as an upstream, 
potentially initiating event of PM-induced follicle loss and that the ovary activates DNA 
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repair genes to protect against PM-induced ovotoxicity. DNA damage repair response protein 
abundance was quantified at the time of follicle loss. ATM and PARP1 were increased while 
RAD51 was decreased by PM exposure. Since ATM, PARP1 and RAD51 are all involved in 
the DSB repair pathway, the decreases in RAD51 was unexpected, however, the increase in 
ATM and PARP1 further support that the ovary is mounting a protective response to PM 
exposure that has caused an assault on the germline DNA.   
          Upon phosphorylation of P53 by ATM, P53 becomes stabilized and blocks cell 
proliferation by up-regulation of P21 (CDKN1a), which triggers G1-S arrest (Roos and 
Kaina, 2006). In this study, Cdkn1a gene was increased after 24 h of PM exposure but there 
were no alterations in p53 mRNA abundance. Low levels of P53 during DSBs are sufficient 
to propel the transcription of the Cdkn1a gene to result in cell-cycle arrest (Roos and Kaina, 
2006). In addition, both ATM and ATR phosphorylate CHK1 and CHK2 to activate the 
transcriptional regulator E2F1 in response to DNA damage and E2F1 then can induce 
apoptosis through a P53-independent pathway (Phillips et al., 1997). In human cancer cell 
lines, E2F1 was activated by etoposide which in turn stimulated the transcription of the p73 
gene in human cancer cell lines (Urist et al., 2004). In this study, both E2f1 and p73 mRNA 
levels were increased after 24 h and the protein elevated after 96 h of PM exposure, 
potentially indicating that PM induces apoptosis independent of P53. MDM2 degrades P53 
using a negative feedback loop resulting in a decrease in exogenous P53 in transient 
transfection experiments or in endogenous P53 induced by DNA damage (Wang et al., 
2001). The transcriptional level of Mdm2 was increased after 24 h while there were no 
changes in p53 mRNA expression which might be due to an increased level of P73.  
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          Transcriptional up regulation of Bbc3 (PUMA) resulted in increased BAX 
mitochondrial translocation and CYCS release during P73-induced apoptosis (Melino et al., 
2004). PM increased Bbc3 and Bax gene expressions after 24 h of exposure, but decreased 
BCL2 protein level after 96 h. This observation was similar to another study in which 
docetaxel/doxorubicin chemotherapy decreased BCL2 in human breast cancer cells 
(Buchholz et al., 2003). BCL-2 inhibits apoptosis by preventing the release of mitochondrial 
apoptogenic factors such as CYCS and apoptosis-inducing factor (AIF) into the cytoplasm. 
This study indicates that PM activates Bbc3 and Bax and decreases BCL2 to cause 
mitochondrial apoptotic cell death. 
           VDAC1 is another key player in mitochondria-mediated apoptosis, participating in the 
release of mitochondrial pro-apoptotic CYCS to the cytosol (Zaid et al., 2005). We found 
that PM increased Vdac1 and Cycs gene expressions after 24 h in rat ovaries. These data are 
similar to a study that demonstrated increased Vdac1 expression after CPA exposure which 
stimulated apoptosis in ovarian granulosa cells (Zhao et al., 2010). It is recognized that 
CYCS release activates both CASP9 and formation of apoptosome to cause apoptosis 
(Ishida, 2004). In this study, CASP3 protein was increased after 96 h by PM exposure, the 
time point at which PM-induced ovotoxicity is occurring (Madden et al., 2014). Increased 
CASP3 has also been demonstrated during apoptosis induced by another ovotoxicant, 7,12-
dimethylbenz[a]anthracene (Ganesan et al., 2013).  
          Since Atm mRNA expression was increased at the earliest time point examined (12 h) 
and was sustained at an elevated level over the time course of PM exposure, we investigated 
a functional role for ATM during PM exposure using the ATM inhibitor KU-55933. 
Interestingly, though no apparent impact of ATM inhibition on primordial, small primary or 
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secondary follicles was observed, lack of ATM increased the number of large primary 
follicles, potentially indicating a role for ATM in viability and/or maturation of this follicular 
subtype. Lack of ATM protected all follicle types from the ovotoxic impacts of PM. This 
result was similar to a previous study that showed that ATM inhibitor improved oocyte 
survival after doxorubicin exposure by activation of c-AbI-Tap63 pathway (Soleimani et al., 
2011). It has been shown previously that blocking ATM activity caused induction of ATM 
protein, which is regulated by p73 and E2f1 transcriptional level (Khalil et al., 2012). These 
results are in correlation with our findings in the ovary, and suggest that ATM serves to 
eliminate cells with excessive DNA damage (Herzog et al., 1998). Whether the follicles in 
the ovarian treated with PM plus ATM inhibitor are “healthy” is doubtful and thus protection 
from PM-induced ovotoxicity may not necessarily result in benefits for fertility. 
          PKCδ is a member of the novel PKC subfamily and catalytic fragment of PKCδ -
mediated phosphorylation of P73β is associated with accumulation of P73β and induction of 
P73β-mediated transactivation (Ren et al., 2002). Since P73 is increased by PM, we utilized 
available PKCδ wild type and deficient mice to determine the role of PKCδ in ovarian 
folliculogenesis and any involvement in PM-induced ovotoxicity. PKCδ knockout reduced 
the numbers of all stage follicles compared to wild type ovaries. When these mice were 
exposed to PM, the number of healthy follicles was reduced by PM in both the wild type and 
deficient mice. However, there was no additional impact of PM exposure on follicle deletion 
percentage due to lack of PKCδ. PKCδ enhanced proliferation and survival of murine 
mammary cells (Grossoni et al., 2007) indicating it’s involvement in cell viability in extra-
ovarian tissues. These results indicate that PKCδ is important for ovarian follicle survival. 
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         In summary, the ovary induces increased levels of mRNA and proteins involved in the 
response to DNA damage following PM exposure, supporting that induction of DNA damage 
is an initiating event of PM-induced ovotoxicity. However, the repair mechanisms were 
reduced and cell death mechanisms were increased at the time of follicle loss. PM-induced 
apoptosis appears P53-independent but is potentially occurring through an E2F1-P73 
dependent mitochondrial apoptotic pathway. In addition, the data support that inhibition of 
ATM prevented elimination of PM-affected oocytes, which may not necessarily represent a 
benefit to the germline. PKCδ is involved in either ovarian endowment or follicular survival 
but there was no impact of PKCδ deficiency on PM-induced ovotoxicity. The data shed 
additional light on potential targets for amelioration of PM-induced infertility that occurs as a 
side effect to anti-neoplastic therapy.   
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Table 1. PM exposure alters DNA damage response genes 
Gene 
Symbol Gene Description 
24h 48h 
P-value 
 
Fold 
Change 
P-value 
 
Fold 
change 
Abl1 
C-abl oncogene 1, receptor 
tyrosine kinase 0.312239 1.1487 0.526479 1.0892 
Apex1 
APEX nuclease 
(multifunctional DNA repair 
enzyme) 1 0.135057 1.2687 0.392677 0.8847 
Atm 
Ataxia telangiectasia 
mutated homolog (human) 0.013108
*
 7.4299 0.011492
*
 5.6569 
Atrx 
Alpha thalassemia/mental 
retardation syndrome X-
linked (RAD54 homolog, S. 
cerevisiae) 0.243991 0.8827 0.810823 0.9772 
Bard1 
BRCA1 associated RING 
domain 1 0.295528 1.1277 0.088753
†
 1.2058 
Bax Bcl2-associated X protein 0.005057
*
 1.2864 0.256135 1.2142 
Bbc3 Bcl-2 binding component 3 0.012387
*
 3.0525 0.007794
*
 2.3241 
Blm 
Bloom syndrome, RecQ 
helicase-like 0.499984 1.0305 0.936065 0.9374 
Brca1 Breast cancer 1 0.782131 1.0257 0.374837 1.1514 
Brca2 Breast cancer 2 0.741006 1.0305 0.958715 0.9749 
Cdc25a 
Cell division cycle 25 
homolog A (S. pombe) 0.118156 1.203 0.352699 1.1173 
Cdc25c 
Cell division cycle 25 
homolog C (S. pombe) 0.396321 1.1329 0.211952 1.2311 
Cdkn1a 
Cyclin-dependent kinase 
inhibitor 1A 0.008436
*
 2.9622 0.00174
*
 4.2673 
Chek1 
CHK1 checkpoint homolog 
(S. pombe) 0.349977 1.0892 0.702184 1.1567 
Chek2 
CHK2 checkpoint homolog 
(S. pombe) 0.260729 1.0644 0.869535 1.0546 
Csnk2a2 
Casein kinase 2, alpha prime 
polypeptide 0.289536 1.1147 0.390566 1.0668 
Dclre1a 
DNA cross-link repair 1A, 
PSO2 homolog (S. 
cerevisiae) 0.717051 1.0546 0.915275 1 
Ddb2 
Damage specific DNA 
binding protein 2 0.447548 1.1199 0.389403 1.2114 
Ddit3 
DNA-damage inducible 
transcript 3 0.077008
†
 1.3013 0.281512 1.1755 
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Ercc1 
Excision repair cross-
complementing rodent repair 
deficiency, complementation 
group 1 0.141285 1.6663 0.996217 1.0521 
Ercc2 
Excision repair cross-
complementing rodent repair 
deficiency, complementation 
group 2 0.085976
†
 1.3134 0.545631 0.9571 
Exo1 Exonuclease 1 0.04755* 1.2864 0.068344
†
 1.3472 
Fanca 
Fanconi anemia, 
complementation group A 0.35111 1.1251 0.563864 0.9615 
Fancc 
Fanconi anemia, 
complementation group C 0.048355
*
 1.234 0.523286 0.9374 
Fancd2 
Fanconi anemia, 
complementation group D2 0.606512 0.9181 0.335255 1.1865 
Fancg 
Fanconi anemia, 
complementation group G 0.463538 1.234 0.812519 0.9352 
Fen1 
Flap structure-specific 
endonuclease 1 0.221919 1.2226 0.814693 0.9772 
Gadd45a 
Growth arrest and DNA-
damage-inducible, alpha 0.213291 1.2541 0.081158
†
 1.146 
Gadd45g 
Growth arrest and DNA-
damage-inducible, gamma 0.033573
*
 1.4675 0.334277 1.1096 
Hus1 
HUS1 checkpoint homolog 
(S. pombe) 0.634427 1.0644 0.325104 1.2426 
Lig1 
Ligase I, DNA, ATP-
dependent 0.069176
†
 1.2397 0.218539 0.9096 
Mbd4 
Methyl-CpG binding domain 
protein 4 0.89147 1.0163 0.661521 0.9266 
Mgmt 
O-6-methylguanine-DNA 
methyltransferase 0.047554
*
 1.3044 0.016206* 1.366 
Mif 
Macrophage migration 
inhibitory factor 0.467063 1.1355 0.076206† 0.8123 
Mlh1 MutL homolog 1 (E. coli) 0.351574 1.1783 0.12086 1.3013 
Mlh3 MutL homolog 3 (E. coli) 0.208399 1.2311 0.561219 0.9504 
Mpg 
N-methylpurine-DNA 
glycosylase 0.235894 1.1674 0.067155
†
 0.7596 
Mre11a 
MRE11 meiotic 
recombination 11 homolog A 
(S. cerevisiae) 0.607192 1.107 0.638172 0.9266 
Msh2 MutS homolog 2 (E. coli) 0.497878 1.1701 0.902053 0.9571 
Msh3 MutS homolog 3 (E. coli) 0.445846 1.1975 0.44164 1.1975 
Nbn Nibrin 0.0541 1.3819 0.856436 1.0093 
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Nthl1 
Nth (endonuclease III)-like 1 
(E.coli) 0.054587
†
 1.3226 0.081719
†
 1.1647 
Ogg1 
8-oxoguanine DNA 
glycosylase 0.126461 1.1728 0.349599 0.9244 
Parp1 
Poly (ADP-ribose) 
polymerase 1 0.264189 1.1728 0.424704 1.057 
Parp2 
Poly (ADP-ribose) 
polymerase 2 0.676188 1.0353 0.931862 0.9885 
Pcna 
Proliferating cell nuclear 
antigen 0.38386 1.1381 0.945307 1.0425 
Pms1 
Postmeiotic segregation 
increased 1 (S. cerevisiae) 0.511449 1.1199 0.643373 1.0644 
Pms2 
PMS2 postmeiotic 
segregation increased 2 (S. 
cerevisiae) 0.560091 1.0473 0.340669 1.0842 
Pold3 
Polymerase (DNA-directed), 
delta 3, accessory subunit 0.010864
*
 1.2924 0.045197
*
 1.2142 
Pole 
Polymerase (DNA directed), 
epsilon 0.375352 1.0918 0.658336 1.0943 
Polh 
Polymerase (DNA directed), 
eta 0.124069 1.3692 0.245529 1.3013 
Poli 
Polymerase (DNA directed), 
iota 0.711749 1.0644 0.99201 1.0234 
Ppm1d 
Protein phosphatase 1D 
magnesium-dependent, delta 
isoform 0.947673 0.9817 0.758303 1.0377 
Ppp1r15
a 
Protein phosphatase 1, 
regulatory (inhibitor) 
subunit 15A 0.480946 1.257 0.942998 0.9931 
Prkdc 
Protein kinase, DNA 
activated, catalytic 
polypeptide 0.587209 0.9682 0.151171 0.9013 
Pttg1 
Pituitary tumor-
transforming 1 0.889429 0.9908 0.143736 1.192 
Rad1 RAD1 homolog (S. pombe) 0.170965 1.2198 0.102001 1.1701 
Rad17 RAD17 homolog (S. pombe) 0.2546 1.3044 0.67232 1.0644 
Rad18 
RAD18 homolog (S. 
cerevisiae) 0.471636 1.107 0.056689
†
 1.3851 
Rad21 RAD21 homolog (S. pombe) 0.029826
*
 1.1567 0.312453 1.0718 
Rad50 
RAD50 homolog (S. 
cerevisiae) 0.843589 1.0546 0.899764 1.0116 
Rad51 
RAD51 homolog (RecA 
homolog, E. coli) (S. 
cerevisiae) 0.712222 0.9117 0.749256 0.9482 
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Rad51c 
Rad51 homolog c (S. 
cerevisiae) 0.127529 1.1728 0.920006 0.984 
Rad51l1 RAD51-like 1 (S. cerevisiae) 0.786838 0.9461 0.244064 1.1865 
Rad52 
RAD52 homolog (S. 
cerevisiae) 0.272424 1.146 0.053884 0.772 
Rad9 RAD9 homolog (S. pombe) 0.424469 1.2454 0.3183 1.2687 
Rev1 
REV1 homolog (S. 
cerevisiae) 0.574057 0.9461 0.233963 1.2454 
Rnf8 Ring finger protein 8 0.487879 1.1408 0.869256 0.9885 
Rpa1 Replication protein A1 0.013334
*
 1.1892 0.556704 0.9526 
Sirt1 
Sirtuin (silent mating type 
information regulation 2 
homolog) 1 (S. cerevisiae) 0.678773 1.0595 0.787997 0.9637 
Smc1a 
Structural maintenance of 
chromosomes 1A 0.746518 1.0353 0.969618 0.9885 
Smc3 
Structural maintenance of 
chromosomes 3 0.638172 1.0187 0.736184 0.984 
Sumo1 
SMT3 suppressor of mif two 
3 homolog 1 (S. cerevisiae) 0.598499 1.0644 0.851358 0.9772 
Terf1 
Telomeric repeat binding 
factor (NIMA-interacting) 1 0.457284 1.1277 0.039905
*
 1.1594 
Topbp1 
Topoisomerase (DNA) II 
binding protein 1 0.025918
*
 1.2483 0.896361 1.0329 
Tp53 Tumor protein p53 0.105159 1.1121 0.877169 1.0521 
Tp53bp1 
Tumor protein p53 binding 
protein 1 0.256613 1.341 0.635593 0.9395 
Ung Uracil-DNA glycosylase 0.045674
*
 1.1303 0.779979 1.0743 
Wrn Werner syndrome 0.073835 1.1199 0.193978 0.8293 
Wrnip1 
Werner helicase interacting 
protein 1 0.159907 1.3256 0.819488 1.0377 
Xpc 
Xeroderma pigmentosum, 
complementation group C 0.070633 1.234 0.305746 0.9033 
Xrcc1 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 1 0.149262 1.2483 0.955513 1.0023 
Xrcc2 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 2 0.03398
*
 1.2483 0.799622 1.0234 
Xrcc6 
X-ray repair complementing 
defective repair in Chinese 
hamster cells 6 0.533041 1.107 0.651773 1.0497 
Actb Actin, beta 0.446612 1.1303 0.589099 1.0521 
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B2m Beta-2 microglobulin 0.157751 1.1674 0.226577 1.2775 
Hprt1 
Hypoxanthine 
phosphoribosyltransferase 1 0.355472 1.1277 0.858521 0.9794 
Ldha Lactate dehydrogenase A 0.588695 1.0792 0.213445 0.0856 
Rplp1 
Ribosomal protein, large, 
P1 0 1 0 1 
 
Fisher 344 PND4 rat ovaries were cultured for 24 or 48 h in medium containing vehicle 
control ± 60 µM PM.  RNA was isolated and used to perform a RT
2 
Profiler PCR array. 
Values represent fold-change ± SEM relative to a control value of 1 (10 ovaries per pool), 
normalized to Rplp1. * = different from control, P < 0.05; † = P < 0.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
210 
 
 
 
Figure 1. PM activates DNA repair genes prior to follicle loss  
Fisher 344 PND4 rat ovaries were cultured for 12 h in medium containing vehicle control ± 
60 µM PM.  RNA was isolated and used to perform qRT-PCR. Values are expressed as mean 
fold change relative to control treated ovaries ± SE; n=3 (10 ovaries per pool). Statistical 
significance was defined as * = P < 0.05. 
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Figure 2. PM activates transcription factor and apoptotic gene mRNA level 
Fisher 344 PND4 rat ovaries were cultured for (A) 24, (B) 48 or (C) 96 h, in medium 
containing vehicle control ± 60 µM PM.  RNA was isolated and used to perform qRT-PCR. 
Values are expressed as mean fold change relative to control treated ovaries ± SE; n=3 (10 
ovaries per pool). Statistical significance was defined as * = P < 0.05. 
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Figure 3. PM activates E2F1-P73 dependent apoptotic pathway 
Following 96 h of PM exposure, protein was isolated and used to perform western blot 
analysis for (A) DNA damage response proteins, (B) Transcription factor proteins, (C) pro-
apoptotic CASP3 and (D) anti-apoptotic BCL-2. Results were normalized to Ponceau S 
densitometric staining and expressed as mean raw data ± SE; n=3 (10 ovaries per pool). 
Statistical significance was defined as * = P < 0.05. 
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Figure 4. ATM inhibition prevents PM-induced ovotoxicity 
Ovaries were cultured in medium containing vehicle control (DMSO) ± PM (60 µM) ± KU-
55933 (10 nM) for 96 h. Following culture, follicles were classified and counted. Total 
number of primordial (A), small primary (B), large primary (C) and secondary (D) follicles 
are presented as mean raw data ± SE; n=5. Different letters indicates statistical difference 
from control treated ovaries at P < 0.05. (E) Histological ovarian sections of the control 
treated (CT), PM treated (PM), ATM inhibitor treated (AI) and PM plus ATM inhibitor 
treated (PM + AI) are presented.   
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Figure 5. PKCδ is essential for follicular survival 
Ovaries from PKCδ wild type (WT) or knockout (KO) mice were cultured with vehicle 
control (DMSO) ± PM (10 µM) for 144 h. Following culture, follicles were counted between 
(A) treatments and strains and (B) the percentage reduction in follicle stage number 
calculated. The total number of primordial, small primary, large primary and secondary 
follicles are expressed as mean raw data ± SE; n=5. Statistical significance was defined as * 
= P < 0.05 between treatments, while differences between strains within each follicle group 
are designated with letters. (C) Histological ovarian sections of the wild type control treated 
(WT CT), wild type PM treated (WT PM), knockout control treated (KO CT) and knockout 
PM treated (KO PM) are presented. 
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Abstract 
          Phosphoramide mustard (PM), an ovotoxic metabolite of cyclophosphamide, destroys 
rapidly dividing cells at least partly, by inducing DNA damage.  γH2AX, marker of DNA 
damage was evident in ovaries from obese mice indicated that obesity increased sensitivity to 
another ovotoxicant, 7,12-dimethylbenz(a)anthracene. This study investigated the effects of 
PM exposure on DNA damage induction and activation of DNA damage repair in both lean 
and obese female mice. Wild type (lean) non agouti (a/a) and KK.Cg-Ay/J heterozygote 
(obese) mice were dosed once with sesame oil or PM (95%; 25 mg/kg; i.p). Obesity 
increased (P < 0.05) liver while decreased (P < 0.05) uterine and spleen weights regardless of 
body composition, however, decreased (P < 0.05) ovarian weight was only observed in the 
obese females exposed to PM.  Exposure to PM decreased (P < 0.05) primordial and primary 
(P < 0.05) follicle numbers. γH2AX protein was increased (P < 0.05) by both obesity and 
PM, indicating DNA damage occurrence. mRNA encoding DNA damage repair genes Atm, 
Prkdc, Parp1, Xrcc6 and Rad51 were not altered by obesity, however, Brca1 was decreased 
(P < 0.05) in ovaries of obese females. PRKDC and XRCC6 protein levels were reduced (P 
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< 0.05) by obesity while ATM, BRCA1 and RAD51 protein levels were increased (P < 0.05) 
by PM exposure. These results indicate that PM induces ovarian DNA damage as a mode of 
ovotoxicity, and that the ovary is responsive to such an insult and activates DNA repair 
proteins in ovaries. Additionally, and of concern, obesity altered the ovarian response to an 
ovotoxic exposure.    
 
Introduction 
          The mammalian ovary is the female gamete-producing reproductive organ. Primordial 
germ cells undergo mitosis during oogenesis to establish a gamete pool, arrested in the 
diplotene stage of meiosis [1]. Females are born with a finite number of gametes, contained 
in primordial follicle structures, which are required to remain viable over the female 
reproductive lifetime [1]. Primordial follicles are activated to either develop towards 
ovulation or undergo atresia, a natural process of elimination [2]. Through this process, 
females are eventually depleted of all follicles and reproductive senescence ensues [1, 2].  
Several factors, including genetics and ovotoxic chemical exposures accelerate loss of 
follicles [3, 4], which can phenotypically manifest as infertility and premature ovarian 
failure.  
          Cyclophosphamide (CPA) is a chemotherapeutic agent used to treat cancer and 
autoimmune diseases. CPA can induce rapid amenorrhea, potentially due to antral follicle 
destruction, or premature ovarian failure, attributed to primordial follicle depletion [5]. CPA 
has also been demonstrated to cause infertility by increasing the number of early growing 
follicles and decreasing primordial follicle numbers through follicular activation in mice 
ovaries [6], a phenomenon previously observed in ovotoxicity induced by 4-
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vinylcyclohexene diepoxide [7]. In rodents, species-specific differences in CPA-induced 
ovarian toxicity are noted, with primordial follicles being most sensitive in mice [8] and 
antral follicles in rats [9]. Oxidation of CPA by hepatic cytochromes P450 to 4-
hydroxycyclophosphamide (4-OH-CPA) involve a cascade of non-enzymatic reactions which 
ultimately leads to the production of phosphoramide mustard (PM) [10]. PM has been shown 
to be an active ovotoxic CPA metabolite by destroying both primordial and primary follicles 
[8, 11]. PM-induced DNA damage represents at least one mechanism by which ovarian 
follicle loss is caused [12]. PM is known to destroy rapidly dividing cells by covalently 
binding to DNA, inducing DNA-DNA, DNA-protein cross links and DNA double strand 
breaks (DSB) [13]. Upon DSB induction, cells activate a DNA damage response (DDR) that 
comprises cell cycle arrest, DNA damage repair, and subsequent cell cycle resumption [14].  
Phosphorylation of the histone H2AX (γH2AX) at Serine 139 is an early event in the DDR, 
resulting in recruitment and maintenance of DNA repair molecules at the sites of DSB until 
repair is complete, and is considered a gold standard for DSB localization. γH2AX can be 
activated by ataxia-telangiectasia mutated (ATM), ATM-related (ATR) and DNA-dependent 
protein kinases (DNA-PKcs) in response to DSB. Repair of the break can be accomplished 
through the action of two major pathways: non-homologous end joining (NHEJ) and 
homologous recombination (HR). The integrity of the gamete genome is critical for the 
health of offspring. If alterations in DNA of primordial follicles remain, these changes could 
cause detrimental changes in offspring [12]. This has been evidenced by mice exposed once 
to CPA which had increased malformations [15]. This is therefore a major concern for 
women wishing to have children subsequent to cancer treatments [16]. 
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          Obesity induces DNA damage in hematopoietic cell transplant recipients that have 
been treated by CPA [17]. It is known that cellular DNA damage can arise from the action of 
free radicals and obesity [18]. In addition, high fat diets can accelerate oxidative stress and 
oxidative DNA damage [19]. BRCA1 and BRCA2 are crucial members of the ATM-
mediated DSB repair family of genes. Impairment of BRCA1-related DNA DSB repair was 
associated with accelerated loss of the ovarian follicular reserve and with accumulation of 
DSB in human oocytes, suggesting that DNA DSB repair efficiency is an important 
determinant of oocyte aging in women [20]. Our previous studies have indicated the presence 
of DNA damage at a basal level in the ovaries of obese mice, and demonstrated increased 
sensitivity to the ovotoxicant [21], 7,12-dimethylbenz[a]anthracene (DMBA) which, similar 
to PM, is an alkylating agent. Also, our work using cultured ovarian granulosa cells [22] and 
an ex vivo ovarian culture system [23], have demonstrated that PM-induced DNA damage as 
a mode of ovotoxicity. Thus, we hypothesized that PM-induced ovotoxicity would cause 
DNA DSB’s in vivo, to which the ovary will mount a protective DNA repair response.  In 
addition, we proposed that the ovaries of obese mice would have an altered response to PM 
exposure.   
 
Methods and Materials 
Reagents 
         PM was acquired from the National Institutes of Health National Cancer Institute 
(Bethesda, MA). Sesame oil (CAS # 8008-74-0), 2-β-mercaptoethanol, 30% 
acrylamide/0.8% bisacrylamide, Ammonium persulphate, Glycerol, N′N′N′N′-
Tetramethylethylenediamine (TEMED), Tris base, Tris HCL, Sodium chloride, Tween-20 
219 
 
 
were purchased from Sigma-Aldrich Inc. (St Louis, MO).  RNeasy Mini kit, QIA shredder 
kit, RNeasy Min Elute kit, and Quantitect TM SYBR Green PCR kit were purchased from 
Qiagen Inc (Valencia, CA). All primers were purchased from the Iowa State University DNA 
facility. All primary antibodies were purchased from Abcam (Cambridge, MA) with the 
exception of the BRCA1(C-20) primary antibody which was from Santa Cruz Biotechnology 
(Santa Cruz, CA). RNA later was obtained from Ambion Inc. (Austin, TX). Goat anti-mouse 
and anti-rabbit secondary antibodies were obtained from Santa Cruz Biotechnology (Santa 
Cruz, CA). Ponceau S was from Fisher Scientific. ECL plus chemical luminescence detection 
kit was obtained from GE Healthcare, Amersham (Buckinghamshire, UK). 
Animals and tissue collection 
          Briefly, four week old female wild type normal non-agouti (a/a; designated lean; n = 
10) and agouti lethal yellow (KK.Cg-Ay/J; designated obese; n = 10) were purchased from 
Jackson laboratories (Bar Harbor, ME 002468).  All animals were housed in cages under a 12 
h light/dark photoperiod with the temperature between 70-73
o
F and humidity approximately 
20-30%. The animals were provided with a standard diet (Teklad 2014 global 14% protein 
rodent maintenance diet) with ad libitum access to food and water until 6, 12, 18 or 24 weeks 
of age. These animals were part of a previously described project [24]. Tissues were 
collected when mice were in the pro-estrus stage of their estrous cycle. All animal 
experimental procedures were approved by the Iowa State University Animal Care and Use 
Committee.  
In vivo PM exposure and tissue collection 
          A separate group of lean and obese mice aged 15 wks of age in both the lean and obese 
groups were intraperitoneally (i.p) dosed once with sesame oil (SO) or PM (95%; 25 mg/kg) 
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(n=5/group). This dose was chosen based on the literature [11, 25]. Mice were euthanized 3 
days after the end of dosing in their pro-estrus phase. Ovary, uterus, liver and spleen weights 
were obtained. One ovary from each mouse was fixed in 4% paraformaldehyde and one 
ovary was preserved in RNA later at -80ºC for RNA and protein isolation.  
Ovarian histology and follicle counting 
        Ovaries were serially sectioned (5 µM thickness) and every 6
th
 section was mounted and 
stained with hematoxylin and eosin. Numbers of healthy follicles were classified and counted 
in every 6
th
 section according to the procedures as previously described [11]. 
RNA isolation and qRT-PCR 
          Total ovarian RNA was isolated using an RNeasy Mini kit (Qiagen) and the 
concentration was determined using an ND-1000 Spectrophotometer (λ = 260/280nm; 
NanoDrop technologies, Inc., Wilmington, DE) (n=3). Total RNA (200 ng) was reverse 
transcribed to cDNA utilizing the Superscript III One-Step RT-PCR (Qiagen).  cDNA was 
diluted (1:20) in RNase-free water. Diluted cDNA (2 μl) were amplified on an Eppendorf 
PCR Master cycler using Quantitect SYBR Green PCR kit (Qiagen). Primers for Atm, Brca1, 
Prkdc, Parp1, Rad51, Xrcc6 and Gapdh were designed by Primer 3 Input Version (0.4.0) 
[26]. The regular cycling program consisted of a 15-min hold at 95
o
C and 45 cycles of 
denaturing at 95
o
C for 15s, annealing at 58
o
C for 15s, and extension at 72
o
C for 20s at which 
point data were acquired. There was no difference in Gapdh mRNA expression between 
treatments, thus each sample was normalized to Gapdh before quantification. Quantification 
of fold-change in gene expression was performed using the 2
-Ct 
method [27, 28]. 
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Protein isolation and Western blotting 
          Total ovarian protein was isolated from randomly chosen animals (n=3) by 
homogenization in tissue lysis buffer containing protease and phosphatase inhibitors as 
previously described [31]. Briefly, homogenized samples were placed on ice for 30 min, 
followed by two rounds of centrifugation at 10,000 rpm for 15 min and protein concentration 
was measured using a standard BCA protocol. SDS-PAGE was used to separate protein 
homogenates which were then transferred to a nitrocellulose membrane. Membranes were 
blocked for 1 hour in 5 % milk in Tris-buffered saline containing tween 20, followed by 
incubation with one of: anti-rabbit PARP1 antibody (1:200), anti-rabbit phosphorylated 
H2AX antibody (γH2AX; 1:100), anti-mouse ATM antibody (1:100), anti-mouse RAD51 
antibody (1:500), anti-mouse XRCC6 antibody (1:100), anti-rabbit BRCA1 antibody (1:500), 
or anti-rabbit PRKDC antibody (1:100) for 36 h at 4
o
C. Following three washes in TTBS 
(1X), membranes were incubated with species-specific secondary antibodies (1:2000-5000) 
for 1h at room temperature. Membranes were washed 3X in TTBS and incubated in 
enhanced chemiluminescence detection substrate (ECL plus) for 5 min followed by X-ray 
film exposure. Densitometry of the appropriate bands was performed using ImageJ software 
(NCBI). Equal protein loading was confirmed by Ponceau S staining of membranes and 
protein level was normalized to Ponceau S densitometry values.     
Statistical analysis 
          Raw data for all the experiments were analyzed by unpaired t-test using Graphpad 
Prism 5.04 software. Different letters indicate P-value < 0.05 which was considered a 
significant difference between treatments. For graphical purposes, protein expression is 
presented as the mean raw densitometry value ± SE of the respective control. 
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Results 
Effect of PM exposure on body and organ weight 
          Body weights were obtained prior to PM injection in both lean and obese groups. As 
expected,  body weights were increased (P < 0.05) in mice that were grouped as the obese 
controls (40.8 ± 0.66 g) and obese PM (43.25 ± 2.28 g) subjects compared to those grouped 
as lean control (34.0 ± 1.81 g) and lean PM (30.40 ± 1.36 g) (Figure 1A).    
          Ovarian weight was not altered by PM exposure (lean control: 0.0146 ± 0.001 g; lean 
PM: 0.0125 ± 0.009 g). In contrast, PM exposure decreased (P < 0.05) ovarian weight in 
obese mice (obese control: 0.0131 ± 0.0013 g; obese PM: 0.0106 ± 0.0008 g) relative to their 
control treated littermates. As previously reported [21] there were no difference in ovarian 
weight between lean control and obese control ovaries (Figure 1B). 
          The uterus weight was decreased (P < 0.05) in both the obese control 0.0796 ± 0.014 
g) and obese PM (0.0610 ± 0.007 g) groups compared to the lean control (0.139 ± 0.024 g) 
and lean PM (0.110 ± 0.004 g) treated mice.  There was no effect of PM exposure on uterine 
weight (Figure 1C). 
           Spleen weight was increased (P < 0.05) in obese (0.142 ± 0.003 g) compared to lean 
control subjects (0.123 ± 0.007 g).  PM exposure reduced (P < 0.05) spleen weight in lean 
PM (0.095 ± 0.002 g) compared to lean control (0.123 ± 0.007 g) treated mice. PM exposure 
also reduced (P < 0.05) spleen weight in obese PM (0.0795 ± 0.002 g) compared to obese 
control (0.142 ± 0.003 g) mice (Figure 1D). Liver weight was increased (P < 0.05) in obese 
control (2.362 ± 0.056 g) and obese PM (1.960 ± 0.151 g) compared to lean control (1.290 ± 
0.077 g) and lean PM (1.44 ± 0.084 g). PM exposure reduced liver weight in obese PM 
(1.960 ± 0.151 g) compared to obese control (2.362 ± 0.056 g) (Figure 1F).   
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Impact of PM exposure on healthy follicle number in lean and obese females 
         There were reduced (P < 0.07) numbers of healthy primordial follicles in ovaries of 
obese mice (Lean: CT: 91.4 ± 20.56; Obese: 60.0 ± 12.72) relative to lean controls. PM 
reduced (P < 0.05) the number of healthy primordial follicles in both lean (CT: 91.4 ± 20.56; 
PM: 55.6 ± 15.61) and obese ovaries (CT: 60.0 ± 12.72; PM: 29.5 ± 19.17) compared to lean 
control (Figure 2A).   
          PM reduced (P < 0.05) the number of healthy primary follicles in both lean (CT: 38.0 
± 4.7; PM: 30.6 ± 3.07) and obese ovaries (CT: 28.2 ± 5.35; PM: 24.25 ± 8.1). There were 
also reduced (P < 0.05) numbers of healthy primary follicles (Lean CT: 38.0 ± 4.7; Obese 
CT: 28.2 ± 5.35) in obese ovaries relative to lean control (Figure 2B). There was no 
difference in secondary healthy follicles between the strains or between the treatments 
(Figure 2C).    
Identification of PM-induced ovarian DNA DSB using γH2AX protein  
          The basal level of γH2AX protein was higher (P < 0.05) in ovaries from obese (0.69 ± 
0.04) compared to lean control mice (0.59 ± 0.01). However, PM exposure increased (P < 
0.05) γH2AX protein abundance in both lean (CT: 0.59 ± 0.01; PM: 0.71 ± 0.04) and obese 
(CT: 0.69 ± 0.04; PM: 0.90 ± 0.05) ovaries (Figure 3A, B).   
Investigation of PM exposure effect on Atm mRNA and protein expression  
          Basal levels of Atm mRNA were increased (P < 0.05) in obese control treated mice 
(0.60-fold ± 0.25) compared to lean control ovaries (1.0-fold ± 0.2). While there was no 
impact of PM exposure in ovaries from lean mice, an increase in Atm mRNA was observed 
in ovaries from obese PM-treated mice (1.5-fold ± 0.39) compared to the vehicle control-
treated group (0.60-fold ± 0.25) (Figure 4A). Basal levels of ATM protein were higher (P < 
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0.05) in obese (0.64 ± 0.01) compared to lean vehicle-control treated ovaries (0.56 ± 0.009). 
PM increased (P < 0.05) ATM protein abundance in both the lean (0.60 ± 0.01) and obese 
PM exposed ovaries (0.63 ± 0.01) (Figure 4B, C).  
Effect of PM exposure on Prkdc mRNA and protein expression in lethal yellow mice 
ovaries 
 
          There were no differences in basal levels of ovarian Prkdc mRNA in obese (0.19-fold 
± 0.25) compared to lean (1.0-fold ± 0.10) mice.  PM exposure increased (P < 0.05) ovarian 
Prkdc mRNA level in both lean (0.33-fold ± 0.14) and obese (0.32-fold ± 0.10) exposed mice 
(Figure 5A). PRKDC protein level was lower (P < 0.05) in ovaries from obese (CT: 0.52 ± 
0.02; PM: 0.56 ± 0.03) compared to lean mice (CT: 0.64 ± 0.02; PM: 0.70 ± 0.03) (Figure 
5B, C).  
Impact of PM exposure on Xrcc6 mRNA and protein expression  
          Basal levels of Xrcc6 mRNA expression were greatly reduced (P < 0.05) in ovaries 
from obese control (0.70-fold ± 0.05) compared to lean control-treated ovaries (1.0-fold ± 
0.13). PM decreased (P < 0.05) Xrcc6 mRNA expression in both obese PM (0.78-fold ± 
0.02) and lean PM (0.88-fold ± 0.02) ovaries compared to lean control ovaries (Figure 6A).  
Similarly, ovarian XRCC6 protein level was lower (P < 0.05) in obese control (0.49 ± 0.02) 
relative to lean control-treated ovaries (0.65 ± 0.04). PM exposure increased (P < 0.05) 
ovarian XRCC6 protein abundance in lean mice (CT: 0.65 ± 0.04; PM: 0.90 ± 0.09), but no 
impact of PM exposure on XRCC6 protein was observed in obese mice (Figure 6B, C).    
Effect of PM exposure on Parp1 mRNA and protein expression in lethal or obese mice 
          There were no changes in basal levels of Parp1 mRNA expression in obese control 
(0.40-fold ± 0.25) compared to lean control (1.0-fold ± 0.10) ovaries. PM decreased (P < 
0.05) Parp1 mRNA expression in both obese PM (0.82-fold ± 0.02) and lean PM (0.72-fold 
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± 0.07) treated ovaries compared to the respective control ovaries (Lean: 1.0-fold ± 0.21; 
Obese 0.40-fold ± 0.18) (Figure 7A). There were no changes in basal abundance of PARP1 
protein in obese control (0.69 ± 0.01) compared to lean control (0.69 ± 0.05) ovaries. PM 
increased (P < 0.05) PARP1 protein expression in lean PM exposed ovaries (1.07 ± 0.09) 
compared to lean control (0.69 ± 0.05) ovaries, but were no changes in PARP1 protein 
expression due to PM exposure in ovaries from obese mice (Figure 7B, C). 
Evaluation of PM effects on Brca1 mRNA and protein expression and impact of obesity 
          There were no differences in the basal level of Brca1 mRNA expression between the 
lean and obese ovaries. PM increased (P < 0.05) ovarian Brca1 mRNA expression in lean 
mice (1.4-fold ± 0.68) relative to the control ovaries but this increase was absent in ovaries 
from obese mice (Figure 8A). The basal level of ovarian BRCA1 protein was lower (P < 
0.05) in obese (0.64 ± 0.01) relative to lean control-treated (0.81 ± 0.03) mice. PM increased 
(P < 0.05) BRCA1 protein level in both lean (1.01 ± 0.05) and obese (0.93 ± 0.08) PM 
exposed groups compared to their respective control (Lean: 0.81 ± 0.03; Obese: 0.64 ± 0.01) 
(Figure 8B, C).  
Investigation of PM impact on Rad51 mRNA and protein expression in lean and obese 
females 
 
          Rad51 mRNA expression was not different in obese ovaries compared to lean ovaries.  
However, PM exposure decreased (P < 0.05) ovarian Rad51 mRNA expression in lean mice 
(CT: 1.0-fold ± 0.2; PM: 0.49-fold ± 0.10). In contrast, Rad51 mRNA expression was 
increased (P < 0.05) in response to PM exposure in ovaries from obese mice (1.0-fold ± 0.21) 
compared to lean mice (0.49-fold ± 0.10) (Figure 9A). There was no basal differential 
RAD51 protein abundance in obese compared to lean ovaries. PM increased (P < 0.05) 
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RAD51 protein level in both lean (0.89 ± 0.06) and obese (0.86 ± 0.03) exposed groups 
compared to their respective controls (Lean: 0.65 ± 0.01; Obese: 0.65 ± 0.01) (Figure 9B, C).  
Temporal effect of genotypic changes in relation to DNA repair gene abundance 
          Since low levels of DNA damage were observed previously [21] and as indicated by 
increased γH2AX protein in this study, the impact of progressive obesity on induction of the 
DNA repair response was determined. After 6 wks of age, obese ovaries had increased (P < 
0.05) expression of a number of DNA DSB repair genes investigated (Atm: 0.87-fold ± 0.2; 
Brca1: 0.30-fold ± 0.04; Xrcc6: 0.82-fold ± 0.13; Rad51: 0.62-fold ± 0.03), compared to the 
lean mouse strain (Figure 10A). After 12 wks of age, there was no differential expression in 
any of the DNA DSB repair gene between the mouse strains (Figure 10B). In the mice aged 
18 and 24 wks of age, Brca1 mRNA abundance was reduced (P < 0.05) in ovaries from 
obese mice (18 wks: 0.37-fold ± 0.11; 24 wks: 0.38-fold ± 0.08) relative to lean mice ovaries 
(Figure 10C and D). 
 
Discussion 
          This study investigated whether PM-induced DNA DSB is an initiating event to 
precipitate follicular atresia. We have previously noted that PM activates the DNA DSB 
repair mechanism in cultured neonatal rat ovaries [23] and in a rat ovarian granulosa cell line 
[22], which we propose is a logical mechanism to protect cells from PM-induced ovotoxicity. 
Also, obesity induces ovarian DNA damage in hematopoietic cells after CPA exposure [17], 
and we have previously demonstrated that progressive obesity induces DNA damage in 
ovaries [26]. Thus, the primary objective of this study was to investigate the impact of PM 
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exposure on the DNA damage response in vivo, and secondly to determine any additive 
impact of obesity on the ovarian protective response to an ovotoxic insult.   
          We found that ovarian weight was not altered by obesity at the time point chosen, 
similar to our previously published findings [21]. We discovered that a single dose of PM 
decreased ovarian weight in obese mice, consistent with a previous study that in utero 
exposure of CPA reduced ovarian weight in mice [29]. Reduced uterine weights were 
reported in obese rats during pseudo pregnancy [30], similar to our findings. As expected, 
obesity increased liver weight which was consistent with another study in which a high fat 
diet increased liver weights in male wistar rats [31, 32]. Obesity increased spleen weight in 
this study, as also previously observed in high fat diet fed mice [32]. No major effect of PM 
on organ weights was observed in the absence of obesity, with the exception of spleen weight 
which was reduced. A single exposure of CPA (250 mg/kg) was found to increase liver 
weights after 8 days in CD-1 female mice [12]. In that study, spleen weights were decreased 
1 day after exposure, similar to our findings, but were increased 8 days later in mice dosed 
with 150 or 250 mg/kg CPA [12]. Taken together, PM reduced ovary and spleen weights 
while obesity altered uterus, spleen and liver weights. 
          PM is a known ovotoxicant and destroys primordial and primary follicles in mice and 
rat ovaries both in vitro [22, 33] and in vivo [8, 11, 12]. We found that a single PM dose 
reduced primordial and primary follicles in lean mice. There were also a lower number of 
primordial and primary follicles numbers in obese mouse ovaries, and no additive effect of 
PM was observed. The lower number of follicles due to obesity was in agreement with a 
previous study from our group which demonstrated that obesity reduced primordial and 
primary follicle number after 12 weeks of age [24]. Since maintenance of primordial follicles 
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in a dormant but viable state is essential for normal reproductive activity, obesity-induced 
reduction of primordial follicle pool could result in premature ovarian failure [1].   
          Localization of γH2AX protein is considered the gold standard technique for 
identification of DNA DSB [34]. PM exposure increased γH2AX protein in both lean and 
obese mice. γH2AX protein recruits DNA repair molecules to the site of damage until repair 
is complete. Thus, these data corroborate our in vitro data and demonstrate that PM-induced 
ovotoxicity involves the formation of DNA DSB. We have previously reported [26], and 
again demonstrate that obesity alone results in a low level of DNA DSB as evidenced by the 
presence of ovarian γH2AX. We do not know the cause of such DNA DSB in ovaries from 
obese mice, but speculate that increased reactive oxygen species could be present [35].  
Considering that protection of the germline is an evolutionary necessity, we next investigated 
that ovarian capacity for DNA DSB repair.   
          ATM is a protein kinase which activates downstream signaling molecules that 
involved in the DNA repair process. ATM also phosphorylates P53 to initiate cell cycle 
arrest [36], DNA repair genes [37] and to regulate the expression of a number of apoptosis-
related genes [38]. PM exposure resulted in increased Atm mRNA and/or protein abundance 
in both lean and obese ovaries, again confirming that DNA DSB is formed as a result of 
ovarian PM exposure. We have previously shown the same effect in two in vitro models; 
cultured granulosa cells [22] and cultured neonatal rat ovaries [23], thus these data confirm 
that ATM activation is a downstream event that results from PM exposure.  Interestingly, 
Atm mRNA was increased in the ovaries from obese mice, a response which was absent in 
ovaries from their lean counterparts. These data indicate that ATM act as an ovarian sensor 
of DNA DSBs and activates the DNA repair mechanism.  
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          A protein that involved in the NHEJ repair pathway is PRKDC, a DNA dependent 
protein kinase. PRKDC activates P53 with help of CHK2 upon DNA damage [39]. Prkdc 
gene expression was increased by PM exposure in both lean and obese ovaries indicating that 
the NHEJ repair pathway was being activated in PM exposed ovaries. We have previously 
found the same effect in cultured granulosa cells [22] and neonatal cultured rat ovaries [23] 
after PM exposure. Interestingly, PRKDC protein was at a lower level in ovaries from obese 
mice and no increase in PRKDC protein level after PM exposure was observed similar to our 
previous study from obese mice [26]. Inhibition of PRKDC enhances heat-induced apoptosis 
independent of heat shock protein in human cervical carcinoma HeLa S3 cells [40], this 
could contribute to obesity-induced reduced fecundity. These data indicates obesity has a low 
level of DNA repair by reducing PRKDC protein abundance while the ovary initiates cell 
survival by inducing the NHEJ repair mechanism in response to PM exposure.  
          XRCC6 is a KU protein essential for formation of a heterodimer with XRCC5 and is 
also part of the NHEJ repair pathway. Ovarian XRCC6 protein was increased by PM 
exposure in lean mice but this response was reduced by obesity. This lower level might be 
due to basal DNA damage which is present in ovarian tissue during obesity. We have 
previously found that PM increased XRCC6 protein expression in SIGC cells [22], while a 
study of progressive obesity showed that obesity decreased XRCC6 protein expression [26].  
Decreased XRCC6 representing the defective DNA repair and chromosomal instability has 
been reported in embryonic cells [41] suggesting that PM activates but obesity attenuates the 
NHEJ repair mechanism by decreasing XRCC6 protein abundance. 
          Studies have demonstrated that PARP1 is involved in the regulation of DNA repair and 
cell survival [42, 43]. PARP1 has a role in repair of single strand DNA breaks (SSBs) and is 
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also involved in post-translational modification of nuclear proteins during DNA damage and 
activated cellular process including DNA replication, DNA repair, apoptosis and genome 
stability [44]. PM exposure decreased Parp1 mRNA expression irrespective of metabolic 
status, while PARP1 protein was increased only in lean ovaries. Our previous study from 
SIGC cells found that PM increased PARP1 protein abundance regardless of dose and time 
of exposure [22] and in cultured neonatal rat ovaries [23]. There were no changes in PARP1 
protein level, but PM decreased Parp1 mRNA expression in obese ovaries. In the absence of 
PARP1, when SSBs are encountered during DNA replication, the replication fork stalls, and 
DSBs accumulate in synchronized HeLa cells by radiation exposure [45]. These data suggest 
that absence of PARP1 protein during obesity might contribute to increased levels of DNA 
damage observed in obese ovaries.  
          BRCA1 is a protein that repairs DNA DSBs through the HR pathway. Impairment of 
BRCA1-related DNA DSB repair has been associated with accelerated loss of the ovarian 
follicular reserve and with accumulation of DSB in human oocytes, suggesting that DNA 
DSB repair efficiency is an important determinant of oocyte aging in women [20]. PM 
increased Brca1 mRNA and protein expression while BRCA1 protein was lowered by 
obesity. This is consistent with our data demonstrating that PM increased BRCA1 protein 
abundance in cultured neonatal rat ovaries [23] and progressive obesity reduced ovarian 
BRCA1 protein [26]. The data from this study suggests that BRCA1 is induced as part of the 
ovarian protective response to PM exposure and that the HR pathway is activated in addition 
to the NHEJ pathways. In addition, reduction of BRCA1 by obesity may accelerate ovarian 
follicle loss by reducing the capacity for DNA repair.  
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          RAD51 plays a major role in homologous recombination of DNA DSB repair using 
sister chromatids [47]. RAD51 protein was increased by PM exposure in both lean and obese 
ovaries while mRNA abundance was decreased by PM exposure in lean ovaries. RAD51 
interacts with BRCA1 during the DDR, and DMBA exposure increased RAD51 protein 
abundance in both prostate tissue [46] and in SIGC cells in a dose- and time-dependent 
manner [22] while RAD51 protein level was reduced during the time of follicle loss in 
neonatal cultured rat ovaries after PM exposure [23]. Also, RAD51 protein level was 
consistent with BRCA1 expression after PM exposure. These data indicated that 
RAD51protein could interact with RAD51 to repair DNA through HR repair mechanism.  
          Taken together, the data described herein strongly support that PM induces DNA 
DSB’s in vivo to which the ovary responds by activation of the DDR.  In addition, a blunted 
DDR was observed in ovaries from obese mice, which could contribute to the basal DNA 
DSB that is apparent in these ovaries. Since a blunted DDR was supported by the data from 
obese ovarian tissue, we examined basal mRNA abundance of DDR genes during 
progressive obesity from samples available through another study by our group. Atm, Brca1, 
Xrcc6 and Rad51 mRNA abundance were increased at 6 wks of age, but no other changes 
with the exception of reduced Brca1 were noted at other time points examined. This seems 
paradoxical since γH2AX was observed in the absence of a chemical insult in ovaries from 
obese mice. It should be noted that the study described only examined a single time point, 
and perhaps the DDR occurred at a faster rate in ovaries from obese ovaries than those from 
lean mice, although, the occurrence of γH2AX in obese ovarian tissue does not support this 
theory. 
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          In conclusion, PM induced ovarian DNA damage with an accompanying increase in 
the ovarian protective response to counteract such damage. Obesity altered the ovarian 
response to PM exposure, which could potentially contribute to a poorer reproductive 
outcome following CPA/PM treatment. Future work directed at preventing PM-induced 
ovarian DNA damage remains necessary.  
 
Funding 
          This work was supported by the National Institute of Environmental Health Sciences at 
the National Institutes of Health (grant number R00ES016818).   
 
References 
1. Hirshfield AN. Development of follicles in the mammalian ovary. Int Rev Cytol 
1991; 124:43-101. 
2. Fortune JE, Cushman RA, Wahl CM, Kito S. The primordial to primary follicle 
transition. Molecular and Cellular Endocrinology 2000; 163:53-60. 
3. Hoyer PB, Sipes IG. Assessment of Follicle Destruction in Chemical-Induced 
Ovarian Toxicity. Annual Review of Pharmacology and Toxicology 1996; 36:307-
331. 
4. Pal L, Santoro N. Premature ovarian failure (POF): discordance between somatic and 
reproductive aging. Ageing Research Reviews 2002; 1:413-423. 
5. Brunner HI, Bishnoi A, Barron AC, Houk LJ, Ware A, Farhey Y, Mongey AB, Strife 
CF, Graham TB, Passo MH. Disease outcomes and ovarian function of childhood-
onset systemic lupus erythematosus. Lupus 2006; 15:198-206. 
6. Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, 
Wolf I, Kanety H, Sredni B, Meirow D. Cyclophosphamide Triggers Follicle 
Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility. 
Science Translational Medicine 2013; 5:185ra162. 
7. Keating AF, C JM, Sen N, Sipes IG, Hoyer PB. Effect of phosphatidylinositol-3 
kinase inhibition on ovotoxicity caused by 4-vinylcyclohexene diepoxide and 7, 12-
233 
 
 
dimethylbenz[a]anthracene in neonatal rat ovaries. Toxicol Appl Pharmacol 2009; 
241:127-134. 
8. Plowchalk DR, Mattison DR. Phosphoramide mustard is responsible for the ovarian 
toxicity of cyclophosphamide. Toxicol Appl Pharmacol 1991; 107:472-481. 
9. Jarrell JF, Bodo L, YoungLai EV, Barr RD, O'Connell GJ. The short-term 
reproductive toxicity of cyclophosphamide in the female rat. Reprod Toxicol 1991; 
5:481-485. 
10. Ludeman SM. The chemistry of the metabolites of cyclophosphamide. Curr Pharm 
Des 1999; 5:627-643. 
11. Desmeules P, Devine PJ. Characterizing the Ovotoxicity of Cyclophosphamide 
Metabolites on Cultured Mouse Ovaries. Toxicological Sciences 2006; 90:500-509. 
12. Petrillo SK, Desmeules P, Truong T-Q, Devine PJ. Detection of DNA damage in 
oocytes of small ovarian follicles following phosphoramide mustard exposures of 
cultured rodent ovaries in vitro. Toxicology and Applied Pharmacology 2011; 
253:94-102. 
13. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways 
as targets for cancer therapy. Nat Rev Cancer 2008; 8:193-204. 
14. Giunta S, Belotserkovskaya R, Jackson SP. DNA damage signaling in response to 
double-strand breaks during mitosis. The Journal of Cell Biology 2010; 190:197-207. 
15. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female 
reproduction. Human Reproduction Update 2001; 7:535-543. 
16. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF, 
Flannery J, Austin DF, Holmes FF, Holmes GE, Strong LC, Mulvihill JJ. Genetic 
Disease in Offspring of Long-Term Survivors of Childhood and Adolescent Cancer. 
The American Journal of Human Genetics 1998; 62:45-52. 
17. Johnson  LaA, Tretyakova N, Jacobson PA. Obesity Effects on Cyclophosphamide-
induced DNA Damage in Hematopoietic Cell Transplant Recipients. In Vivo 2012; 
26:853-857. 
18. Gursatej Gandhi Gk. Assessment of DNA Damage in Obese Individuals Research 
Journal of Biology 2012; 2:37-44. 
19. Djuric Z, Kritschevsky D. Modulation of oxidative DNA damage levels by dietary fat 
and calories. Mutation Research/DNAging 1993; 295:181-190. 
20. Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, Dickler M, Robson M, Moy F, 
Goswami S, Oktay K. Impairment of BRCA1-Related DNA Double-Strand Break 
234 
 
 
Repair Leads to Ovarian Aging in Mice and Humans. Science Translational Medicine 
2013; 5:172ra121. 
21. Nteeba J, Ganesan S, Keating AF. Impact of Obesity on Ovotoxicity Induced by 7,12-
dimethylbenz[a]anthracene in Mice. Biology of Reproduction 2014; 90:68, 61-10. 
22. Ganesan S, Keating AF. Phosphoramide mustard-induced DNA adduct formation and 
damage repair response in rat ovarian granulosa cells. Toxicology and Applied 
Pharmacology; Under Review. 
23. Ganesan S, Keating AF. The ovarian DNA damage repair response is increased prior 
to phosphoramide mustard-induced follicle depletion, which is preventable by 
inhibition of Ataxia telangiectasia mutated. Toxicological Sciences ; Under Review. 
24. Nteeba J, Ganesan S, Keating AF. Progressive Obesity Alters Ovarian 
Folliculogenesis with Impacts on Pro-Inflammatory and Steroidogenic Signaling in 
Female Mice. Biology of Reproduction 2014. 
25. Mattison DR, Nightingale MS, Shiromizu K. Effects of toxic substances on female 
reproduction. Environ Health Perspect 1983; 48:43-52. 
26. Ganesan S, Nteeba J, Keating AF. Obesity alters the 7,12-dimethylbenz[a]anthracene-
induced ovarian DNA damage response in mice. Toxicol and Appl Pharmacol 2014; 
Under Review. 
27. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-
Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001; 25:402-408. 
28. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-
PCR. Nucleic Acids Res 2001; 29:e45. 
29. Comish PB, Drumond AL, Kinnell HL, Anderson RA, Matin A, Meistrich ML, 
Shetty G. Fetal Cyclophosphamide Exposure Induces Testicular Cancer and Reduced 
Spermatogenesis and Ovarian Follicle Numbers in Mice. PLoS ONE 2014; 9:e93311. 
30. Syed Saiduddin GAB, David A. York, and Ronald S. Swerdloff. Reproductive 
Function in the Genetically Obese “Fatty” Rat. Endocrinology 1973; 93:1251-1256. 
31. Milagro FI, Campión J, Martínez JA. Weight Gain Induced by High-Fat Feeding 
Involves Increased Liver Oxidative Stress. Obesity 2006; 14:1118-1123. 
32. DeLany JP, Blohm F, Truett AA, Scimeca JA, West DB. Conjugated linoleic acid 
rapidly reduces body fat content in mice without affecting energy intake. American 
Journal of Physiology - Regulatory, Integrative and Comparative Physiology 1999; 
276:R1172-R1179. 
235 
 
 
33. Madden JA, Keating AF. Ovarian Xenobiotic Biotransformation Enzymes Are 
Altered During Phosphoramide Mustard-Induced Ovotoxicity. Toxicological 
Sciences, 2014. 
34. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A 
critical role for histone H2AX in recruitment of repair factors to nuclear foci after 
DNA damage. Current Biology 2000; 10:886-895. 
35. Igosheva N, Abramov AY, Poston L, Eckert JJ, Fleming TP, Duchen MR, McConnell 
J. Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in 
Mouse Oocytes and Zygotes. PLoS ONE 2010; 5:e10074. 
36. Zhou B-BS, Elledge SJ. The DNA damage response: putting checkpoints in 
perspective. Nature 2000; 408:433-439. 
37. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, 
ubiquitination and DNA repair. Current Opinion in Cell Biology 2003; 15:345-350. 
38. Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, 
Prives C, Reiss Y, Shiloh Y, Ziv Y. Enhanced Phosphorylation of p53 by ATM in 
Response to DNA Damage. Science 1998; 281:1674-1677. 
39. Jack MT, Woo RA, Motoyama N, Takai H, Lee PWK. DNA-dependent Protein 
Kinase and Checkpoint Kinase 2 Synergistically Activate a Latent Population of p53 
upon DNA Damage. Journal of Biological Chemistry 2004; 279:15269-15273. 
40. Okazawa S, Furusawa Y, Kariya A, Hassan MA, Arai M, Hayashi R, Tabuchi Y, 
Kondo T, Tobe K. Inactivation of DNA–Dependent Protein Kinase Promotes Heat–
Induced Apoptosis Independently of Heat–Shock Protein Induction in Human Cancer 
Cell Lines. PLoS ONE 2013; 8:e58325. 
41. Gu Y, Jin S, Gao Y, Weaver DT, Alt FW. Ku70-deficient embryonic stem cells have 
increased ionizing radiosensitivity, defective DNA end-binding activity, and inability 
to support V(D)J recombination. Proceedings of the National Academy of Sciences 
1997; 94:8076-8081. 
42. Wang Z-Q, Stingl L, Morrison C, Jantsch M, Los M, Schulze-Osthoff K, Wagner EF. 
PARP is important for genomic stability but dispensable in apoptosis. Genes & 
Development 1997; 11:2347-2358. 
43. Ziegler M, Oei SL. A cellular survival switch: poly(ADP-ribosyl)ation stimulates 
DNA repair and silences transcription. BioEssays 2001; 23:543-548. 
44. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 
1992; 356:356-358. 
45. Noël G, Godon C, Fernet M, Giocanti N, Mégnin-Chanet F, Favaudon V. 
Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-
236 
 
 
naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA 
synthesis. Molecular Cancer Therapeutics 2006; 5:564-574. 
46. Xu J, Osuga Y, Yano T, Morita Y, Tang X, Fujiwara T, Takai Y, Matsumi H, Koga 
K, Taketani Y, Tsutsumi O. Bisphenol A Induces Apoptosis and G2-to-M Arrest of 
Ovarian Granulosa Cells. Biochemical and Biophysical Research Communications 
2002; 292:456-462.  
47.      Jean-Yves Masson, Alicja Z. Stasiak, Andrzej Stasiak, Fiona E. Benson and Stephen 
C. West. Complex formation by the human RAD51C and XRCC3 recombination 
repair proteins. Proc Natl Acad Sci 2001; 98(15): 8440–8446. 
 
 
 
 
 
 
 
 
 
 
 
237 
 
 
 
Figure 1. Effect of PM exposure on body and organ weight 
Body weights were measured at 15 wks old in both lean and obese group and then mice were 
intraperitoneally (i.p) dosed with sesame oil (SO) or PM to measure other organ weights. 
Values are expressed as mean ± SE; n=5. Different letters indicate the statistical difference 
P-value < 0.05. Obesity increases body and liver weight while reduces uterus weight. PM 
decreases spleen and ovarian weight. 
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Figure 2. Impact of PM exposure on healthy follicle number  
Mice were intraperitoneally (i.p) dosed with sesame oil (SO) or PM to determine healthy 
follicles. Follicles are classified as (A) primordial follicles; (B) primary follicles; and (C) 
secondary follicles. Values are expressed as mean ± SE; n=5. Statistical significance was 
defined as *= P < 0.05 while P < 0.1 was considered a trend towards a difference from 
control. Both obesity and PM reduces number of healthy follicles. 
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Figure 3. Identification of PM-induced ovarian DNA DSB using γH2AX protein  
After treatment, protein was isolated from ovaries to determine the γH2AX protein 
expression using Western blotting (A, B). In western blotting, equal protein loading was 
confirmed by Ponceau S staining of membranes and protein level was normalized to Ponceau 
S densitometry values. Values are expressed as mean ± SE; n=3. Different letters indicate P 
< 0.05. Both obesity and PM increases DNA damage. 
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Figure 4. Investigation of PM exposure effect on Atm mRNA and protein expression  
After treatment, RNA and protein was isolated from ovaries to determine the Atm (A) mRNA 
and (B, C) protein expression using qPCR and Western blotting, respectively. In qPCR, each 
sample was normalized to Gapdh before quantification. In western blotting, equal protein 
loading was confirmed by Ponceau S staining of membranes and protein level was 
normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05. Both obesity and PM increases DNA damage. 
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Figure 5. Effect of PM exposure on Prkdc mRNA and protein expression  
 
After treatment, RNA and protein was isolated from ovaries to determine the Prkdc (A) 
mRNA and (B, C) protein expression using qPCR and Western blotting, respectively. In 
qPCR, each sample was normalized to Gapdh before quantification. In western blotting, 
equal protein loading was confirmed by Ponceau S staining of membranes and protein level 
was normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05. Obesity reduces PRKDC protein level. 
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Figure 6. Impact of PM exposure on Xrcc6 mRNA and protein expression 
After treatment, RNA and protein was isolated from ovaries to determine the Xrcc6 (A) 
mRNA and (B, C) protein expression using qPCR and Western blotting, respectively. In 
qPCR, each sample was normalized to Gapdh before quantification. In western blotting, 
equal protein loading was confirmed by Ponceau S staining of membranes and protein level 
was normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05. Obesity reduces XRCC6 protein level. 
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Figure 7. Effect of PM exposure on Parp1 mRNA and protein expression  
 
After treatment, RNA and protein was isolated from ovaries to determine the Parp1 (A) 
mRNA and (B, C) protein expression using qPCR and Western blotting, respectively. In 
qPCR, each sample was normalized to Gapdh before quantification. In western blotting, 
equal protein loading was confirmed by Ponceau S staining of membranes and protein level 
was normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05.  PM increases PARP1 protein level only in lean ovaries. 
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Figure 8. PM effects on Brca1 mRNA and protein expression and impact of obesity 
 
After treatment, RNA and protein was isolated from ovaries to determine the Brca1 (A) 
mRNA and (B,C) protein expression using qPCR and Western blotting, respectively. In 
qPCR, each sample was normalized to Gapdh before quantification. In western blotting, 
equal protein loading was confirmed by Ponceau S staining of membranes and protein level 
was normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05. PM increase BRCA1 protein level while obesity reduces 
in control ovaries. 
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Figure 9. Investigation of PM impact on Rad51 mRNA and protein expression  
 
After treatment, RNA and protein was isolated from ovaries to determine the Rad51 (A) 
mRNA and (B, C) protein expression using qPCR and Western blotting, respectively. In 
qPCR, each sample was normalized to Gapdh before quantification. In western blotting, 
equal protein loading was confirmed by Ponceau S staining of membranes and protein level 
was normalized to Ponceau S densitometry values. Values are expressed as mean ± SE; n=3. 
Different letters indicate P < 0.05. PM increases RAD 51 protein levels. 
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Figure 10. Temporal effect of genotypic changes in relation to DNA repair  
gene abundance 
 
Ovaries were collected from 6, 12, 18 and 24 wks mice and RNA was isolated to perform 
qRT-PCR. Values are expressed as mean fold change ± SE; n=3. Statistical significance was 
defined as * = P < 0.05. DNA repair genes were increases in obese mice at earlier time but 
no changes at later time point. Brca1 decreases during progressive obesity. 
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CHAPTER 9. GENERAL DISCUSSION 
          The female reproductive organ ovary is composed of follicles at different stages of 
development. Chemicals which selectively damage large growing or antral follicles can cause 
temporary loss reproductive function while primordial follicle loss can result in permanent 
infertility and premature ovarian failure. This dissertation research focused on investigating 
cellular and molecular mechanism of chemical-induced ovarian follicle loss (ovotoxicity). 
Specifically, mRNA and protein expression profiles of DNA repair, cell cycle arrest, 
apoptosis and gap junction members were quantified using qRT-PCR, western blotting or 
immunohistochemistry techniques after exposure to two different chemicals: Phosphoramide 
mustard (PM) and 7,12-dimethylbenz[a]anthracene (DMBA). Three physiological models 
were employed 1) spontaneously immortalized rat granulosa cells (SIGC); 2) In vitro ovarian 
culture system; 3) In vivo obese mice model. 
 
7,12-Dimethylbenz[a]anthracene-Induced Ovotoxicity 
DMBA-induced DNA damage and repair mechanism 
          DMBA is a polyaromatic hydrocarbon liberated from burning of organic matter, 
including cigarette smoke, charred foods and car exhaust fumes (Gelboin, 1980). DMBA 
causes destruction of all follicle types leading to premature ovarian failure in mice and rats 
(Mattison and Nightingale, 1980). For first study, we used an in vitro rat ovarian culture 
system because this system mimics the effects of ovotoxicant with those reported in vivo 
(Plowchalk and Mattison, 1991; Desmeules and Devine, 2006). For our second study, we 
used an in vivo obese mouse model because we wanted to compare the impact of DMBA 
exposure between in vitro and in vivo systems and also determine if there was elevated levels 
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of DNA damage due to obesity, based on another study from our group which demonstrated 
enhanced sensitivity of the ovaries from obese females of DMBA-induced ovotoxicity, likely 
due to elevated basal levels of microsomal epoxide hydrolase, the enzyme that converts 
DMBA to the DMBA-3,4-diol-1,2-epoxide metabolite, which has the potential to interact 
with DNA due to the presence of two epoxide groups thereon (Rajapaksa et al., 2007; Igawa 
et al., 2009).  
          Use of a neonatal ovary culture system has determined that a single DMBA exposure 
depleted large primary follicles at concentrations of 12.5 and 75 nM, while secondary 
follicles were destroyed at the 12.5 nM concentration only (Madden et al., 2013). We also 
used the same DMBA concentration for our in vitro ovarian culture system and confirmed 
that DMBA induced apoptosis at these concentrations by increasing caspase-3 in the ovary. 
DMBA can cause dose-dependent DNA damage in extra-ovarian tissues (peripheral 
lymphocytes, liver and skin cells) when exposed along with physical stress in rats (Muqbil et 
al., 2006). Having confirmed that atresia via apoptosis is ongoing after DMBA exposure; we 
determined the impact of DMBA on DNA repair proteins as a proxy measurement for DNA 
damage induction. We localized γH2AX protein to the nucleus and granulosa cells of large 
primary and secondary follicles after DMBA exposures; however this staining was negligible 
in the oocyte nucleus of control-treated ovaries. Additionally, γH2AX total protein was 
increased in ovaries exposed to a concentration of DMBA that causes primordial and small 
primary depletion after 4 days. Since, detection of γH2AX is considered the gold standard for 
localization of DNA double strand breaks (DSBs) (Paull et al., 2000; Svetlova et al., 2010) 
these data indicate that DNA damage is occurring in ovaries exposed to DMBA. DSB in 
DNA are the most cytotoxic lesions, generated by ionizing radiation, man-made chemicals 
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(Van Gent et al., 2001) and chemotherapeutic drugs (Helleday et al., 2008). These DSB’s 
pose a serious threat to genome stability if either unrepaired or repaired incorrectly, and 
could potentially lead to permanent damage that could be a negative consequence for gamete 
health (Petrillo et al., 2011). DSB are repaired by two major pathways that are Homologous 
Recombination (HR) and Non-Homologous End Joining (NHEJ). In this study, mRNA 
encoding Atm, Xrcc6, Brca1, Rad51 and ATM and PARP1 protein were increased in a dose- 
and time-dependent manner. This indicates that exposure to DMBA causes ovotoxicity 
through DSB formation and that the ovary mounts a protective response in order to repair 
this damage. 
          For our second study, we employed both lean and obese mice to confirm in vivo 
DMBA-induced DNA damage  and obese mice, since obesity has negative consequences on 
reproduction such as polycystic ovarian syndrome, menstrual disorders, intrauterine fetal 
death and infertility (Haslam and James, 2005; Cardozo et al., 2012). Obesity also 
detrimentally affects pregnancy rates in natural and assisted conception potentially by 
reducing oocyte quality (Wu et al., 2011). Primordial and small primary follicle numbers 
were reduced in ovaries from obese mice with a concomitant increase in number of 
secondary and pre-ovulatory follicles relative to lean mouse ovaries (Nteeba et al., 2014). 
Also higher basal levels of mEH and greater mEH induction in response to DMBA exposure  
(Nteeba et al., 2014) indicates that ovarian tissue from obese females could have potentially 
greater exposure to the ovotoxic metabolite of DMBA (Miyata et al., 1999). We also used the 
same mouse model for our study to investigate DMBA-induced DNA damage and ovarian 
DNA repair responses against chemical-induced ovotoxicity. Additionally, since obesity is 
associated with increased incidence of offspring birth defects, we hypothesized that a 
250 
 
 
DMBA-induced DNA damage response (DDR) might be compromised in ovarian tissue 
from obese females. In this study, basal protein abundance of PRKDC and BRCA1 proteins 
was lower in ovaries from obese females, while higher levels of γH2AX and PARP1 were 
observed. Impairment of BRCA1-related DNA DSB repair has been associated with 
accelerated loss of the ovarian follicular reserve and with accumulation of DSB in human 
oocytes, suggesting that DNA DSB repair efficiency is an important determinant of oocyte 
aging in women (Titus et al., 2013). Ovarian ATM, XRCC6, PRKDC, RAD51 and PARP1 
proteins were increased by DMBA exposure in lean mice. A blunted DMBA-induced 
increase in XRCC6, PRKDC, RAD51 and BRCA1 was observed in ovaries from obese mice, 
relative to lean counterparts. This indicates that exposure to DMBA causes ovotoxicity 
through DSB formation and the ovarian DDR was partially attenuated in obese females 
raising concern that obesity may be an additive factor during chemical-induced ovotoxicity.  
Impact of DMBA exposure on connexin gap junction proteins 
          The initiating event in DMBA-induced follicle destruction remains unclear; however, 
since cell to cell communication is vital for follicular viability, it is possible that perturbation 
to communication within the follicle could have detrimental consequences for the oocyte. 
CX37, CX43 and CX45 are the major ovarian gap junction proteins, shown to be essential 
for folliculogenesis and production of fertilizable oocytes (Kidder and Mhawi, 2002). CX37 
is located between the granulosa cell and oocyte (Simon et al., 1997), while CX43 and 45 are 
located between granulosa cells (Granot et al., 2002; Kidder and Mhawi, 2002). Cx37-null 
mouse oocytes suffer growth retardation and do not survive to become meiotically competent 
(Carabatsos et al., 2000). Follicle growth is also interrupted: Cx37
-/-
 granulosa cells form 
structures resembling corpora lutea in the absence of ovulation. CX43 levels are increased in 
251 
 
 
granulosa cells following activation of follicular growth and maturation (Melton et al., 2001), 
while reduced granulosa cell expression of CX43 is linked to elevated apoptosis in porcine, 
bovine (Johnson et al., 1999; Cheng et al., 2005) and avian (Krysko et al., 2004) species. 
Thus, CX37, CX43 and CX45 play important roles in the ovary to maintain follicular and 
oocyte viability and quality. Little is known about the impact of ovotoxicant exposures on 
ovarian function, thus in this study we investigated any impact of DMBA on ovarian gap 
junction genes Cx37, Cx43 and Cx45. We utilized a neonatal rat whole ovary culture and an 
in vivo obese mouse model to determine the effect of DMBA exposure on gap junction 
protein expression.  
          In the neonatal rat ovarian culture system, a single DMBA exposure at two 
concentrations: 12.5 nM and 75 nM were used to determine the effect of DMBA on Cx37 
and Cx43 mRNA and protein level. These exposures have previously been shown to cause 
large primary and secondary follicle loss (Madden et al., 2013). In addition, we have 
previously shown that these concentrations induce DNA damage and increased caspase 3 
levels after 8 days of exposure. Our hypothesis was that altered Cx37 and Cx43 at time points 
prior to observed follicle loss may support that they are targets for DMBA as part of 
DMBA’s mechanism of ovotoxicity. In this study, CX37 and CX43 protein were increased at 
4 days of DMBA exposure while DMBA decreased CX37 and CX43 protein after 8 days. 
DMBA is proposed to induce apoptosis in granulosa and theca cells of pre-ovulatory follicles 
through generation of reactive oxygen species (ROS), leading to increased expression of pro-
apoptotic BAX, activation of the executioner CASP3 and ultimately cell death (Tsai-Turton 
et al., 2007). In support of this, BAX-deficient mice ovaries are resistant to DMBA-induced 
primordial follicle destruction (Matikainen et al., 2001). We found mRNA expression of pro-
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apoptotic p53 was decreased but no changes in Bax expression were observed after 4 days 
while increased p53 and Bax mRNA levels were found after 8 days of DMBA exposures. 
These findings support that DMBA exposure impacts ovarian Cx37 and Cx43 mRNA and 
protein prior to follicle loss. 
Impact of obesity and DMBA on gap junction protein expression 
          Approximately one-third of adults in the USA are obese (Flegal Km et al., 2010; 
Meeker et al., 2010), and negative female phenotypic associations include polycystic ovarian 
syndrome, menstrual disorders, intrauterine fetal death and infertility (Haslam and James, 
2005; Cardozo et al., 2012). Obesity also detrimentally affects pregnancy rates in natural and 
assisted conception potentially by reducing oocyte quality (Wu et al., 2011). Primordial and 
small primary follicle numbers were reduced in ovaries from obese mice with a concomitant 
increase in number of secondary and pre-ovulatory follicles relative to lean mouse ovaries 
(Nteeba et al., 2014). Additionally, ovaries from mice fed a high fat diet showed increased 
accumulation of endoplasmic reticulum stress, decreased mitochondrial activity and 
increased apoptosis of cumulus oocyte complexes and ovarian cells (Wu et al., 2010).  
Interestingly, a high fat diet also reduced cardiovascular connexin expression in female rats 
resulting in increased risk of ventricular arrhythmia (Aubin et al., 2010). This suggest that 
obesity have impact on Cx gene mRNA and protein levels, thus this study investigated the 
impact of obesity on ovarian Cx mRNA and protein levels using the lethal yellow mouse 
model of progressive obesity. For this study ovaries were collected from lean and obese mice 
aged 6, 12, 18, or 24 wks. Cx43, Cx45 mRNA and protein levels were decreased after 18 wks 
while Cx37 mRNA and protein levels were decreased after 24 wks in obese ovaries. These 
data support that obesity temporally alters gap junction protein in ovaries in a manner that 
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could contribute to compromised reproduction observed during these physiological 
paradigms.   
          Cx37 mRNA and antral follicle protein staining intensity were reduced by obesity 
while total CX43 protein was reduced in DMBA exposed obese ovaries. Cx43 mRNA and 
total protein levels were decreased by DMBA in both lean and obese ovaries while basal 
protein staining intensity was reduced in obese controls. Cx45 mRNA, total protein and 
protein staining intensity level were decreased by obesity. These data support that obesity 
temporally alters gap junction protein expression and that DMBA-induced ovotoxicity may 
involve reduced gap junction protein function. It is possible that such interference in 
communication between follicular cell types is detrimental to follicle viability, and may play 
a role in DMBA-induced follicular atresia. 
 
Phosphoramide Mustard-Induced Ovotoxicity 
PM-induced DNA adduct formation and DNA damage repair responses 
          Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent 
cyclophosphamide (CPA), destroys rapidly dividing cells by forming NOR-G-OH, NOR-G 
and G-NOR-G adducts with DNA, potentially leading to DNA damage (Cushnir et al., 1990; 
Johnson et al., 2011). PM causes primordial and small primary follicle loss and induces 
ovarian DNA damage in rat ovaries (Petrillo et al., 2011). The granulosa cell is the somatic 
cell component of the oocyte-containing follicle, and close association between the granulosa 
cell and oocyte is required for follicular development. Loss of granulosa cells during pre-
antral and antral stages of follicular development leads to a premature reduction in female 
fecundity through reduced follicle health and oocyte viability (Walters et al., 2012). An in 
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vivo study demonstrated that the destruction of granulosa cells by CPA potentially occurs 
through apoptosis in rats (Lopez and Luderer, 2004). Since PM-induced DNA damage could 
predispose the follicle towards atresia, this study investigated whether PM exposure to 
granulosa cells results in PM-DNA adducts formation and subsequent DDR induction. To 
investigate whether PM induces DNA adduct formation, DNA damage and induction of the 
DDR, rat spontaneously immortalized granulosa cells were treated with PM at different time 
points and concentrations to isolate DNA, RNA and protein to perform mass spectrometry, 
qRT-PCR, immunofluorescence and western blotting techniques. In this study, cell viability 
was reduced after 48 h of exposure PM while DNA adducts was detected earlier than cell 
death. γH2AX, a marker of DNA double stranded break occurrence, was also increased by 
PM exposure, coincident with DNA adduct formation. Additionally, induction of genes and 
proteins involved in DNA repair were observed in both a time- and dose-dependent manner. 
These data support that PM induces DNA adduct formation in ovarian granulosa cells, 
induces DNA damage and elicits the ovarian DNA repair response. 
Mechanism of PM-induced ovarian follicle loss 
          PM causes dose- and time-dependent primordial and primary ovarian follicle loss 
following DNA damage in mice and rat oocytes (Petrillo et al., 2011). DSBs and DNA 
replication blocking lesions are apoptotic DNA lesions and, therefore, cells are equipped in 
detecting these lesions upon formation. Recognition of these DNA lesions starts a protein 
cascade, which finally results in cell cycle arrest and DNA repair (Zhou and Elledge, 2000). 
If DNA repair fails, or is overwhelmed by too many DNA lesions, these sensors initiate 
apoptosis (Friedberg, 2003). To investigate the mechanism of PM induced ovarian follicle 
loss we used a neonatal rat ovarian culture system and ovaries were exposed to 60 µM of PM 
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for 4 days. PM caused primordial, small primary, large primary and secondary follicles after 
4 days of exposure (Madden et al., 2014). PM activated DNA repair genes after 12 h of 
exposure which indicated that PM induces DNA damage earlier than follicle loss. PM 
activates the DDR genes after 24 h and proteins ATM, PARP1, E2F1, P73 and CASP3 after 
96 h of exposure; however PM decreases RAD51 and BCL2 proteins after 96 h of exposure. 
DNA repair genes are activated earlier than apoptotic genes and proteins and number of 
DNA repair genes expressed during follicle loss was reduced. Although other studies have 
found that CPA or PM induces apoptosis to cause cell death (Chen et al., 1994; Schwartz and 
Waxman, 2001), this study found that PM activates Bbc3 and Bax and decreases BCL2 to 
cause apoptotic cell death. Also, PM-induced apoptosis is not occurring via P53 dependent 
pathway but through the E2F1-P73 dependent mitochondrial apoptotic pathway.  
          The main players of DNA damage recognition are ATM, ATR and DNA-PK, which 
phosphorylate a multitude of proteins and thus induce the  in which P53 and BRCA1/2 play 
important roles (Roos and Kaina, 2006). ATM is implicated in three crucial functions: 
regulation and stimulation of DSB repair, activation of cell cycle checkpoints, and signaling 
to apoptosis. Therefore, they are key nodes in making the decision between survival and 
death following genotoxin exposure (Roos and Kaina, 2012). To determine the role of ATM 
during PM exposure we used the ATM inhibitor KU-55933. ATM inhibition prevented loss 
of primordial, large primary and secondary follicles. Also, small primary numbers were not 
completely restored to those of control but PM-induced small primary follicle depletion was 
partially attenuated. This result was similar to a previous study showing that ATM inhibitor 
improved oocyte survival after doxorubicin exposure (Soleimani et al., 2011) by activation of 
c-AbI-Tap63 pathway. This indicates that ATM has a pro-apoptotic function in the DNA 
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damaged ovaries, which was coincident with ATM’s role in neurons of developing mouse 
central nervous system (Herzog et al., 1998). Blocking of ATM activity can cause induction 
of ATM protein, which might be regulated by P73 and E2f1 transcriptional level (Khalil et 
al., 2012). These results are in correlation with our findings in the ovary, and suggest that 
ATM serves to eliminate cells with excessive DNA damage by acting on developmental 
survival checkpoint (Herzog et al., 1998). 
          Protein kinase c (PKC) is a another serine-threonine kinases expressed in rat ovary 
(Peters et al., 2000), activated by diverse stimuli and participates in cellular process such as 
growth, differentiation and apoptosis (Hug and Sarre, 1993). A recent study showed that the 
catalytic fragment of PKCδ interacts with P73β and phosphorylates the transactivation and 
DNA binding domains of P73β to induce apoptotic function (Ren et al., 2002). However, 
PKCδ also enhances proliferation and survival of murine mammary cells (Grossoni et al., 
2007). This indicates that PKCδ is involved in both apoptotic and anti-apoptotic activities. To 
investigate the role of PKCδ in neonatal ovaries during PM exposure, we used a PKCδ 
knockout mice model and cultured ovaries from postnatal day 4 females.  
          PKCδ knockout mice had reduced number of all stage ovarian follicles compared to 
wild type ovaries. When these mice were exposed to PM, the number of healthy follicles was 
reduced by PM but the percentage decline did not differ from the WT ovaries, indicating lack 
of an additional impact of PKCδ deficiency with PM-induced ovotoxicity. These data do 
support that PKCδ is essential for ovarian follicle survival which is correlated with previous 
study that PKCδ enhances proliferation and survival of murine mammary cells (Grossoni et 
al., 2007) and human breast cancer cell lines (McCracken et al., 2003). 
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          In conclusion, PM induces DNA damage as an upstream event of PM-induced 
ovotoxicity. Ovary activates DNA repair mechanism at earlier time points to protect against 
PM-induced follicle loss. However, the repair mechanisms were reduced and cell death 
mechanisms were overwhelmed at the time of follicle loss. PM-induced apoptosis is not 
happening by P53 dependent pathway but it occurs through E2F1-P73 dependent 
mitochondrial apoptotic pathway. Results from PKCδ mice indicated that PKCδ is essential 
for survival of ovarian follicles and ATM inhibitor improves the survival of ovarian follicles 
during PM exposure. Although ATM inhibition sensitizes cancer cells to genotoxic agents, 
the mechanism of ATM regulation might be useful for making more accurate tactics for 
modulation of ATM activity in cancer therapy. 
Impact of obesity on PM-induced ovotoxicity 
          Obesity induces DNA damage in hematopoietic cell transplant recipients that have 
been treated by CPA (Johnson  et al., 2012).  It is known that cellular DNA damage can arise 
from the action of free radicals and obesity (Gursatej Gandhi, 2012). In addition, high fat 
diets can accelerate oxidative stress and oxidative DNA damage (Djuric and Kritschevsky, 
1993).  BRCA1 and BRCA2 are crucial members of the ATM-mediated DSB repair family 
of genes. Impairment of BRCA1-related DNA DSB repair was associated with accelerated 
loss of the ovarian follicular reserve and with accumulation of DSB in human oocytes, 
suggesting that DNA DSB repair efficiency is an important determinant of oocyte aging in 
women (Titus et al., 2013). Our previous studies have indicated that presence of DNA 
damage at a basal level in the ovaries of obese mice, and demonstrated increased sensitivity 
to another ovotoxicant DMBA (Nteeba et al., 2014) which, similar to PM, is also an 
alkylating agent. Also, our work using cultured ovarian granulosa cells (Ganesan and 
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Keating, Under Review) and an ex vivo ovarian culture systems (Ganesan and Keating, 
Under Review) have demonstrated that PM-induced DNA damage as a mode of ovotoxicity.  
Thus, we hypothesized that PM-induced ovotoxicity would cause DNA DSB’s in vivo, to 
which the ovary will mount a protective DDR. In addition, we proposed that the ovaries of 
obese mice would have an altered response to PM exposure. As expected, obesity increased 
liver weight which was consistent with another study in which a high fat diet increased liver 
weights in male wistar rats (DeLany et al., 1999; Milagro et al., 2006).  Obesity increased 
spleen weight in this study, as was previously observed in high fat diet fed mice (DeLany et 
al., 1999). PM exposure reduced spleen weight regardless of body composition, however, 
decreased ovarian weight was only observed in the obese females exposed to PM. Exposure 
to PM decreased primordial and primary follicle number which was similar to a previous 
study from mice and rats (Desmeules and Devine, 2006; Petrillo et al., 2011). γH2AX protein 
was increased by both obesity and PM, indicating DNA damage occurrence. mRNA 
encoding DNA damage repair genes Atm, Prkdc, Parp1, Xrcc6 and Rad51 were not altered 
by obesity, however, Brca1 mRNA abundance was decreased in ovaries of obese females. 
This seems paradoxical since γH2AX was observed in the absence of a chemical insult in 
ovaries from obese mice. PRKDC and XRCC6 protein levels were reduced by obesity while 
ATM, BRCA1 and RAD51 protein levels were increased by PM exposure. These results 
indicate that PM induces ovarian DNA damage as a mode of ovotoxicity, and that the ovary 
is responsive to such an insult and activates DNA repair proteins in ovaries. Additionally, 
and of concern, obesity altered the ovarian response to an ovotoxic exposure which could 
potentially contribute to a poorer reproductive outcome following CPA/PM treatment. Future 
work directed at preventing PM-induced ovarian DNA damage remains necessary.  
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Future Directions 
          Though, these studies have found novel results, it is necessary to note that they also 
generated important questions for future research. From our data we demonstrated that 
chemical-induced DNA damage is an upstream event for follicle loss and the ovary activates 
DNA repair mechanisms to prevent follicle loss using in vitro and in vivo models. We did not 
look at the impact of chemical exposure in the offspring of exposed females. So, future 
studies will need to address the impact of these chemicals after in utero maternal exposure.  
          Although, the impact of DMBA exposure on gap junction proteins was investigated, 
we did not examine the effect of PM on ovarian gap junction proteins. Since we found a 
“gap” between the oocyte and granulosa cells in hematoxylin and eosin stained ovaries after 
PM exposure, and use of electron microscopy to examine PM-exposed ovaries indicated loss 
of granulosa cells prior to death of the oocyte (Madden and Keating, under review), these 
lend support to determining the impact of PM exposure on gap junction protein 
communication.  
          Even though, ovotoxicant chemical-induced DNA damage was partially repaired by 
activation of ovarian repair mechanisms, the unrepaired or mis-repaired DSBs can culminate 
into severe mutagenic changes in the surviving primordial follicles. Though clinical data do 
not suggest an increase in the incidence of genetic disorders in children born to cancer 
survivors (Green et al., 2002), studies from rodent models showed that single dose of 
doxorubicin treatment increased rates of neonatal death, physical malformations, and 
chromosomal abnormalities in up to 6 generations of offspring. So, it is very important to 
study the effect of accumulation of DSBs in ovarian follicles using both in vitro as well as in 
vivo model. 
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          In our study, ATM inhibition rescued only small follicles but not larger follicles during 
PM exposure, suggest that some of the follicles are sensitive to PM-induced activation of 
ATM and some are not sensitive. If such individual differences exist, exploration of factors 
regulating DSB repair in oocytes will develop a new strategies to protect oocytes by 
enhancing DNA repair efficiency and preserve fertility in the face of chemotherapy. Also, we 
are not sure, whether exposure of PM along with ATM inhibited oocytes are good quality or 
not and studying the quality of oocytes after this exposure will be beneficial too. 
 
Overall Summary 
          The data presented herein demonstrates that ovotoxicants induce DNA damage in both 
oocytes and in granulosa cells. If this DNA damage passes to next generation it may cause 
abnormalities in offspring. The ovary activates DNA repair responses to protect against 
chemical-induced ovotoxicity. These responses are active at lower doses and at earlier time 
points and the cell death response is activated at later times and at higher doses. Also, gap 
junction proteins are altered by ovotoxicant chemical exposures studied as part of this work. 
Obesity had impact on follicular development by interfering with gap junction protein levels 
and also reduced the DNA repair mechanism after chemical exposure. These findings suggest 
that ovaries from obese females are more vulnerable to chemical-induced toxicity. Finally 
understanding the mechanisms of chemical-induced follicle loss will provide therapeutic 
importance to prevent chemical-induced infertility. This research is not only of benefit for the 
female themselves, but is also aimed at minimizing damage to female eggs, which could 
potentially result in negative consequences for the offspring. Ultimately, the goal of this 
research is to improve reproductive health of both human and animals. 
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Concentration dependent PM-induced follicle loss 
PND4 Fisher 344 rat ovaries were cultured for 8 d in medium containing vehicle control 
(CEZ) ± PM (30, 45 and 60 µM). Following culture, follicles were counted between the 
treatments and analyzed. Total number of primordial (A), Small primary (B), large primary 
(C) and Secondary follicles (D) were expressed as mean raw data ± SE; n=5. Statistical 
significance was defined as * = P value 0.01, **= P value 0.001, *** P value 0.0001.  
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Figure 2. Localization of γH2AX protein after PM exposure 
PND4 Fisher 344 rat ovaries were cultured for 8 d or 1d in medium containing vehicle 
control (CEZ) ± PM (30 or 60 µM). Immunofluorescence staining was used to determine 
localization and staining intensity for γH2AX proteins (A). Images were taken using a Leica 
fluorescent Microscope and number of oocytes with foci (B) and over al foci for γH2AX 
were analyzed using ImageJ software (NCBI). (n=3 ovaries; 4 section/ovary).    
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Figure 3. Validation of RT
2
 Profiler PCR array results using qRT-PCR 
Fisher 344 rat ovaries were cultured for 2 or 4 d in media containing vehicle control ± 30 µM 
PM.  RNA was isolated and used to perform qRT-PCR. Values are expressed as mean fold 
change ± SE; n=3 (10 ovaries per pool). Statistical significance was defined as * = P < 0.05. 
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Figure 4. PM alters DNA repair protein expressions against CEZ 
Fisher 344 rat ovaries were cultured for 2 or 4 d in media containing vehicle control ± 30 µM 
PM and protein was isolated to perform western blot. Results were normalized to Ponceau S 
and expressed as mean raw data ± SE; n=3 (10 ovaries per pool). Statistical significance was 
defined as * = P < 0.05. 
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Table 1. PM alters DNA damage response genes against CEZ  
Gene 
Symbol 
Gene Description 2d 4d 
P-value Fold 
Chang
e 
P-value Fold 
Chang
e 
Apex1 APEX nuclease (multifunctional 
DNA repair enzyme) 1 
0.12919 1.1947 0.1278 1.162 
Atm Ataxia telangiectasia mutated 
homolog (human) 
0.50682 1.0994 0.0010* 1.5984 
Atrx Alpha thalassemia/mental 
retardation syndrome X-linked 
(RAD54 homolog, S. cerevisiae) 
0.40132 1.0718 0.0044* 1.488 
Brca1 Breast cancer 1 0.03006* 1.4641 0.0192* 1.7291 
Brca2 Breast cancer 2 0.63722 1.2002 0.0626 1.4273 
Chek1 CHK1 checkpoint homolog (S. 
pombe) 
0.15480 1.2805 0.0198* 1.3851 
Cry2 Cryptochrome 2 (photolyase-like) 0.46461 1.0693 0.1988 1.2599 
Smc3 Structural maintenance of 
chromosomes 3 
0.07507 1.181 0.0660 1.366 
Dclre1a DNA cross-link repair 1A, PSO2 
homolog (S. cerevisiae) 
0.41104 1.146 0.2912 1.1755 
Ercc1 Excision repair cross-
complementing rodent repair 
deficiency, complementation group 
1 
0.15043 1.3597 0.0106* 1.5547 
Ercc2 Excision repair cross-
complementing rodent repair 
deficiency, complementation group 
2 
0.04087* 1.3692 0.0182* 1.4473 
Exo1 Exonuclease 1 0.06262 1.5655 0.0041* 1.5948 
Fancc Fanconi anemia, complementation 
group C 
0.02896* 1.5122 0.1126 1.3597 
Fen1 Flap structure-specific 
endonuclease 1 
0.03295* 1.4406 0.0101* 1.5476 
Gadd45
a 
Growth arrest and DNA-damage-
inducible, alpha 
0.85695 0.9817 0.0046* 1.6208 
Gtf2h1 General transcription factor IIH, 
polypeptide 1 
0.21852 1.1045 0.0168* 1.4573 
Gtf2h2 General transcription factor IIH, 
polypeptide 2 
0.74862 1.0718 0.0111* 1.2775 
Dpagt1 Dolichyl-phosphate (UDP-N-
acetylglucosamine) N-
acetylglucosaminephosphotransfera
se 1 (GlcNAc-1-P transferase) 
0.01606* 1.1865 0.0060* 1.3787 
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Lig1 Ligase I, DNA, ATP-dependent 0.15786 1.2226 0.7779 1.057 
Chaf1a Chromatin assembly factor 1, 
subunit A (p150) 
0.03212* 1.3535 0.0076* 1.5404 
Hus1 HUS1 checkpoint homolog (S. 
pombe) 
0.19902 1.2002 0.09249 1.3787 
Mbd4 Methyl-CpG binding domain 
protein 4 
0.04030* 1.4208 0.0104* 2.1835 
Rad21 RAD21 homolog (S. pombe) 0.00895* 1.2198 0.0393* 1.4208 
Pms1 Postmeiotic segregation increased 1 
(S. cerevisiae) 
0.06768 1.3013 0.03872
* 
1.4777 
Mgmt O-6-methylguanine-DNA 
methyltransferase 
0.73435 1.0521 0.0001* 1.7211 
Mif Macrophage migration inhibitory 
factor 
0.25284 0.8274 0.14554 1.3195 
Mlh1 MutL homolog 1 (E. coli) 0.05096 1.2746 0.0181* 1.6021 
Mlh3 MutL homolog 3 (E. coli) 0.05103 1.4208 0.05448 1.5837 
Mpg N-methylpurine-DNA glycosylase 0.13995 1.217 0.0122* 
 
1.6358 
Mre11a MRE11 meiotic recombination 11 
homolog A (S. cerevisiae) 
0.34343 1.2716 0.0283* 1.8575 
Msh2 MutS homolog 2 (E. coli) 0.09615 1.2628 0.0229* 1.6096 
Msh3 MutS homolog 3 (E. coli) 0.08763 1.2226 0.0417* 
 
1.3472 
Mutyh MutY homolog (E. coli) 0.34069 1.3692 0.14815 1.4175 
Nthl1 Nth (endonuclease III)-like 1 
(E.coli) 
0.18809 1.257 0.0062* 1.5511 
Ogg1 8-oxoguanine DNA glycosylase 0.02582* 1.4142 0.0248* 1.4845 
Parp1 Poly (ADP-ribose) polymerase 1 0.20627 1.3379 0.05528 1.5122 
Parp2 Poly (ADP-ribose) polymerase 2 0.04500* 1.1865 0.05191
2 
1.3787 
Pms2 PMS2 postmeiotic segregation 
increased 2 (S. cerevisiae) 
0.00347* 1.1567 0.0233* 1.3472 
Pold1 Polymerase (DNA directed), delta 1, 
catalytic subunit 
0.11101 1.3104 0.0103* 6.105 
Pold3 Polymerase (DNA-directed), delta 
3, accessory subunit 
0.01445* 1.4914 0.0030* 1.5263 
Pole Polymerase (DNA directed), epsilon 0.55295 1.1837 0.0033* 1.6548 
Polh Polymerase (DNA directed), eta 0.02421* 1.4983 0.0303* 1.5728 
Poli Polymerase (DNA directed), iota 0.12635 1.2894 0.08498 1.5192 
Polk Polymerase (DNA directed) kappa 0.19843 1.2775 0.0073* 1.488 
Prkdc Protein kinase, DNA activated, 
catalytic polypeptide 
0.95179 1.0353 0.0053* 7.1107 
Pttg1 Pituitary tumor-transforming 1 0.02972* 1.3472 0.0442* 1.3883 
Rad1 RAD1 homolog (S. pombe) 0.26669 1.181 0.0012* 1.5369 
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Rad17 RAD17 homolog (S. pombe) 0.05992 1.2368 0.0408* 1.4077 
Rad18 RAD18 homolog (S. cerevisiae) 0.12268 1.2255 0.0385* 1.5837 
Rad23a RAD23 homolog A (S. cerevisiae) 0.09550 1.1567 0.0335* 1.3787 
Rad50 RAD50 homolog (S. cerevisiae) 0.15092 1.2086 0.0490* 1.4473 
Rad51 RAD51 homolog (RecA homolog, E. 
coli) (S. cerevisiae) 
0.08390 1.3195 0.0110* 1.4845 
Rad52 RAD52 homolog (S. cerevisiae) 0.11396 1.154 0.0456* 1.3883 
Rad9 RAD9 homolog (S. pombe) 0.01215* 1.4607 0.0466* 1.5583 
Rad9b RAD9 homolog B (S. cerevisiae) 0.15996 1.3947 0.0205* 1.4914 
Rev1 REV1 homolog (S. cerevisiae) 0.53550 1.1199 0.0099* 1.4241 
Nprl3 Alpha globin regulatory element 
containing gene 
0.02877* 1.2983 0.0305* 1.4641 
Rad51c Rad51 homolog c (S. cerevisiae) 0.15883 1.3195 0.0068* 1.617 
Xrcc2 X-ray repair complementing 
defective repair in Chinese hamster 
cells 2 
0.09004 1.3104 0.0034* 1.7053 
Pinx1 PIN2-interacting protein 1 0.26553 1.192 0.0126* 1.5018 
Slk STE20-like kinase (yeast) 0.70397 1.0425 0.17886 1.2226 
Smc1a Structural maintenance of 
chromosomes 1A 
0.63926 1.0425 0.0252* 1.4607 
Srd5a2 Steroid-5-alpha-reductase, alpha 
polypeptide 2 (3-oxo-5 alpha-
steroid delta 4-dehydrogenase 
alpha 2) 
0.52358 1.1514 0.09168 1.3134 
Sumo1 SMT3 suppressor of mif two 3 
homolog 1 (S. cerevisiae) 
0.35245 1.1121 0.0050* 1.2086 
Tdg Thymine-DNA glycosylase 0.78744 1.1147 0.2019 1.2255 
Terf1 Telomeric repeat binding factor 
(NIMA-interacting) 1 
0.04974* 1.2687 0.0213* 1.5948 
Tlk1 Tousled-like kinase 1 0.27795 1.1408 0.0180* 1.366 
Tnp1 Transition protein 1 0.79632 1.007 0.12811 1.2599 
Tp53 Tumor protein p53 0.22940 1.2086 0.06828 1.2805 
Trex1 Three prime repair exonuclease 1 0.47550 1.1783 0.0178* 1.3566 
Trpc2 Transient receptor potential cation 
channel, subfamily C, member 2 
0.04194* 2.2191 0.08049 1.0918 
Ube2a Ubiquitin-conjugating enzyme E2A 
(RAD6 homolog) 
0.29102 1.1329 0.05792 1.4044 
Ung Uracil-DNA glycosylase 0.09478 1.3195 0.10260 1.3226 
Wrn Werner syndrome 0.61768 1.1045 0.0207* 1.4473 
Wrnip1 Werner helicase interacting protein 
1 
0.26350 1.2002 0.0125* 1.4241 
Xpa Xeroderma pigmentosum, 
complementation group A 
0.96494 0.9931 0.0202* 1.5263 
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Xpc Xeroderma pigmentosum, 
complementation group C 
0.04025* 1.3287 0.06878 1.3503 
Xrcc1 X-ray repair complementing 
defective repair in Chinese hamster 
cells 1 
0.01184* 1.2983 0.09160 1.4373 
Xrcc6 X-ray repair complementing 
defective repair in Chinese hamster 
cells 6 
0.18119 1.1975 0.0502 1.4641 
Xrn2 5'-3' exoribonuclease 2 0.07416 1.2058 0.0247* 1.434 
Rplp1 Ribosomal protein, large, P1 0.77047 0.9885 0.0228* 1.3629 
Hprt1 Hypoxanthine 
phosphoribosyltransferase 1 
0.80194 1.0234 0.0042* 1.6548 
Rpl13a Ribosomal protein L13A 0.99093 1.007 0.0001* 1.5619 
Ldha Lactate dehydrogenase A 0.61892 0.9033 0.15947 1.2283 
Actb Actin, beta 0 1 0 1 
 
Fisher 344 rat ovaries were cultured for 2 or 4 d in media containing vehicle control ± 30 µM 
PM. RNA was isolated and used to perform a RT
2 
Profiler PCR array. Values represent fold-
change ± SEM relative to a control value of 1 (10 ovaries per pool), normalized to Actb. * = 
different from control, P < 0.05. 
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Table 2. Effect of DMBA on glucose metabolism gene expressions 
Gene Symbol Gene Description p-value 
Fold 
change 
Acly ATP citrate lyase 0.059539 0.4796 
Aco1 Aconitase 1, soluble 0.172505 0.0195 
Aco2 Aconitase 2, mitochondrial 0.0831 0.6598 
Agl 
Amylo-1,6-glucosidase, 4-alpha-
glucanotransferase 0.119533 0.3384 
Aldoa Aldolase A, fructose-bisphosphate 0.137154 1.4273 
Aldob Aldolase B, fructose-bisphosphate 0.009347* 0.0166 
Aldoc Aldolase C, fructose-bisphosphate 0.13543 1.7053 
Bpgm 2,3-bisphosphoglycerate mutase 0.022937* 0.0902 
Cs Citrate synthase 0.06818 0.5797 
Dlat Dihydrolipoamide S-acetyltransferase 0.06307 0.4244 
Dld Dihydrolipoamide dehydrogenase 0.003478* 0.4644 
Dlst 
Dihydrolipoamide S-succinyltransferase (E2 
component of 2-oxo-glutarate complex) 0.000406* 0.3789 
Eno1 Enolase 1, (alpha) 0.583778 1.1173 
Eno2 Enolase 2, gamma, neuronal 0.028012* 4.9019 
Eno3 Enolase 3, beta, muscle 0.114727 0.4719 
Fbp1 Fructose-1,6-bisphosphatase 1 0.010157* 0.0412 
Fbp2 Fructose-1,6-bisphosphatase 2 0.044123* 0.0974 
Fh1 Fumarate hydratase 1 0.205522 0.699 
G6pc Glucose-6-phosphatase, catalytic subunit 0.08263 0.0264 
G6pc3 Glucose 6 phosphatase, catalytic, 3 0.061658 0.6659 
G6pd Glucose-6-phosphate dehydrogenase 0.119924 0.4024 
Galm Galactose mutarotase (aldose 1-epimerase) 0.012822* 2.6574 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase 0.791855 1.234 
Gapdhs 
Glyceraldehyde-3-phosphate dehydrogenase, 
spermatogenic 0.024797* 0.0253 
Gck Glucokinase 0.032611* 0.0028 
Gpi Glucose phosphate isomerase 0.062838 0.6184 
Gsk3a Glycogen synthase kinase 3 alpha 0.00258* 0.3544 
Gsk3b Glycogen synthase kinase 3 beta 0.089571 0.3172 
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Gys1 Glycogen synthase 1, muscle 0.120951 0.5891 
Gys2 Glycogen synthase 2 0.009321* 0.0188 
H6pd 
Hexose-6-phosphate dehydrogenase (glucose 1-
dehydrogenase) 0.37931 0.7526 
Hk2 Hexokinase 2 0.659947 0.9439 
Hk3 Hexokinase 3 (white cell) 0.185189 0.1224 
Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble 0.087755 0.1952 
Idh2 
Isocitrate dehydrogenase 2 (NADP+), 
mitochondrial 0.027945* 2.042 
Idh3a Isocitrate dehydrogenase 3 (NAD+) alpha 0.002732* 0.2872 
Idh3b Isocitrate dehydrogenase 3 (NAD+) beta 0.094541 0.5704 
Idh3g Isocitrate dehydrogenase 3 (NAD), gamma 0.025842* 0.2007 
Mdh1 Malate dehydrogenase 1, NAD (soluble) 0.937962 0.9749 
Mdh1b Malate dehydrogenase 1B, NAD (soluble) 0.008958* 0.0069 
Mdh2 Malate dehydrogenase 2, NAD (mitochondrial) 0.022588* 0.3043 
Ogdhl Oxoglutarate dehydrogenase-like 0.013365* 0.0793 
Pc Pyruvate carboxylase 0.022245* 0.1025 
Pck1 Phosphoenolpyruvate carboxykinase 1 (soluble) 0.015369* 0.0473 
Pck2 
Phosphoenolpyruvate carboxykinase 2 
(mitochondrial) 0.005678* 2.9554 
Pdha2 Pyruvate dehydrogenase (lipoamide) alpha 2 0.006835* 0.0815 
Pdhb Pyruvate dehydrogenase (lipoamide) beta 0.042756* 0.6029 
Pdhx Pyruvate dehydrogenase complex, component X 0.117506 0.4444 
Pdk1 Pyruvate dehydrogenase kinase, isozyme 1 0.450835 0.7596 
Pdk2 Pyruvate dehydrogenase kinase, isozyme 2 0.007252* 0.2026 
Pdk3 Pyruvate dehydrogenase kinase, isozyme 3 0.00045* 0.133 
Pdk4 Pyruvate dehydrogenase kinase, isozyme 4 0.122115 0.0594 
Pdp2 
Pyruvate dehyrogenase phosphatase catalytic 
subunit 2 0.995101 1.0892 
Pdpr 
Pyruvate dehydrogenase phosphatase regulatory 
subunit 0.130104 0.6846 
Pfkl Phosphofructokinase, liver 0.012867* 2.9897 
Pgam2 Phosphoglycerate mutase 2 (muscle) 0.227058 0.1166 
Pgk1 Phosphoglycerate kinase 1 0.492236 0.8217 
Pgk2 Phosphoglycerate kinase 2 0.00887* 0.0039 
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Pgls 6-phosphogluconolactonase 0.045247* 0.278 
Pgm1 Phosphoglucomutase 1 0.045707* 0.5471 
Pgm2 Phosphoglucomutase 2 0.144318 1.632 
Pgm3 Phosphoglucomutase 3 0.075212 0.5905 
Phka1 Phosphorylase kinase, alpha 1 0.043812* 0.3455 
Phkb Phosphorylase kinase, beta 0.0117* 0.0825 
Phkg1 Phosphorylase kinase, gamma 1 0.017841* 0.198 
Phkg2 Phosphorylase kinase, gamma 2 (testis) 0.076106 0.2161 
Pklr Pyruvate kinase, liver and RBC 0.112241 0.0116 
Prps1 Phosphoribosyl pyrophosphate synthetase 1 0.019196* 0.155 
Prps1l1 
Phosphoribosyl pyrophosphate synthetase 1-like 
1 0.00887* 0.0039 
Pygl Phosphorylase, glycogen, liver 0.057756 1.6283 
Pygm Phosphorylase, glycogen, muscle 0.000253* 0.0661 
Rbks Ribokinase 0.042784* 0.3238 
Rpia Ribose 5-phosphate isomerase A 0.006329* 0.3368 
Sdha 
Succinate dehydrogenase complex, subunit A, 
flavoprotein (Fp) 0.0064978 0.2643 
Sdhb 
Succinate dehydrogenase complex, subunit B, 
iron sulfur (Ip) 0.020822* 0.2012 
Sdhc 
Succinate dehydrogenase complex, subunit C, 
integral membrane protein 0.000074* 0.3376 
Sdhd 
Succinate dehydrogenase complex, subunit D, 
integral membrane protein 0.001051* 0.2865 
Sucla2 
Succinate-CoA ligase, ADP-forming, beta 
subunit 0.072076 0.3754 
Suclg1 Succinate-CoA ligase, alpha subunit 0.02412* 0.3291 
Suclg2 
Succinate-CoA ligase, GDP-forming, beta 
subunit 0.298696 0.5297 
Taldo1 Transaldolase 1 0.0301788 0.4977 
Tkt Transketolase 0.040248* 2.271 
Tpi1 Triosephosphate isomerase 1 0.098654 1.7695 
Ugp2 UDP-glucose pyrophosphorylase 2 0.130739 0.6567 
Actb Actin, beta 0 1 
B2m Beta-2 microglobulin 0.017519* 2.2501 
Hprt1 Hypoxanthine phosphoribosyltransferase 1 0.067392 0.6099 
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Ldha Lactate dehydrogenase A 0.011131* 2.9622 
Rplp1 Ribosomal protein, large, P1 0.029232* 0.3291 
 
Following 4 d of culture, RNA was isolated from PND4 rat ovaries exposed to control (CT), 
12.5 nM DMBA. RNA was isolated and used to perform a RT
2 
Profiler PCR array. Values 
represent fold-change ± SEM relative to a control value of 1 (10 ovaries per pool), 
normalized to Actb. * = different from control, P < 0.05. 
 
 
 
